
<html lang="en"     class="pb-page"  data-request-id="67d3b70d-a0fa-4af3-b9ed-6921ebec5f3c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b00300;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-10;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)" /></meta><meta name="dc.Creator" content="Christopher L.  Shaffer" /></meta><meta name="dc.Creator" content="Nandini C.  Patel" /></meta><meta name="dc.Creator" content="Jacob  Schwarz" /></meta><meta name="dc.Creator" content="Renato J.  Scialis" /></meta><meta name="dc.Creator" content="Yunjing  Wei" /></meta><meta name="dc.Creator" content="Xinjun J.  Hou" /></meta><meta name="dc.Creator" content="Longfei  Xie" /></meta><meta name="dc.Creator" content="Kapil  Karki" /></meta><meta name="dc.Creator" content="Dianne K.  Bryce" /></meta><meta name="dc.Creator" content="Sarah M.  Osgood" /></meta><meta name="dc.Creator" content="William E.  Hoffmann" /></meta><meta name="dc.Creator" content="John T.  Lazzaro" /></meta><meta name="dc.Creator" content="Cheng  Chang" /></meta><meta name="dc.Creator" content="Dina F.  McGinnis" /></meta><meta name="dc.Creator" content="Susan M.  Lotarski" /></meta><meta name="dc.Creator" content="JianHua  Liu" /></meta><meta name="dc.Creator" content="R. Scott  Obach" /></meta><meta name="dc.Creator" content="Mark L.  Weber" /></meta><meta name="dc.Creator" content="Laigao  Chen" /></meta><meta name="dc.Creator" content="Kenneth R.  Zasadny" /></meta><meta name="dc.Creator" content="Patricia A.  Seymour" /></meta><meta name="dc.Creator" content="Christopher J.  Schmidt" /></meta><meta name="dc.Creator" content="Mihály  Hajós" /></meta><meta name="dc.Creator" content="Raymond S.  Hurst" /></meta><meta name="dc.Creator" content="Jayvardhan  Pandit" /></meta><meta name="dc.Creator" content="Christopher J.  O’Donnell" /></meta><meta name="dc.Description" content="A unique tetrahydrofuran ether class of highly potent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiators has been identified using rational and structure-based drug design. ..." /></meta><meta name="Description" content="A unique tetrahydrofuran ether class of highly potent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiators has been identified using rational and structure-based drug design. ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 14, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b00300" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00300" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b00300" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b00300" /></link>
        
    
    

<title>The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b00300" /></meta><meta property="og:title" content="The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0016.jpeg" /></meta><meta property="og:description" content="A unique tetrahydrofuran ether class of highly potent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiators has been identified using rational and structure-based drug design. An acyclic lead compound, containing an ether-linked isopropylsulfonamide and biphenyl group, was pharmacologically augmented by converting it to a conformationally constrained tetrahydrofuran to improve key interactions with the human GluA2 ligand-binding domain. Subsequent replacement of the distal phenyl motif with 2-cyanothiophene to enhance its potency, selectivity, and metabolic stability afforded N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242, 3), whose preclinical characterization suggests an adequate therapeutic index, aided by low projected human oral pharmacokinetic variability, for clinical studies exploring its ability to attenuate cognitive deficits in patients with schizophrenia." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b00300"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00300">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b00300&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b00300&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b00300&amp;href=/doi/10.1021/acs.jmedchem.5b00300" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4291-4308</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b00257" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b00308" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator <i>N</i>-{(3<i>S</i>,4<i>S</i>)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+L.++Shaffer">Christopher L. Shaffer</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nandini+C.++Patel">Nandini C. Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacob++Schwarz">Jacob Schwarz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Renato+J.++Scialis">Renato J. Scialis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunjing++Wei">Yunjing Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun+J.++Hou">Xinjun J. Hou</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Longfei++Xie">Longfei Xie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kapil++Karki">Kapil Karki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dianne+K.++Bryce">Dianne K. Bryce</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+M.++Osgood">Sarah M. Osgood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+E.++Hoffmann">William E. Hoffmann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+T.++Lazzaro">John T. Lazzaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng++Chang">Cheng Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dina+F.++McGinnis">Dina F. McGinnis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+M.++Lotarski">Susan M. Lotarski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=JianHua++Liu">JianHua Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=R.+Scott++Obach">R. Scott Obach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+L.++Weber">Mark L. Weber</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laigao++Chen">Laigao Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>||</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kenneth+R.++Zasadny">Kenneth R. Zasadny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>||</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patricia+A.++Seymour">Patricia A. Seymour</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schmidt">Christopher J. Schmidt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mih%C3%A1ly++Haj%C3%B3s">Mihály Hajós</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raymond+S.++Hurst">Raymond S. Hurst</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jayvardhan++Pandit">Jayvardhan Pandit</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++O%E2%80%99Donnell">Christopher J. O’Donnell</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Pharmacokinetics, Dynamics and Metabolism, <sup>‡</sup>Neuroscience Research Unit, <sup>§</sup>Worldwide Medicinal Chemistry and <sup>||</sup>BioImaging Center, Worldwide Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>For C.L.S.: phone, +1 617.395.0769; E-mail, <a href="/cdn-cgi/l/email-protection#9ad9f2e8f3e9eef5eaf2ffe8b4d6b4c9f2fbfcfcffe8daeafcf3e0ffe8b4f9f5f7"><span class="__cf_email__" data-cfemail="6b28031902181f041b030e1945274538030a0d0d0e192b1b0d02110e1945080406">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For C.J.O.: phone, +1 860.715.4118; E-mail, <a href="/cdn-cgi/l/email-protection#aeedc6dcc7dddac1dec6cbdc80e480e1eac1c0c0cbc2c2eedec8c7d4cbdc80cdc1c3"><span class="__cf_email__" data-cfemail="a8ebc0dac1dbdcc7d8c0cdda86e286e7ecc7c6c6cdc4c4e8d8cec1d2cdda86cbc7c5">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00300&amp;href=/doi/10.1021%2Facs.jmedchem.5b00300" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4291–4308</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 23, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 February 2015</li><li><span class="item_label"><b>Published</b> online</span>14 May 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 May 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00300</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4291%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BL.%2BShaffer%252C%2BNandini%2BC.%2BPatel%252C%2BJacob%2BSchwarz%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D10%26contentID%3Dacs.jmedchem.5b00300%26title%3DThe%2BDiscovery%2Band%2BCharacterization%2Bof%2Bthe%2B%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2BAcid%2B%2528AMPA%2529%2BReceptor%2BPotentiator%2BN-%257B%25283S%252C4S%2529-4-%255B4-%25285-Cyano-2-thienyl%2529phenoxy%255Dtetrahydrofuran-3-yl%257Dpropane-2-sulfonamide%2B%2528PF-04958242%2529%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4308%26publicationDate%3DMay%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b00300"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2539</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">17</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b00300" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery and Characterization of the α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Potentiator N-{(3S,4S)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;L. Shaffer&quot;},{&quot;first_name&quot;:&quot;Nandini&quot;,&quot;last_name&quot;:&quot;C. Patel&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;Schwarz&quot;},{&quot;first_name&quot;:&quot;Renato&quot;,&quot;last_name&quot;:&quot;J. Scialis&quot;},{&quot;first_name&quot;:&quot;Yunjing&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;J. Hou&quot;},{&quot;first_name&quot;:&quot;Longfei&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Kapil&quot;,&quot;last_name&quot;:&quot;Karki&quot;},{&quot;first_name&quot;:&quot;Dianne&quot;,&quot;last_name&quot;:&quot;K. Bryce&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;M. Osgood&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;E. Hoffmann&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;T. Lazzaro&quot;},{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Dina&quot;,&quot;last_name&quot;:&quot;F. McGinnis&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;M. Lotarski&quot;},{&quot;first_name&quot;:&quot;JianHua&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;R.&quot;,&quot;last_name&quot;:&quot;Scott Obach&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;L. Weber&quot;},{&quot;first_name&quot;:&quot;Laigao&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Kenneth&quot;,&quot;last_name&quot;:&quot;R. Zasadny&quot;},{&quot;first_name&quot;:&quot;Patricia&quot;,&quot;last_name&quot;:&quot;A. Seymour&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;Mihály&quot;,&quot;last_name&quot;:&quot;Hajós&quot;},{&quot;first_name&quot;:&quot;Raymond&quot;,&quot;last_name&quot;:&quot;S. Hurst&quot;},{&quot;first_name&quot;:&quot;Jayvardhan&quot;,&quot;last_name&quot;:&quot;Pandit&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. O’Donnell&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;4291-4308&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b00300&quot;},&quot;abstract&quot;:&quot;A unique tetrahydrofuran ether class of highly potent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiators has been identified using rational and structure-based drug design. An acyclic lead compound, containing an ether-linked isopropylsulfonamide and biphenyl group, was pharmacologically augmented by converting it to a conformationally constrained tetrahydrofuran to improve key interactions with the human GluA2 ligand-binding domain. Subsequent replacement of the distal phenyl motif with 2-cyanothiophene to enhance its potency, selectivity, and metabolic stability afforded N-{(3S,4S)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242, 3), whose preclinical characterization suggests an adequate therapeutic index, aided by low projected human oral pharmacokinetic variability, for clinical studies exploring its ability to attenuate cognitive deficits in patients with schizophrenia.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00300&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00300" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00300&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00300" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b00300&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00300" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b00300&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b00300&amp;href=/doi/10.1021/acs.jmedchem.5b00300" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b00300" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b00300" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b00300%26sid%3Dliteratum%253Aachs%26pmid%3D25905800%26genre%3Darticle%26aulast%3DShaffer%26date%3D2015%26atitle%3DThe%2BDiscovery%2Band%2BCharacterization%2Bof%2Bthe%2B%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2BAcid%2B%2528AMPA%2529%2BReceptor%2BPotentiator%2BN-%257B%25283S%252C4S%2529-4-%255B4-%25285-Cyano-2-thienyl%2529phenoxy%255Dtetrahydrofuran-3-yl%257Dpropane-2-sulfonamide%2B%2528PF-04958242%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D10%26spage%3D4291%26epage%3D4308%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291411" title="Pharmacokinetics">Pharmacokinetics</a>,</li><li><a href="/action/doSearch?ConceptID=290716" title="Sulfones">Sulfones</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/jmcmar.2015.58.issue-10/20150528/jmcmar.2015.58.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A unique tetrahydrofuran ether class of highly potent α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor potentiators has been identified using rational and structure-based drug design. An acyclic lead compound, containing an ether-linked isopropylsulfonamide and biphenyl group, was pharmacologically augmented by converting it to a conformationally constrained tetrahydrofuran to improve key interactions with the human GluA2 ligand-binding domain. Subsequent replacement of the distal phenyl motif with 2-cyanothiophene to enhance its potency, selectivity, and metabolic stability afforded <i>N</i>-{(3<i>S</i>,4<i>S</i>)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242, <b>3</b>), whose preclinical characterization suggests an adequate therapeutic index, aided by low projected human oral pharmacokinetic variability, for clinical studies exploring its ability to attenuate cognitive deficits in patients with schizophrenia.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors (AMPAR) mediate fast glutamatergic excitatory neurotransmission in the central nervous system, and alterations in their density and subunit composition are involved in dynamically regulating synaptic function.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Specifically, AMPAR opening depolarizes neuronal membranes to relieve the Mg<sup>2+</sup> block of colocalized <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors (NMDAR), which increases NMDAR-mediated Ca<sup>2+</sup> gating<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> that ultimately generates changes in the synaptic morphology and function<a onclick="showRef(event, 'cit1a ref3'); return false;" href="javascript:void(0);" class="ref cit1a ref3">(1a, 3)</a> thought to underlie learning and memory.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> A key mechanism of NMDAR-regulated increases in synaptic activity is AMPAR insertion into the synapse.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Thus, enhanced AMPAR activation by a positive allosteric modulator (“potentiator”)<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> would be expected to augment NMDAR-induced synaptic potentiation. Accordingly, AMPAR stimulation is an attractive mechanism for treating various neurological and psychiatric diseases,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> particularly certain cognitive impairments in schizophrenia<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> because they are hypothesized to primarily result from dysfunction in NMDAR glutamatergic neurotransmission.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> This theory is supported by clinical studies<a onclick="showRef(event, 'cit9c ref10'); return false;" href="javascript:void(0);" class="ref cit9c ref10">(9c, 10)</a> in which healthy volunteers receiving acute subanesthetic doses of nonselective NMDAR antagonists (e.g., ketamine) present with schizophrenia-like symptoms including memory deficits. AMPAR potentiators have demonstrated procognitive properties in numerous animal models of hippocampal/cortical function and working memory<a onclick="showRef(event, 'cit6a cit7a ref11'); return false;" href="javascript:void(0);" class="ref cit6a cit7a ref11">(6a, 7a, 11)</a> and in small clinical trials.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> However, excessive AMPAR excitation, via orthosteric or allosteric molecular interactions, can cause motor coordination disruptions,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> neurotoxicity,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and/or convulsion.<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13, 15)</a> Because the effects of variations in AMPAR subtypes (GluA1–4), splice forms (flip (i) and flop (o)) and binding partners on an AMPAR potentiator’s therapeutic index (TI) are unknown, it is essential to understand potentiator exposures causing desired versus harmful effects to identify a safe molecule for clinical testing. Thus, unbound brain compound concentration (<i>C</i><sub>b,u</sub>), a high-confidence surrogate of interstitial fluid drug concentrations<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> that determine AMPAR ligand-binding domain (LBD) interactions, was deemed the most appropriate exposure value for defining this mechanism-based TI.</div><div class="NLM_p">On the basis of these concepts, we previously reported our strategy for identifying and profiling the two structurally unique AMPAR potentiators <i>N</i>-{(3<i>R</i>,4<i>S</i>)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2<i>H</i>-pyran-4-yl}propane-2-sulfonamide (PF-4778574, <b>1</b>)<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> and <i>N</i>-((5<i>S</i>)-(3-(3-fluoro-4-(pyrrolidin-1-yl)phenyl)-4,5-dihydroisoxazol-5-yl)methyl)propane-2-sulfonamide (PF-4701475, <b>2</b>)<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). Other AMPAR potentiators of this sulfonamide class, specifically the biarylpropylsulfonamides (<i>R</i>)-3,5-difluoro-<i>N</i>-(4-(1-((1-methylethyl)sulfonamide)propan-2-yl)phenyl)benzamide (LY450108)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and (<i>R</i>)-<i>N</i>-(2-(4′-(2-(methylsulfonamido)ethyl)-[1,1′-biphenyl]-4-yl)propyl)propane-2-sulfonamide (LY451395, mibampator)<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> and the amino indane sulfonamide <i>N</i>-[(2<i>S</i>)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide (GSK729327),<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> have demonstrated excellent safety and tolerability in humans. Compounds <b>1</b> and <b>2</b>, and those within their respective chemical series, were characterized in select in vitro and single-dose in vivo assays assessing AMPAR-dependent activities related to nootropic effects and safety. Because of the aforementioned complex functional heterogeneity of AMPARs and the lack of a clear understanding of the optimal AMPAR-subtype specificity profile for TI maximization, potentiator binding affinity and functional potency were determined in rodent brain tissue expected to express a native mixture of AMPAR subunits and their associated proteins to afford composite pharmacological values. Functional activity was further evaluated in recombinant cell lines stably expressing human GluA2i and GluA2o because other AMPAR potentiators bind within these flip/flop domains,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and structure-based drug design (SBDD) using X-ray crystal structures of the LBD of human GluA2o<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> iteratively informed GluA2-based structure–activity relationships (SAR). For memory-related effects (i.e., “efficacy”) in animal models of pharmacologically provoked NMDAR hypofunction, both <b>1</b><a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> and <b>2</b><a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> reversed the [5<i>R</i>,10<i>S</i>]-5-methyl-10,11-dihydro-5<i>H</i>-dibenzo[<i>a</i>,<i>d</i>]cyclohepten-5,10-imine (MK-801)-generated subiculum-medial prefrontal cortex (PFC) dysfunction in rats, and <b>1</b> attenuated ketamine-mediated spatial working memory impairment in nonhuman primates (NHP).<a onclick="showRef(event, 'cit11a'); return false;" href="javascript:void(0);" class="ref cit11a">(11a)</a> Safety studies with <b>1</b> looked for cerebellum-based AMPAR activation (mouse) and motor coordination disruptions (mouse, dog, and NHP), as well as convulsions (mouse, rat, and dog). The resulting <i>C</i><sub>b,u</sub>-normalized exposure-response continuum for <b>1</b> showed adequate separation between <i>C</i><sub>b,u</sub> linked to efficacy and adverse events (AE). Critically, this work with <b>1</b> demonstrated an excellent correlation across species of <i>C</i><sub>b,u</sub> required for procognitive characteristics and specific AE, suggesting a common and translatable exposure–response relationship in rodents and higher-order species. Progressively higher <i>C</i><sub>b,u</sub> led sequentially from efficacy to cerebellar 3′,5′-cyclic guanosine monophosphate (cGMP) elevation to motor coordination disruptions to convulsion. These initial studies also underscored the need for a potentiator with low human pharmacokinetic variability to ensure highly predictable maximal plasma drug concentrations (<i>C</i><sub>max</sub>) due to the clinical dose-capping nature of these threshold-mediated AE.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Appropriately, this strategy, and the interspecies relationships it established for four chemically distinct AMPAR potentiators,<a onclick="showRef(event, 'ref13 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref13 ref21 ref22">(13, 21, 22)</a> aided in the identification of the current clinical candidate <i>N</i>-{(3<i>S</i>,4<i>S</i>)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242, <b>3</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which is described herein.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative compounds of the tetrahydropyran (<b>1</b>), dihydroisoxazole (<b>2</b> and <b>4</b>), tetrahydrofuran ether (<b>3</b>), and biarylpropylsulfonamide (<b>5</b>) structural classes of AMPAR potentiators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41306" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41306" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Discovery of the Novel Tetrahydrofuran Ether Series of AMPAR Potentiators</h3><div class="NLM_p">As described previously,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> an internally developed fluorometric imaging plate reader (FLIPR)-based functional assay utilizing mouse embryonic stem (mES) cell-derived neuronal precursors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> enabled a high throughput screen (HTS) of our corporate compound file that identified two lead chemotypes.<a onclick="showRef(event, 'cit13b ref23'); return false;" href="javascript:void(0);" class="ref cit13b ref23">(13b, 23)</a> Subsequent SBDD using X-ray crystal structures of the human GluA2o LBD led to the discovery of <i>N</i>-((<i>S</i>)-1-(3,5-[<sup>3</sup>H]-2-fluoro-4-((<i>S</i>)-5-((1-methylethylsulfonamido)methyl)-4,5-dihydroisoxazol-3-yl)phenyl)pyrrolidin-3-yl)acetamide ([<sup>3</sup>H]PF-04725379, <b>4</b>), a proprietary radioligand, and other active compounds in its dihydroisoxazole series including prototype <b>2</b>, which was used to evaluate AMPAR-mediated pharmacology in vivo.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> Simultaneously during the HTS, we explored and expanded upon the SAR of the published biarylpropylsulfonamide AMPAR potentiator (<i>R</i>)-<i>N</i>-[2-(4′-cyano[1,1′-biphenyl]-4-yl)propyl]propane-2-sulfonamide (LY451646, <b>5</b>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> In this report, we describe our medicinal chemistry strategy to ascertain a unique series of AMPAR potentiators with improved efficacy, selectivity, and metabolic stability compared to <b>5</b>. This approach was guided by the X-ray structure of <b>5</b> bound to the GluA2o LBD and applied known conformational preferences to generate a new lead series of AMPAR potentiators. Additionally, we describe considerations of the physicochemical properties to impart desired absorption, distribution, metabolism, and excretion (ADME) characteristics into newly generated molecules. As a result, we identified the novel potentiator <b>3</b>, whose complete primary pharmacology and interspecies ADME profiles are revealed.</div><div class="NLM_p">Prior to achieving an X-ray crystal structure of <b>5</b> bound to the human GluA2o LBD, a number of design hypotheses (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) were explored: investigation of different vectors around the central aromatic ring (e.g., <i>meta</i>-substitution and heteroaryl replacement), linker modulation (e.g., chain length alteration and heteroatom incorporation), sulfonamide variations/replacements, and a variety of ring-building strategies to restrict the conformational flexibility of the ethylene chain. Synthetic tractability was a key component of the chemistry strategy, often taking advantage of library-enabled routes to rapidly expand our SAR knowledge. In all cases, the physicochemical properties of virtual molecules were carefully considered so that only compounds having desirable properties<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> of oral CNS drugs were prepared. To facilitate the optimization of matter from hit-to-lead through lead development, various libraries were designed and screened (32 μM) in our mES cell-derived functional assay. For the original design hypotheses, neither vector modification (e.g., <i>meta</i>-substitution) nor heteroaliphatic ring (e.g., piperidine) replacement of the central aromatic ring afforded compounds with EC<sub>50</sub> <32 μM. Extending the length of the two-carbon linker between the central aromatic ring and sulfonamide was also an ineffective strategy. However, linker modulations, specifically the incorporation of an ether moiety, proved advantageous. As with the all-carbon-linker analogues, <i>para</i>-substitution on the central aromatic ring was favored over <i>meta</i>-substitution (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>; <b>6</b> vs <b>8</b> and <b>7</b> vs <b>9</b>). Interestingly, while the 2-cyanophenyl-substituted analogue <b>7</b> was 2-fold less potent than <b>5</b>, it had ca. 60% greater efficacy, suggesting a possible functionally favorable AMPAR interaction for this distal aromatic substituent.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. AMPAR Functional Activity and Select Physicochemical Properties of Carbon Linker Ether Analogues <b>6</b>–<b>9</b><a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup>Table a</sup><p class="last">Functional potency (EC<sub>50</sub>; geometric mean, <i>N</i> ≥ 3) in mES cell-derived neurons as assessed by measuring effects induced by <i>S</i>-AMPA (100 μM) alone and following potentiator (up to 32 μM) pretreatment using fluorometric imaging plate reading (FLIPR).</p></div><div class="footnote" id="t1fn3"><sup>Table b</sup><p class="last">Functional efficacy (<i>E</i><sub>max</sub>; arithmetic mean, <i>N</i> ≥ 3) in the aforementioned mES cell-derived neurons assay relative to the average response to <i>S</i>-AMPA (100 μM) in the presence of cyclothiazide (32 μM), which was defined as 100%.</p></div><div class="footnote" id="t1fn1"><sup>Table c</sup><p class="last">NA, not applicable.</p></div></div><div></div></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Visualization of the design hypotheses explored to discover a unique chemotype from the biarylpropylsulfonamide structural class of AMPAR potentiators (exemplified by <b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray cocrystal structure of <b>5</b> bound to the human GluA2o LBD (Protein Data Bank ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5">4LZ5</a>) revealed informative potentiator–AMPAR contacts.<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> The sulfonamide hydrogen of <b>5</b> forms a backbone hydrogen bond to the carbonyl oxygen of Pro-494, while its biaryl group projects across the dimeric LBD filling the symmetrical binding interface. The model structure of <b>7</b>, the most functionally efficacious carbon linker ether analogue, was docked<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> onto the crystal structure of <b>5</b>. This overlay suggested that the 2-cyano group on the distal aromatic ring of <b>7</b> accessed the symmetrical space to the sulfonamide pocket on the other side of the binding motif (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). The binding model of <b>7</b> shows that the 2-cyano group on the distal aromatic ring is precisely positioned to access the symmetrical binding pocket that is occupied by the sulfonamide group and that the ether group is merely serving as a linker between these two pockets. The acyclic amido-alkoxyethane substructure in <b>7</b> prompted us to consider the use of physical organic principles of conformational preference to preorganize the ligand for binding site complementarity to optimize pharmacological activity.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Particularly, 1,2-dialkoxy- or 1,2-dihaloethanes, similar in nature to <b>7</b>, are known to prefer a conformation favoring the gauche orientation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The gauche orientation of a 1,2-dialkoxyethane is favored by ca. 0.5 kcal/mol, and in this case, it affords an opportunity for an intramolecular hydrogen bond within <b>7</b> between its sulfonamide hydrogen and ether oxygen. Therefore, it was hypothesized that further constraint, via a carbo- or heterocycle, should enhance the conformational preference imparted to the acyclic series by the gauche effect. Using 5- or 6-membered rings anchored on the ethylene linker within <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A), a number of conformationally restricted analogues were designed to afford both <i>trans</i>- and <i>cis</i>-isomers (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). Additional analyses of these virtual compounds by superimposing their structures onto the crystal structure of <b>5</b> indicated the <i>cis</i>-isomers were optimal to match the bioactive conformations. Consistent with prior findings,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> further consideration of the physicochemical properties of these molecules allowed additional refinement and selection of the <i>cis</i>-tetrahydrofuran (THF) ether analogues as the primary series (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B, A = O).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of <b>7</b> (cyan) docked onto the X-ray cocrystal structure of <b>5</b> (magenta) in the symmetrical binding pocket of the human GluA2o LBD. Only one binding pose of symmetric poses for each compound is shown for clarity. The sulfonamide of <b>5</b> forms a hydrogen bond with the backbone carbonyl oxygen of Pro-494; assuming an identical interaction, the sulfonamide of <b>7</b> was overlaid onto that of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Visualization of the heterocycle design hypothesis from <b>7</b>. (A) Newman projection of the structural conformation of the energy-minimized model of <b>7</b> projected to bind to the GluA2o LBD. (B) Design hypotheses based on the ring-construction strategy to constrain the GluA2o LBD-bound conformation of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A five-step synthetic sequence assembled the <i>cis</i>-THF ethers (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Highlights of the synthetic strategy include employing classical resolution to avoid chiral chromatography and late-stage introduction of both the sulfonamide and aromatic substituents to facilitate their efficient diversification for rapid SAR development. Opening of epoxide <b>10</b> by <i>p</i>-bromophenol <b>11</b> in the presence of a base, such as cesium carbonate, in refluxing dioxane installed the aryl ether group. The resulting alcohol was treated with methanesulfonyl chloride and triethylamine to give diastereomeric <b>12</b> (quantitative yield over the two steps). Treatment of <b>12</b> with sodium azide afforded the corresponding azide, which was converted to amine <b>13</b> via the Staudinger reduction. Classical resolution of <b>13</b> with camphorsulfonic acid provided enantiopure <b>14</b> (30–35% yield, >99% ee). Alternatively, treatment of mesylate <b>12</b> with ammonium hydroxide in 2-propanol at 110 °C cleanly afforded racemic <i>cis</i>-amine <b>14</b> in ca. 80% yield. Next, <b>14</b> was reacted with isopropylsulfonyl chloride in the presence of 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) to quantitatively afford sulfonamide <b>15</b>, which underwent Suzuki coupling with either boronic acid or ester <b>16</b> to effectively generate the desired THF-ethers <b>17</b>–<b>28</b>. In instances where standard Suzuki coupling conditions were unsuccessful, specifically with 5-membered heteroaryls, either reverse Suzuki coupling or CH-activation enabled the desired product.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BnNEt<sub>3</sub>Cl, dioxane, reflux, 18 h, quant; (b) MsCl, Et<sub>3</sub>N, DCM, 0 °C to rt, 18 h, quant; (c) NaN<sub>3</sub>, DMF, 110 °C, 66 h, 85%; (d) PPh<sub>3</sub>, THF, 0 °C to rt, 18 h, 78%; (e) (+)-CSA, IPA/H<sub>2</sub>O, 18 h, 30–35%; (f) <i>i</i>PrSO<sub>2</sub>Cl, DBU, DCM, 0 °C to rt, 20 h, quant; (g) boronic acid or boronate ester (<b>16</b>), XPhos, Pd(OAc)<sub>2</sub>, KF, 1:1 MeOH/toluene, 40–75%.</p></p></figure><div class="NLM_p">The impact of this ring-incorporation design strategy was immediately reflected in differing functional activity improvements between THF-ether vs ethyl-ether analogues with constant distal aromatics such as unsubstituted phenyl (<b>17</b> vs <b>6</b>, <i>E</i><sub>max</sub> of 125% vs 32%) or <i>o</i>-cyanophenyl (<b>18</b> vs <b>7</b>, EC<sub>50</sub> of 21.9 vs 7350 nM) analogues (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Enantiopurification of <b>18</b> revealed its functional potency was predominately due to its (3<i>S</i>,4<i>S</i>)-(<b>19</b>) and not its (3<i>R</i>,4<i>R</i>)-enantiomer (<b>20</b>). For all THF-ether analogues for which both isomers were prepared, the (3<i>S</i>,4<i>S</i>)-enantiomer was always most active (data not shown). A model of <b>19</b> bound to the human GluA2o LBD showed that it overlays similarly to <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>) in that the <i>o</i>-cyano is optimally positioned to access a pocket within the binding site that seems to enhance potency. Compound <b>19</b> also had physicochemical properties that translated to high membrane permeability (<i>P</i><sub>app,A→B</sub> = 32.3 × 10<sup>–6</sup> cm/s) and no P-glycoprotein-mediated efflux (MDR1 ER = 1.39), suggesting favorable central penetration in vivo. However, its human liver microsomes-derived intrinsic clearance (HLM <i>CL</i><sub>int</sub>) was unacceptably high (138 mL/min/kg) because a molecule with low human pharmacokinetic variability was desired due to the known clinical dose-capping nature of AMPAR potentiator-mediated AE.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> To improve metabolic stability, we reasoned that the facile metabolism of <b>19</b> was due to hydroxylation of the <i>o</i>-cyanophenyl. Accordingly, functionally equipotent analogues, such as 2-cyano-6-fluoro (<b>21</b>) and 2-cyano-4-fluoro (<b>22</b>), indeed had lower HLM CL<sub>int</sub> than <b>19</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, subsequent modifications that successfully reduced aromatic ring lipophilicity to achieve even lower HLM CL<sub>int</sub> (e.g., <b>23</b>) concomitantly reduced functional potency while increasing the number of hydrogen bond donors, TPSA, and P-glycoprotein liability.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Alternatively, replacing the distal phenyl group with aromatic heterocycles afforded low HLM CL<sub>int</sub>, high permeability, and no P-glycoprotein susceptibility while retaining acceptable functional potency. Such substitution of the distal phenyl group with more polar heteroaromatics (e.g., pyridine (e.g., <b>24</b> and <b>25</b>) or pyrimidine (e.g., <b>26</b>)) also imparted lower clogP, which tends to decrease the likelihood of in vivo toxicity by small molecules.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Several 5- or 6-membered aromatic heterocycles were prepared, such as cyanothiophene <b>3</b>, cyanothiazole <b>27</b>, and dimethylpyrazole <b>28</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Compounds <b>3</b> and <b>27</b> provide a different vector for the cyano group, which potentially occupies a different binding pocket that could impact flip/flop selectivity. It has been speculated<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> that the smaller serine-754-containing side chain within the flip splice variant creates a pocket having a more favorable binding interaction with the requisite cyano moiety that fills it, resulting in a flip-favoring selectivity for such potentiators. An X-ray cocrystal structure of <b>3</b> bound to the human GluA2o LBD (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) revealed the common hydrogen bond between the sulfonamide and Pro-494 and also showed that the cyano group occupied the same space in the vicinity of Asn-754 as the cyano group in <b>5</b>. Of these exemplified compounds, <b>3</b>, whose absolute stereochemistry was unambiguously elucidated as the (3<i>S</i>,4<i>S</i>)-enantiomer via single crystal X-ray analysis (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>), was selected for further profiling because it provided the best overall balance of functional potency and efficacy with desired in vitro ADME properties.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of Tetrahydrofuran Ethers with a Select Aryl or Heteroaryl Distal Aromatic Ring<a class="ref internalNav" href="#t2fn1" aria-label="g">g</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn2"><div class="footnote" id="t2fn2"><sup>Table a</sup><p class="last">Functional potency (EC<sub>50</sub>; geometric mean, <i>N</i> ≥ 3) in mES cell-derived neurons as assessed by measuring effects induced by <i>S</i>-AMPA (100 μM) alone and following potentiator (up to 32 μM) pretreatment using fluorometric imaging plate reading (FLIPR).</p></div><div class="footnote" id="t2fn3"><sup>Table b</sup><p class="last">Functional efficacy (<i>E</i><sub>max</sub>; arithmetic mean, <i>N</i> ≥ 3) in the aforementioned mES cell-derived neurons assay relative to the average response to <i>S</i>-AMPA (100 μM) in the presence of cyclothiazide (32 μM), which was defined as 100%.</p></div><div class="footnote" id="t2fn4"><sup>Table c</sup><p class="last"><i>K</i><sub>i</sub> (geometric mean, <i>N</i> ≥ 3) determined by displacement studies using [<sup>3</sup>H]PF-04725379 in rat cortical tissue.</p></div><div class="footnote" id="t2fn5"><sup>Table d</sup><p class="last">Human liver microsomes-derived intrinsic clearance.</p></div><div class="footnote" id="t2fn6"><sup>Table e</sup><p class="last">RRCK cells, isolated from Madin-Darby canine kidney cells and having low transporter activity, were used to estimate absorptive apparent permeability (<i>P</i><sub>app,A→B</sub>) of a potentiator (1 μM).</p></div><div class="footnote" id="t2fn7"><sup>Table f</sup><p class="last">The ratio of secretory apparent permeability (<i>P</i><sub>app,B→A</sub>) to <i>P</i><sub>app,A→B</sub> of a potentiator (1 μM) across contiguous monolayers from human multidrug resistance protein-1-transfected MDCK cells (MDR1-MDCK).</p></div><div class="footnote" id="t2fn1"><sup>Table g</sup><p class="last">ND, not determined.</p></div></div><div></div></div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray cocrystal structure of <b>3</b> in the symmetrical binding pocket of the human GluA2o LBD; only one binding pose is shown for clarity. The sulfonamide of <b>3</b> interacts with Pro-494 when its 2-cyano moiety accesses a flip isoform-selective pocket. The flip vs flop GluA2 isoforms are differentiated by a Ser vs Asn, respectively, at amino acid 754.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Characterization and Preclinical Profile of <b>3</b></h3><div class="NLM_p">Potentiator <b>3</b> was carefully profiled in a series of single-dose rodent assays to determine its neuropharmacokinetics and mechanism-mediated exposure–response continuum using the previously described interspecies knowledge for select AMPAR potentiators.<a onclick="showRef(event, 'cit13a ref21 ref22'); return false;" href="javascript:void(0);" class="ref cit13a ref21 ref22">(13a, 21, 22)</a> Observed animal effects were most likely solely AMPAR-dependent because <b>3</b> (10 μM) only inhibited three receptors/transporters and one enzyme within a broad human-based receptor/enzyme selectivity panel (Cerep, 118 targets), with the serotonin transporter (<i>K</i><sub>i</sub> of 530 nM) having the most potent interaction. For each animal dose, <i>C</i><sub>b,u</sub> was calculated to define a <i>C</i><sub>b,u</sub>-normalized AMPAR-dependent exposure–response continuum for <b>3</b> to understand separations between <i>C</i><sub>b,u</sub> enhancing cognition and disturbing motor coordination, as well as in vitro–in vivo pharmacological correlations. Additionally, animal and human ADME data were generated and used to project human pharmacokinetic parameters, an efficacious dose and the expected <i>C</i><sub>max</sub> variability at this dose. Collectively, these data sets afforded an acute TI that supported the progression of <b>3</b> into chronic toxicology studies.</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> In Vitro Pharmacology</h4><div class="NLM_p">The in vitro pharmacological characterization of <b>3</b> used a primary strategy of quantifying its properties in rodent tissues expected to express native populations of AMPARs and their associated proteins; a good correlation was found for AMPAR potentiator functional potencies in mouse and human ES cell-derived neurons suggesting interspecies consistency.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Using the proprietary radioligand [<sup>3</sup>H]<b>4</b>,<a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a><b>3</b> had a mean <i>K</i><sub>i</sub> of 170 nM in a rat cortical homogenate. Functionally, <b>3</b> showed a glutamate-dependent AMPAR positive allosteric modulation of <i>S</i>-AMPA-evoked current in rat primary cortical neurons (EC<sub>50</sub> of 43 ± 10 nM, ca. 5-fold increase of the maximal <i>S</i>-AMPA-induced current; <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and <i>S</i>-AMPA-mediated Ca<sup>2+</sup> influx measured in mES cell-derived neuronal precursors (EC<sub>50</sub> of 310 nM, <i>E</i><sub>max</sub> of 110%) and recombinant human GluA2i (EC<sub>50</sub> of 24 nM, <i>E</i><sub>max</sub> of 124%) and GluA2o (EC<sub>50</sub> of 880 nM, <i>E</i><sub>max</sub> of 108%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Summary of the Primary in Vitro Pharmacology and Interspecies Exposure–Response Continuum for <b>3</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">assay</th><th class="colsep0 rowsep0" align="center">concentration or <i>C</i><sub>b,u</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">In Vitro<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat cortical tissue <i>K</i><sub>i</sub></td><td class="colsep0 rowsep0" align="left">170</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat primary cortical neurons EC<sub>50</sub></td><td class="colsep0 rowsep0" align="left">43 ± 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mES cell-derived neurons EC<sub>50</sub> (efficacy, %)</td><td class="colsep0 rowsep0" align="left">310 (110 ± 4)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hGluA2i EC<sub>50</sub> (efficacy, %)</td><td class="colsep0 rowsep0" align="left">24 (124 ± 11)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hGluA2o EC<sub>50</sub> (efficacy, %)</td><td class="colsep0 rowsep0" align="left">880 (108 ± 5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="2" align="center">In Vivo</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rotarod</td><td class="colsep0 rowsep0" align="left">10.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cGMP</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PPF<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">0.23/0.18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RAM</td><td class="colsep0 rowsep0" align="left">0.029–0.29</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Geometric means for <i>K</i><sub>i</sub> and EC<sub>50</sub>, arithmetic means ± SEM for percent efficacy, <i>N</i> ≥ 3 for each assay.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last"><i>C</i><sub>b,u</sub> were determined by the Spearman–Karber-determined ED<sub>50</sub> (0.003 mg/kg, IV) from the cumulative-dose study or the PK/PD model-derived value that was able to reverse 50% of the MK-801-induced PPF disruption in the single-dose (0.01 mg/kg, IV) time-course study, respectively.</p></div></div></div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> Neuropharmacokinetics</h4><div class="NLM_p">Single (CD-1 mouse) or multiple (rat) time point neuropharmacokinetics studies were performed with <b>3</b> in rodents (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) prior to respective in vivo pharmacology tests to optimize both dose selection and the time of pharmacodynamic assessment(s). Furthermore, doses within the respective species-specific pharmacology models (except the mouse rotarod assay) were assumed to have the same dose–<i>C</i><sub>b,u</sub> relationship as in the neuropharmacokinetics studies, and thus their <i>C</i><sub>b,u</sub> were extrapolated linearly from the neuropharmacokinetics data to define the exposure–response relationships of <b>3</b> at a specific time point postdose. Thirty minutes after a single dose (1.78 mg/kg, SC) of <b>3</b>, CD-1 mice had a mean ± SD total plasma compound concentration (<i>C</i><sub>p</sub>) of 242 ± 106 ng/mL and total brain compound concentration (<i>C</i><sub>b</sub>) of 247 ± 26 ng/mL (equating to a <i>C</i><sub>b,u</sub> of 12.0 ± 1.3 nM using the rat unbound fraction of compound in brain homogenate (<i>f</i><sub>u,b</sub>) of 0.019), which afforded a <i>C</i><sub>b</sub>:<i>C</i><sub>p</sub> of 1.1 ± 0.3. After a single dose (1 mg/kg, SC) to rats, <b>3</b> demonstrated a similar terminal half-life (<i>t</i><sub>1/2</sub>) in plasma (0.76 h), cerebrospinal fluid (0.71 h), and brain (0.53 h) and a <i>T</i><sub>max</sub> of 0.75 h within each neuromatrix. Consistent with the in vitro data predicting it to be a highly permeable non-P-glycoprotein substrate (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), <b>3</b> afforded AUC<sub>0–Tlast</sub>-derived ratios suggesting it is readily brain penetrant (<i>C</i><sub>b</sub>:<i>C</i><sub>p</sub> of 1.5) with net equilibrium at the blood–brain barrier (<i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub> of 0.59) (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Similarly, an IV bolus (0.01 mg/kg) neuropharmacokinetics study, performed in urethane-anesthetized rats under paired-pulse facilitation (PPF) assay conditions, showed <b>3</b> had parallel <i>t</i><sub>1/2</sub> in each neurocompartment, a <i>C</i><sub>b</sub>:<i>C</i><sub>p</sub> of 2.6 and <i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub> of 1.0. The data suggest urethane anesthesia has no significant effect on the neuropharmacokinetics of <b>3</b> in rats.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Mean Pharmacokinetic Parameters of <b>3</b> in Rats, Dogs, and Nonhuman Primates (NHP)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">species<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">NHP</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub></td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="left">0.110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,b</sub></td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub></td><td class="colsep0 rowsep0" align="left">0.59<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>CL</i><sub>p</sub> (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">169/NA</td><td class="colsep0 rowsep0" align="left">11.2<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i> (L/kg)</td><td class="colsep0 rowsep0" align="left">3.6/NA</td><td class="colsep0 rowsep0" align="left">6.0<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.31/0.84</td><td class="colsep0 rowsep0" align="left">6.21</td><td class="colsep0 rowsep0" align="left">12.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left">NA/134</td><td class="colsep0 rowsep0" align="left">23.9</td><td class="colsep0 rowsep0" align="left">6.87</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">NA/0.25</td><td class="colsep0 rowsep0" align="left">0.79</td><td class="colsep0 rowsep0" align="left">4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–∞</sub> (ng·h/mL)</td><td class="colsep0 rowsep0" align="left">20.1/175</td><td class="colsep0 rowsep0" align="left">158</td><td class="colsep0 rowsep0" align="left">149</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left">58</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,LM</sub></td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.46</td><td class="colsep0 rowsep0" align="left">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.84</td><td class="colsep0 rowsep0" align="left">0.87</td><td class="colsep0 rowsep0" align="left">0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">LM <i>CL</i><sub>H</sub> (mL/min/kg)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">40.2/63.6</td><td class="colsep0 rowsep0" align="left">1.5/7.4</td><td class="colsep0 rowsep0" align="left">10.2/22.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IM <i>CL</i><sub>int,app</sub> (μL/min/mg)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left"><15</td><td class="colsep0 rowsep0" align="left"><22</td><td class="colsep0 rowsep0" align="left"><29</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">ND, not determined; NA, not applicable.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">In vivo pharmacokinetic parameters were determined using doses of: 0.2 mg/kg, IV (<i>N</i> = 2)/3.0 mg/kg, PO (<i>N</i> = 3) for rats, 0.1 mg/kg, PO (<i>N</i> = 6) for dogs, and, 0.032 mg/kg, SC (<i>N</i> = 2) for NHP.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">AUC<sub>0–Tlast</sub>-derived ratio of unbound brain compound concentration-to-unbound plasma compound concentration (<i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub>) determined in a rat neuropharmacokinetics study (1 mg/kg, SC; <i>N</i> = 2/time point).</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Apparent value.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Blood-to-plasma concentration ratio.</p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Liver microsomes-derived hepatic blood clearance (LM <i>CL</i><sub>H</sub>) using the well-stirred model with/without binding factors.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Intestinal microsomes-derived apparent intrinsic clearance (IM <i>CL</i><sub>int,app</sub>) without binding factors.</p></div></div></div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> In Vivo Pharmacology</h4><div class="NLM_p">Compound <b>3</b> was evaluated in specific rodent pharmacology models to define the relationship between its <i>C</i><sub>b,u</sub> and AMPAR-mediated effects. Collectively, this allowed a <i>C</i><sub>b,u</sub>-normalized exposure–response continuum for <b>3</b> across multiple models of AMPAR-dependent mechanism, safety, and procognitive properties (“efficacy”) to determine its single-dose TI (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). From a mechanism perspective, <b>3</b> was first assessed for its ability to elevate cerebellar cGMP in CD-1 mice, where it showed statistically significant increases (<i>P</i> < 0.05 vs vehicle-treated animals) 0.5 h after receiving a dose of 1.0 mg/kg, SC (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A). On the basis of the satellite CD-1 mouse neuropharmacokinetics study (1.78 mg/kg, SC) and assuming stationary pharmacokinetics at all tested doses, the projected mean <i>C</i><sub>b,u</sub> at this cGMP-increasing dose was 6.7 nM. Subsequently, the ability of <b>3</b> to produce motor deficits was assessed in C57BL/6J mice undergoing an accelerating rotarod test because prior data with <b>1</b> defined a very close relationship between <i>C</i><sub>b,u</sub> decreasing fall latency in this mouse assay to those causing movement-related tremors/ataxia in NHP.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> Potentiator <b>3</b> caused statistically significant (<i>P</i> < 0.05) motor deficits in mice 0.5 h after 0.32 mg/kg, SC (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B), which corresponded to a mean <i>C</i><sub>b,u</sub> of 10.8 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>3</b> dose-dependently increased CD-1 mouse cerebellum cGMP (A) and decreased fall latency in C57BL/6J mice traversing an accelerating rotarod (B). For both assays, single doses were administered subcutaneously with a 0.5 h pretreatment time; for each dose, the projected mean <i>C</i><sub>b,u</sub> at 0.5 h after administration of <b>3</b> is shown within brackets. The data are expressed as the mean ± SEM with <i>N</i> = 5–6/dose (cGMP) or <i>N</i> = 12/dose (rotarod). *<i>P</i> < 0.05 (one-way ANOVA followed by posthoc Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For efficacy, <b>3</b> was tested in two contemporary rat models of pharmacologically provoked NMDAR hypofunction:<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> MK-801-induced subiculum-medial PFC dysfunction<a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> and ketamine-disrupted spatial working memory in the radial arm maze (RAM).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In the electrophysiological model, an initial cumulative IV dose–response study (0.001 to 0.01 mg/kg, <i>N</i> = 5) was conducted with <b>3</b>, and a significant (<i>P</i> < 0.01) reversal of the disruptive effects of MK-801 on both cortical electroencephalography (EEG) and PPF were observed following 0.01 mg/kg, IV (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>A). For each dose, <i>C</i><sub>b,u</sub> was projected linearly from the <i>C</i><sub>b,u</sub> (0.77 nM) observed at 5 min postdose in the 0.01 mg/kg, IV neuropharmacokinetics study performed under identical assay conditions. A Spearman–Karber analysis revealed an effective dose for 50% of animals (ED<sub>50</sub>) of 0.003 mg/kg (<i>C</i><sub>b,u</sub> of 0.23 nM). Subsequently, a single (i.e., noncumulative) 0.01 mg/kg, IV time-course study was conducted for pharmacokinetic/pharmacodynamic (PK/PD) modeling (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>B); mean onset of the reversal by <b>3</b> of the MK-801-dependent PPF disruption was 8 ± 3 min postdose (<i>C</i><sub>b,u</sub> of ca. 0.77 nM). Using a link model, the estimated slope of <b>3</b> to reverse the MK-801-induced PPF disruption was 14.2%·mL/ng, the population mean baseline (i.e., MK-801-mediated disruption) was 79.2% and the <i>K</i><sub>e0</sub> was estimated to be 1.93 h<sup>–1</sup>. Before the MK-801 disruption, the percent of low frequency delta power for untreated rats was 38%. The PD response observed in the PPF experiment ranged from 0% to 73% of the reversal of the MK-801-induced disruption, hence the model may reliably predict the extent of this reversibility up to an inhibitory concentration maximum of 73%. The modeling results indicate that in rats <b>3</b> is able to reverse 50% of the MK-801-induced PPF disruption at a <i>C</i><sub>p</sub> of 1.5 ng/mL, which, based on the IV bolus neuropharmacokinetics data, equates to a <i>C</i><sub>b,u</sub> of 0.18 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As reported<a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> for another AMPAR potentiator in this electrophysiological model, the restorative effects of <b>3</b> were fully blocked by pretreatment (1 mg/kg, IV; 10 min after MK-801 administration and 20 min before dosing <b>3</b>) with the selective AMPAR antagonist (<i>S</i>)-3-(2-chlorophenyl)-2-[2-(6-diethylaminomethyl-pyridin-2-yl)-vinyl]-6-fluoro-3<i>H</i>-quinazolin-4-one (CP-465022)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (data not shown).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In rats, <b>3</b> reversed the MK-801-mediated reduction in PPF after cumulative (A) or a single (B; 0.01 mg/kg) intravenous dose(s). Each column represents PPF values (mean ± SEM, <i>N</i> = 3–5) collected over a 10 min period following administration of <b>3</b>, and the projected mean <i>C</i><sub>b,u</sub> for each period is shown within brackets. (A) *<i>P</i> < 0.01 vs vehicle–vehicle condition, <sup>#</sup><i>P</i> < 0.01 vs MK-801-vehicle condition (two-tailed Student’s <i>t</i> test). (B) *<i>P</i> < 0.05 vs pre-MK-801-administration (−10 min period), <sup>#</sup><i>P</i> < 0.05 vs post-MK-801/pre-<b>3</b>-administration (0 min period) (two-tailed Student’s <i>t</i> test); arrows designate compound administration, the mean onset of the <b>3</b>-mediated effect was 8 ± 3 min, and <b>3</b> reversed the MK-801-disruption through 50 min postdose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Results in this electrophysiological assay provided the theoretical basis for studying the ability of <b>3</b> to curb the disruptive effects of the NMDAR antagonist ketamine on spatial working memory in rats because monosynaptic projection from the hippocampus/subiculum to the medial PFC contributes to working memory,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> and such dysfunction is implicated in the decreased cognitive performance of patients with schizophrenia.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Thus, employing a spatial working memory version of the RAM,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a><b>3</b> significantly attenuated the ketamine-evoked working memory errors at doses of 0.0032–0.032 mg/kg, SC (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), which equated to projected <i>C</i><sub>b,u</sub> of 0.029–0.29 nM (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) per the subcutaneous rat neuropharmacokinetics study. As compared to the ketamine-treated group, the 0.032 mg/kg dose also significantly improved several other performance indices (data not shown): it decreased the average time to maze completion, it increased the average number of choices prior to first error, and it increased the percentage of correct choices on the maze. The data suggest increased glutamatergic neurotransmission produced by <b>3</b> afforded significant protection from the ketamine-dependent deficits in spatial working memory in a hormetic exposure–response fashion typical of procognitive agents.<a onclick="showRef(event, 'cit11a ref38'); return false;" href="javascript:void(0);" class="ref cit11a ref38">(11a, 38)</a></div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>3</b> attenuated ketamine-induced working memory disruptions in rats as determined by mean errors in a radial arm maze. Single doses were administered subcutaneously with 1 and 0.5 h pretreatment times for <b>3</b> or the positive control (PC) and (±)-ketamine (10 mg/kg), respectively; for each dose, the projected mean <i>C</i><sub>b,u</sub> at 1 h after <b>3</b> administration is shown within brackets. The data are expressed as the mean ± SEM with <i>N</i> = 12/dose. *, **<i>P</i> = 0.05, 0.01 vs vehicle-ketamine condition (using a generalized linear mixed model assuming an underlying Poisson distribution followed by a Hochberg’s test for multiple post hoc comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Once demonstrating both electrophysiological and behavioral effects in rats, <b>3</b> was further studied in rats using 2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose (FDG) positron emission tomography (PET) as a potential methodology for determining a clinically translatable central biomarker of AMPAR potentiation. Prior FDG-PET studies with <b>5</b> in rats<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> and NHP<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> revealed increased cerebral glucose metabolism rotating from cortical regions to the cerebellum at <i>C</i><sub>b,u</sub>, paralleling the behavioral transition from procognitive effects (rat and NHP) to elevation in cerebellar cGMP (rat) and motor coordination disruptions (NHP). Thus, FDG-PET studies strategically used doses of <b>3</b> (0.027, 0.08, and 0.60 mg/kg, SC), affording at the time of FDG administration maximal <i>C</i><sub>b,u</sub> of 0.3 to 6.7 nM, which showed activity in the rat RAM and mouse cerebellar cGMP models, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In rats, <b>3</b> produced significant increases in FDG uptake (<i>P</i> < 0.05 vs vehicle-treated animals) in cortex and cerebellum (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>A). As observed with <b>5</b>, the magnitude of increased FDG uptake, as measured by the number of significantly increased voxels within a brain region of interest, caused by <b>3</b> had an opposite pattern in cortex and cerebellum. Specifically, the <b>3</b>-dependent FDG-uptake increase at the low dose, which afforded a <i>C</i><sub>b,u</sub> of 0.3 nM that showed the most robust effects in the rat RAM, was almost exclusively within the cortex vs the cerebellum (210 vs 6 significantly increased voxels). Conversely, FDG uptake at the high dose, which yielded the minimally effective cGMP-elevating <i>C</i><sub>b,u</sub> of 6.7 nM, was almost exclusively within the cerebellum vs the cortex (1182 vs 58 significantly increased voxels) (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>B). Because small molecule concentrations are essentially homogeneous across brain regions,<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> these data suggest that different concentrations of <b>3</b> are required to selectively (and optimally) activate the respective brain regions associated with procognitive effects (e.g., cortex) and motor coordination (e.g., cerebellum), which may be due to intrinsically different biophysical properties of circuit-specific AMPAR subpopulations. As in the rat PPF model, these increases in FDG uptake were completely blocked by pretreatment (3.2 mg/kg, SC; 30 min before dosing <b>3</b>) with the AMPAR antagonist CP-465022 (data not shown). Subsequently, a similar FDG-PET-based exposure–response relationship was determined for <b>3</b> in NHP,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> suggesting this methodology could be considered as a potential translatable central biomarker for both efficacy- and safety-related effects of AMPAR potentiation by <b>3</b> in humans.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In rats, <b>3</b> dose-dependently affected the regional brain uptake of FDG. (A) Representative slices at bregma coordinates (−0.50 (top row) and −11.00 mm (bottom row)) overlaid onto rat brain histological slices with color indicating brain regions with significantly (<i>P</i> < 0.05, unpaired one-tailed <i>t</i> test) increased (yellow-to-red) or decreased (blue) FDG uptake in rats (<i>N</i> = 12/group) receiving <b>3</b> (0.027, 0.08, or 0.60 mg/kg, SC) vs vehicle. The color bar represents both the direction and relative magnitude of the uptake change. (B) Number of voxels with significantly (<i>P</i> < 0.05, unpaired one-tailed <i>t</i> test) increased FDG uptake in rats (<i>N</i> = 12/group) receiving <b>3</b> (0.027, 0.08, or 0.60 mg/kg, SC) vs vehicle within the entire volume of the cortex and cerebellum. Each voxel size is 0.5 mm × 0.5 mm × 0.5 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Interestingly, the <i>C</i><sub>b,u</sub> of <b>3</b> generating physiological effects in all in vivo assays were just fractions of its concentrations required to produce half-maximal responses in the receptor-based in vitro assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Using the rat <i>K</i><sub>i</sub> and respective <i>C</i><sub>b,u</sub>, in vivo measures of efficacy and motor deficits occur at projected AMPAR occupancies of <1% and 6%, respectively, and 10 nM was the lowest tested concentration of <b>3</b> that clearly enhanced <i>S</i>-AMPA-evoked currents in rat cortical neurons (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). It is hypothesized<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> that this phenomenon is due to animals, unlike the employed in vitro systems, having completely intact synergistic neural networks in which only minimal AMPAR potentiation produces enough excitatory neurotransmission for the nonlinear activation of downstream pathways.</div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Pharmacokinetics and Metabolism</h4><div class="NLM_p">Consistently across all species tested and a 10-fold concentration range, <b>3</b> showed a moderate unbound fraction in liver microsomes (<i>f</i><sub>u,LM</sub>; 0.42–0.52), near-unity blood-to-plasma concentration ratio (B/P; 0.82–0.90) and low unbound fraction in plasma (<i>f</i><sub>u,p</sub>; 0.047–0.110) (Tables <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Single-dose pharmacokinetic studies (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) indicate <b>3</b> is rapidly absorbed in rats and dogs (<i>T</i><sub>max</sub> ≤0.8 h) following oral (PO) administration. In rats, <b>3</b> had very high systemic plasma clearance (<i>CL</i>, 169 mL/min/kg, <1% renal), moderate steady-state volume of distribution (<i>V</i><sub>ss</sub>, 3.5 L/kg), and moderate oral bioavailability (<i>F</i>, 58%). In dogs, its apparent <i>CL</i> (11.2 mL/min/kg) and apparent <i>V</i><sub>ss</sub> (6.0 L/kg) were moderate. Mean <i>t</i><sub>1/2</sub> of <b>3</b> were short in rats (≤0.8 h) and moderate-to-long in dogs (6.2 h) and NHP (12.3 h).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Projected Human Pharmacokinetic Parameters and Human Binding Factors for <b>3</b><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center"><b>3</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>eff</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="center">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>CL</i><sub>p</sub> (mL/min/kg)</td><td class="colsep0 rowsep0" align="center">3.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>H</sub></td><td class="colsep0 rowsep0" align="center">0.81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i><sub>a</sub>·<i>F</i><sub>g</sub></td><td class="colsep0 rowsep0" align="center">1.00<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="center">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="center">0.63<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="center">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (mg)</td><td class="colsep0 rowsep0" align="center">0.3 BID<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,p</sub></td><td class="colsep0 rowsep0" align="center">0.079</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>f</i><sub>u,HLM</sub></td><td class="colsep0 rowsep0" align="center">0.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">B/P<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="center">0.82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM <i>CL</i><sub>H</sub> (mL/min/kg)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center">0.8/3.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HHeps <i>CL</i><sub>H</sub> (mL/min/kg)<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="center">ND/7.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HIM <i>CL</i><sub>int,app</sub> (μL/min/mg)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="center"><15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rhCYP <i>CL</i><sub>int,app</sub> (μL/min/pmol)<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="center">CYP3A4 (0.472), CYP2C19 (0.061)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">ND, not determined.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Calculated from rat IV/PO pharmacokinetics studies.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">In silico-derived value.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Projected using <i>C</i><sub>ss,av</sub> = (<i>CL</i><sub>p</sub>·τ·<i>C</i><sub>eff</sub>)/<i>F</i> and assuming a 70 kg subject.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Blood-to-plasma concentration ratio.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">Human liver microsomes (HLM)- or human hepatocytes (HHeps)-derived hepatic blood clearance (<i>CL</i><sub>H</sub>) using the well-stirred model with/without binding factors.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">Human intestinal microsomes (HIM)- or recombinant human CYP (rhCYP)-derived apparent intrinsic clearance (<i>CL</i><sub>int,app</sub>) without binding factors.</p></div></div></div><div class="NLM_p">Compound <b>3</b> demonstrated low and moderate scaled clearance in HLM (<i>CL</i><sub>H</sub> ≤3.8 mL/min/kg) and hepatocytes (<i>CL</i><sub>H</sub> ≤7.1 mL/min/kg), respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Equivalent studies in rat (<i>CL</i><sub>H</sub> ≤63.6 mL/min/kg) and dog (<i>CL</i><sub>H</sub> ≤7.4 mL/min/kg) hepatic microsomes were consistent with their respective in vivo <i>CL</i> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Preliminary in vitro interspecies (rat, dog, and human) biotransformation studies with nonradiolabeled <b>3</b> (10 μM) found it underwent similar metabolism in dog and human systems where tetrahydrofuran hydroxylation predominates; <i>O</i>-dealkylation occurred in all species (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Initial metabolite profiling of plasma (rat and dog) and brain (rat) samples identified both <b>3</b> and its <i>O</i>-dealkylated metabolite in rat plasma, but only <b>3</b> in both dog plasma and rat brain. These studies coupled with those employing major recombinant human cytochrome P450 (rhCYP) isoforms suggest the predominant human clearance pathway for <b>3</b> is hepatic CYP-mediated metabolism via CYP2C19 and CYP3A4, both at minimal rates (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). Although a CYP3A4 substrate, no turnover (i.e., <i>t</i><sub>1/2</sub> >93 min) of <b>3</b> (1 μM) was detected in human intestinal microsomes, consistent with its very low rhCYP3A4 <i>CL</i><sub>int,app</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The ability of <b>3</b> to inhibit seven major CYPs was investigated using HLM and probe substrates, and its lowest IC<sub>50</sub> was 18 μM (CYP2D6).</div><div class="NLM_p">For clinical pharmacokinetic parameter projections, both more traditional and newer in silico methods were employed. Primarily for the latter methodology, Simcyp software<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> used select experimentally determined data and predicted human pharmacokinetic values to simulate <i>C</i><sub>p</sub>–time profiles for a forecasted efficacious dose of <b>3</b> to estimate the clinical variability in <i>C</i><sub>max</sub> relative to both <i>C</i><sub>eff</sub> and motor coordination disruptions, an exposure threshold-dictated AE. Particularly, this clarified the adequacy of exposure separation between the 95th percentile <i>C</i><sub>max</sub>, which corresponds to the lowest <i>C</i><sub>max</sub> for the five virtual subjects exhibiting the least extensive metabolism of <b>3</b> and the <i>C</i><sub>p</sub> for movement-related deficits (<i>C</i><sub>AE</sub>) at the putative efficacious oral dose. For this exercise, projected clinical <i>C</i><sub>eff</sub> (2.4 ng/mL) and <i>C</i><sub>AE</sub> (89 ng/mL) were derived using eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a> (<a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>) from rodent <i>C</i><sub>b,u</sub> corresponding to the highest effective exposure in the rat efficacy models (<i>C</i><sub>b,u</sub> of 0.29 nM) and to the mean value inducing statistically meaningful motor deficits in the mouse rotarod assay (<i>C</i><sub>b,u</sub> of 10.8 nM), respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Using previously described methodology,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> integration of the interspecies in vitro and in vivo metabolism data sets predicts <b>3</b> to have in humans a low-to-moderate <i>CL</i> (3.12 mL/min/kg) and <i>V</i><sub>ss</sub> (0.63 L/kg), resulting in a short-to-moderate <i>t</i><sub>1/2</sub> (2.3 h) and a moderate-to-high <i>F</i> (81%) (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The human efficacious dose (0.3 mg) was calculated from these pharmacokinetic parameters, a dosing interval (τ) of 12 h (BID), an assumed 70 kg subject, and the desire to maintain <i>C</i><sub>eff</sub> as the average <i>C</i><sub>p</sub> at steady-state (<i>C</i><sub>ss,av</sub>). Using these same <i>C</i><sub>eff</sub> and pharmacokinetic parameters, but substituting respective rhCYP-generated <i>CL</i><sub>int,app</sub>, Simcyp simulations support this projected dosing regimen after a single or multiple (BID for 7 d) dose(s) of 0.3 mg, with low intersubject pharmacokinetic variability and ≤2-fold accumulation at steady state (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). Importantly, the modeling of this clinically efficacious dosing regimen of <b>3</b> expects no violation of its <i>C</i><sub>AE</sub> by its 95th percentile <i>C</i><sub>max</sub>. Assuming that both rodent efficacy and motor coordination disruptions are directly translatable, the described animal data suggest that <b>3</b> has a single-dose-defined TI of 37 in humans for self-limiting intention tremors, a readily clinically monitorable AE. This, coupled with the projected low variability in human <i>C</i><sub>p</sub>–time profiles, supported the progression of <b>3</b> to preclinical safety studies.</div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Simulated human total plasma <b>3</b> concentration–time profiles following a single (A) or multiple (B; BID for 7 d) oral dose(s) of 0.3 mg. In both plots, the mean (solid line), 5th percentile (lower dashed line) and 95th percentile (upper dashed line) plasma drug concentration–time curves are shown to capture the intersubject pharmacokinetic variability projected by Simcyp for a virtual population of 100 healthy volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">On the basis of the described holistically favorable data set, <b>3</b> underwent 90 day regulatory toxicology studies in rats and dogs in which adequate TIs (both <i>C</i><sub>max</sub>- and AUC-based) were achieved to advance it to human testing. To date, <b>3</b> has been evaluated in 11 clinical trials (see <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a>), where it has been safe and well tolerated in healthy volunteers (18–55 y old), in patients (55–70 y old) with age-related sensorineural hearing loss,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and as adjunctive treatment in subjects with schizophrenia on stable doses of antipsychotics and other psychotropic medications. Current clinical studies are evaluating <b>3</b> for procognitive effects in select neurodisease populations but principally for its ability to overcome cognitive impairments associated with schizophrenia.</div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21672" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21672" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Rational drug design optimizing both ADME-related physicochemical properties and molecular interactions with the human GluA2 LBD led to the discovery of a new tetrahydrofuran ether class of highly potent AMPAR potentiators. This novel chemical series ultimately afforded <i>N</i>-{(3<i>S</i>,4<i>S</i>)-4-[4-(5-cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (PF-04958242, <b>3</b>), whose preclinical characterization predicted in humans both a single-dose-defined TI of 37 for self-limiting tremors and low intersubject pharmacokinetic variability. This profile is expected to greatly minimize the potential of eliciting threshold-mediated AEs at a clinically efficacious dosing regimen. Consistent with favorable regulatory toxicology studies that included 90 day studies in rats and dogs, <b>3</b> has been safe and well-tolerated in both healthy volunteers (young and elderly) and targeted disease populations, and it is currently being tested for its ability to attenuate cognitive deficits in schizophrenia.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General</h3><div class="NLM_p last">All compounds were synthesized and fully characterized at Pfizer Worldwide Research & Development (WRD, Groton, CT). Chemicals and solvents of reagent or HPLC grade were supplied by Sigma-Aldrich Corporation (St. Louis, MO), Thermo Fisher Scientific (Waltham, MA), and Mallinckrodt Baker, Inc. (Phillipsburg, NJ). For control matrices, species-specific plasma was acquired from Bioreclamation, Inc. (Hicksville, NY) and rat brain tissue was obtained at WRD. Male CD-1 mice (20–25 g) and rats (200–275 g) were bought from Harlan Laboratories (Indianapolis, IN) or Charles River Laboratories, Inc. (Wilmington, MA), male C57BL/6J mice (20–25 g) were procured from The Jackson Laboratory (Bar Harbor, ME), and beagle dogs (9.4–10.3 kg) were sourced from Marshall BioResources (North Rose, New York). Non-naı̈ve NHP (<i>Macaca fascicularis</i>, 6.8–8.5 kg) resided within the WRD NHP colony (Groton, CT). All animal studies were performed in accordance with the <i>Guide for the Care and Use of Laboratory Animals</i><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> using protocols reviewed and approved by the WRD Institutional Animal Care and Use Committee. Under a protocol approved by Schulman Associates IRB (Cinicnnati, OH), human blood was collected at WRD from three anonymous medication-free male donors on the assay day and a portion of it was used to harvest plasma. Liver microsomes were either prepared and characterized by WRD (Groton, CT) or purchased from BD Gentest (Woburn, MA), cryopreserved human hepatocytes were acquired from Invitrogen (Carlsbad, CA), intestinal microsomes were procured from Xenotech LLC (Lenexa, KS), and recombinant Baculosomes expressing human cytochrome P450 isozymes (CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) were obtained from PanVera Corporation (Madison, WI). All blood samples were collected into EDTA-containing tubes and processed immediately to obtain plasma, and the collection of neuromatrices from rodents followed published techniques.<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> All biomatrices collected for drug quantification were stored at −70 °C until processing for bioanalysis.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> General Chemistry Procedure</h4><div class="NLM_p last">All reagents and solvents were used as purchased from commercial sources. Reactions were performed under nitrogen. Mass spectral data were collected on a Micromass ADM atmospheric pressure chemical ionization instrument (LRMS APCI) (Micromass UK Ltd., Manchester, UK). NMR spectra were generated on a Varian 300, 400, or 500 MHz (Varian Medical Systems, Inc., Palo Alto, CA) or Bruker 400 MHz (Bruker Corporation, Coventry, UK) instrument. Chemical shifts were recorded in ppm relative to TMS, with multiplicities given as s (singlet), d (doublet), t (triplet), q (quartet), sep (septet), dd (doublet of doublets), dt (doublet of triplets), ddd (doublet of doublet of doublets), m (multiplet), and br (broad signal). Accurate MS analyses (HRMS) were conducted on an Agilent 6220 TOF mass spectrometer (Agilent Technologies, Wilmington, DE) in electrospray mode in either positive ion mode using an Agilent ZORBAX column (1.8 μ, 3.0 mm × 50 mm, 60 °C) or negative ion mode using a Waters XBridge column (2.5 μ, 3.0 mm × 50 mm, 60 °C) (Waters Corporation, Milford, MA). The system was calibrated to greater than 1 ppm accuracy across the mass range prior to analyses according to manufacturer’s specifications. The samples were separated using UHPLC on an Agilent 1200 system prior to mass spectrometric analysis. The resulting spectra were automatically lock mass-corrected, and the target mass ions and any confirming adducts (Na<sup>+</sup>, NH<sub>4</sub><sup>+</sup>) were extracted and combined as a chromatogram. The mass accuracy was calculated for all observed isotopes against the theoretical mass ions derived from the chemical formula using MassHunter software (Agilent Technologies). Low-resolution mass spectra were determined on a Waters/Micromass system. The X-ray diffraction measurements were performed at 298 K on a Bruker SMART APEX CCD area detector system equipped with a graphite monochromator and sealed-tube Cu radiation (1.54178 Å) source. Compound purity was determined by either combustion analysis (Intertek Pharmaceutical Services, Whitehouse, NJ), where the analyses, indicated by the symbols of the elements, were within ±0.4% of the theoretical values, or HPLC, confirming it to be ≥95% pure, or by a combination of these two methods. For HPLC (<i>A</i><sub>254</sub>), analytes were eluted on a Waters XBridge C18 analytical column (5 μ, 4.6 mm × 150 mm) at 1.5 mL/min with acetonitrile (solvent A) and water containing 0.1% TFA (solvent B) using the following gradient: 0–1.5 min, 5% solvent A in solvent B; 1.5–10 min, 5–100% A in B; 10– 11 min, 100% A; 11–12.5 min, 100–5% A in B. Retention times (<i>t</i><sub>R</sub>) are reported in min, and purity is calculated as the percent of total area.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>trans</i>-4-(4-Bromophenoxy)tetrahydrofuran-3-yl methanesulfonate (<b>12</b>)</h4><div class="NLM_p">3,6-Dioxabicyclo[3.1.0]hexane (<b>10</b>, 100 g, 1.16 mol), 4-bromophenol (<b>11</b>, 241.1 g, 1.39 mol), cesium carbonate (492 g, 1.51 mol), and benzyltriethylammonium chloride (52.9 g, 0.23 mol) were suspended in dioxane (1 L) and heated at reflux for 18 h. The reaction was cooled to rt, diluted with ethyl acetate, and then washed with saturated aqueous sodium carbonate solution. The aqueous layer was extracted with ethyl acetate, the combined organic portions were dried over sodium sulfate and filtered, and the solvent was removed under reduced pressure to provide crude product (354 g, >100%, assumed quantitative), which solidified on standing; this was used without purification in the next step. Material from a smaller-scale experiment carried out in similar fashion was purified by silica gel chromatography for characterization (gradient of 10–35% ethyl acetate in heptane) to afford <i>trans</i>-4-(4-bromophenoxy)tetrahydrofuran-3-ol as a solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40 (d, <i>J</i> = 9.1 Hz, 2H), 6.81 (d, <i>J</i> = 9.0 Hz, 2H), 4.67 (m, 1H), 4.41 (br s, 1H), 4.26 (dd, <i>J</i> = 10.4, 4.9 Hz, 1H), 4.05 (dd, <i>J</i> = 10.1, 4.0 Hz, 1H), 3.91 (dd, <i>J</i> = 10.3, 2.1 Hz, 1H), 3.83 (m, 1H), 2.09 (br d, <i>J</i> = 4.5 Hz, 1H).</div><div class="NLM_p last">Triethylamine (181.9 mL, 1.31 mol) was added to a solution of <i>trans</i>-4-(4-bromophenoxy)tetrahydrofuran-3-ol (354 g, assumed 300.6 g, 1.16 mol) in methylene chloride (2 L), and the reaction was cooled to 0 °C in an ice bath. Methanesulfonyl chloride (101.3 mL, 1.31 mol) was then added dropwise while keeping the reaction temperature <5 °C, and the reaction was stirred at rt for 18 h. Water (1.5 L) was added, and the aqueous layer was extracted with methylene chloride. The organics were combined, dried over sodium sulfate, and filtered, and the solvent was removed under reduced pressure to yield the brown oil product (399.6 g, quantitative). Material from a smaller-scale experiment performed similarly was triturated with ethanol for characterization to afford <i>trans</i>-4-(4-bromophenoxy)tetrahydrofuran-3-yl methanesulfonate (<b>12</b>). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42 (d, <i>J</i> = 9.0 Hz, 2H), 6.85 (d, <i>J</i> = 9.1 Hz, 2H), 5.20 (m, 1H), 4.98 (br d, <i>J</i> = 4.6 Hz, 1H), 4.23 (dd, <i>J</i> = 10.5, 4.6 Hz, 1H), 4.16 (dd, <i>J</i> = 11.1, 3.9 Hz, 1H), 4.07 (m, 1H), 4.00 (br dd, <i>J</i> = 10.4, 1.9 Hz, 1H), 3.10 (s, 3H). Elemental Analysis Calcd for C<sub>11</sub>H<sub>13</sub>BrO<sub>5</sub>S: C, 39.18; H, 3.89. Found: C, 39.31; H, 3.71. HRMS (ESI<sup>–</sup>) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>11</sub>H<sub>13</sub>BrO<sub>5</sub>S, 360.9539; found, 360.9543.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>cis</i>-4-(4-Bromophenoxy)tetrahydrofuran-3-amine (<b>13</b>)</h4><div class="NLM_p">Sodium azide (192.6 g, 2.96 mol) was added to a solution of <i>trans</i>-4-(4-bromophenoxy)tetrahydrofuran-3-yl methanesulfonate (<b>12</b>, 133.2 g, 0.395 mol) in DMF (3 L), and the reaction was heated at 110 °C for 66 h. The reaction was cooled to rt, and water (12 L) was added. This reaction was conducted a total of three times on the same scale, and the combined batches were extracted with MTBE. The organic layers were then dried over sodium sulfate and the solvent removed under reduced pressure to afford <i>cis</i>-3-azido-4-(4-bromophenoxy)tetrahydrofuran as a red–brown oil contaminated with 18% DMF (corrected yield of 286.7 g, 85%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 9.0 Hz, 2H), 6.83 (d, <i>J</i> = 9.1 Hz, 2H), 4.90 (ddd, <i>J</i> = 5.4, 5.4, 4.4 Hz, 1H), 4.17 (dd, <i>J</i> = 10.0, 5.6 Hz, 1H), 4.09 (dd, <i>J</i> = 8.7, 5.8 Hz, 1H), 4.00 (m, 1H), 3.93–3.97 (m, 2H).</div><div class="NLM_p last">A solution of <i>cis</i>-3-azido-4-(4-bromophenoxy)tetrahydrofuran (286.7 g, 1.01 mol) in THF (1.25 L) was cooled to 0 °C and treated with triphenylphosphine (278 g, 1.06 mol). The reaction was allowed to warm to rt and stirred for 18 h, after which water (53 mL) was added and the reaction was further stirred at rt for 66 h. Solvent was removed under reduced pressure, and the residue was mixed with diethyl ether. The supernatant was decanted, and the solvent was removed under reduced pressure to provide a residue, which was filtered through a short plug of silica gel (gradient of 0–5% methanol in methylene chloride) to afford <i>cis</i>-4-(4-bromophenoxy)tetrahydrofuran-3-amine (<b>13</b>, 155 g) and impure material (366 g). An acid/base extraction of the impure material yielded additional <b>13</b> (combined yield of 203.5 g, 78%).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Resolution of <i>cis</i>-4-(4-Bromophenoxy)tetrahydrofuran-3-amine (<b>13</b>)</h4><div class="NLM_p">A mixture of <i>cis</i>-4-(4-bromophenoxy)tetrahydrofuran-3-amine (<b>13</b>, 191 g, 0.74 mol) and (1<i>S</i>)-(+)-10-camphorsulfonic acid (154.2 g, 0.66 mol) was dissolved in 2-propanol (2.4 L) and water (100 mL) at reflux. The clear solution was cooled to rt over 18 h, and the resulting crystals were isolated, washed, and dried to afford the (+)-camphorsulfonic acid salt of (3<i>S</i>,4<i>S</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine (139.2 g, 0.284 mol) with an 85% ee. Recrystallization from 2-propanol (1.2 L) and water (70 mL) provided the (+)-camphorsulfonic acid salt of (3<i>S</i>,4<i>S</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine (113.2 g, 31% yield). Chiral HPLC, using a Chiralpak IA column (4.6 mm × 250 mm) at 0.7 mL/min with heptanes:2-propanol:diethylamine (v/v/v, 80:20:0.2), determined 98.7% ee at 220 nm and 99.4% ee at 260 nm with a <i>t</i><sub>R</sub> of 14.7 min. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.23 (br s, 3H), 7.52 (d, <i>J</i> = 9.0 Hz, 2H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 5.04 (m, 1H), 3.96–4.10 (m, 3H), 3.78–3.84 (m, 2H), 2.85 (d, <i>J</i> = 14.7 Hz, 1H), 2.66–2.73 (m, 1H), 2.35 (d, <i>J</i> = 14.7 Hz, 1H), 2.19–2.28 (m, 2H), 1.76–1.94 (m, 2H), 1.29 (d, half of AB q, <i>J</i> = 10 Hz, 1H), 1.23 (d, half of AB q <i>J</i> = 10 Hz, 1H), 1.05 (s, 3H), 0.74 (s, 3H). Elemental Analysis Calcd for C<sub>10</sub>H<sub>12</sub>BrNO<sub>2</sub>·C<sub>10</sub>H<sub>16</sub>O<sub>4</sub>S: C, 48.98; H, 5.75; N, 2.86. Found: C, 49.15; H, 5.40; N, 2.80. HRMS (ESI<sup>–</sup>) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>10</sub>H<sub>12</sub>BrNO<sub>2</sub>, 258.0124; found, 258.0125.</div><div class="NLM_p">The (3<i>S</i>,4<i>S</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine (+)-camphorsulfonic acid salt (126.8 g, 0.258 mol) was washed with 2 N aqueous sodium hydroxide solution and extracted three times with methylene chloride. The organic layers were combined, and the solvent was removed under reduced pressure to provide (3<i>S</i>,4<i>S</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine (<b>14a</b>, 65.6 g, 98% yield, 99% ee) as a white solid.</div><div class="NLM_p last">Subsequently, the combined mother liquors, enriched in (3<i>R</i>,4<i>R</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine, were washed with 2 N sodium hydroxide and extracted with methylene chloride. The combined organic layers were dried over sodium sulfate, and the solvent was removed under reduced pressure to give a residue (156.3 g, 0.606 mol of product and its enantiomer). This material was combined with (1<i>R</i>)-(−)-10-camphorsulfonic acid (126.2 g, 0.54 mol) and dissolved in 2-propanol (1.65 L) and water (100 mL) at reflux. The clear solution cooled to rt over 18 h, and the resulting crystals were isolated, washed, and dried to generate the (−)-camphorsulfonic acid salt of (3<i>R</i>,4<i>R</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine (152.6 g, 90% ee). The previously described recrystallization afforded the (−)-camphorsulfonic acid salt of (3<i>R</i>,4<i>R</i>)-4-(4-bromophenoxy)tetrahydrofuran-3-amine as a white solid (132 g, 36% yield). Chiral HPLC, using a Chiralpak IA column (4.6 mm × 250 mm) at 0.7 mL/min with heptanes:2-propanol:diethylamine (v/v/v, 80:20:0.2), determined 99.0% ee at 220 nm and 99.7% ee at 260 nm with a <i>t</i><sub>R</sub> of 12.6 min.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>cis</i>-<i>N</i>-[4-(4-Bromophenoxy)tetrahydrofuran-3-yl]propane-2-sulfonamide (<b>15</b>)</h4><div class="NLM_p last">1,8-Diazabicyclo[5.4.0]undec-7-ene (53 mL, 0.35 mol) was added to a solution of <i>cis</i>-4-(4-bromophenoxy)tetrahydrofuran-3-amine (<b>13</b>, 65.6 g, 0.254 mol) in methylene chloride (500 mL). The reaction mixture was cooled to 0 °C, and propane-2-sulfonyl chloride (31.2 mL, 0.28 mol) was added dropwise. The mixture was then stirred at rt for 18 h. Over the course of 20 h, the reaction was monitored by <sup>1</sup>H NMR, and additional propane-2-sulfonyl chloride (2 × 2.8 mL, 25 mmol) was added. Water (500 mL) was added, and the layers were separated. The aqueous layer was extracted with methylene chloride, the combined organic layers were dried over sodium sulfate and filtered, and the solvent was removed under reduced pressure. The residue was dissolved in methylene chloride and washed with aqueous 1 N hydrochloric acid (2 × 300 mL), dried over sodium sulfate, and filtered, and the solvent was removed under reduced pressure to provide <i>cis</i>-<i>N</i>-[4-(4-bromophenoxy)tetrahydrofuran-3-yl]propane-2-sulfonamide (<b>15</b>, 92.5 g, quantitative) as an orange–brown oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.41 (d, <i>J</i> = 9.0 Hz, 2H), 6.78 (d, <i>J</i> = 9.0 Hz, 2H), 4.81 (d, <i>J</i> = 9.5 Hz, 1H), 4.75 (ddd, <i>J</i> = 5.9, 4.4, 1.8 Hz, 1H), 4.26–4.18 (m, 1H), 4.17–4.11 (m, 2H), 3.93 (dd, <i>J</i> = 10.7, 1.7 Hz, 1H), 3.69 (t, <i>J</i> = 8.7 Hz, 1H), 3.15 (sep, <i>J</i> = 6.8 Hz, 1H), 1.38 (d, <i>J</i> = 6.8 Hz, 3H), 1.35 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 155.6, 132.7, 117.5, 114.5, 76.3, 71.9, 70.2, 55.5, 54.5, 16.6. Elemental Analysis Calcd for C<sub>13</sub>H<sub>18</sub>BrNO<sub>4</sub>S: C, 42.87; H, 4.98; N, 3.85. Found: C, 43.38; H, 4.55; N, 3.49. HRMS (ESI<sup>–</sup>) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>18</sub>BrNO<sub>4</sub>S, 364.0213; found, 364.0206.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>N</i>-[(3<i>S</i>,4<i>S</i>)-4-(4-Bromophenoxy)tetrahydrofuran-3-yl]propane-2-sulfonamide (<b>15a</b>)</h4><div class="NLM_p last">Compound <b>15a</b> was analogously prepared as <b>15</b>. Chiral HPLC, using a Chiralpak IA column (4.6 mm × 250 mm) at 0.7 mL/min with heptanes:2-propanol:diethylamine (v/v/v, 80:20:0.2), determined 99.1% ee at 220 nm and 98.7% ee at 260 nm with a <i>t</i><sub>R</sub> of 15.2 min. Elemental analysis calcd for C<sub>13</sub>H<sub>18</sub>BrNO<sub>4</sub>S: C, 42.87; H, 4.98; N, 3.85. Found: C, 42.93; H, 4.85; N, 3.85. HRMS (ESI<sup>–</sup>) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>13</sub>H<sub>18</sub>BrNO<sub>4</sub>S, 364.0213; found, 364.0217.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>N</i>-{(3<i>S</i>,4<i>S</i>)-4-[4-(5-Cyano-2-thienyl)phenoxy]tetrahydrofuran-3-yl}propane-2-sulfonamide (<b>3</b>)</h4><div class="NLM_p last">Sulfonamide <b>15a</b> (0.340 mmol) and (5-cyano-2-thienyl)boronic acid (0.521 mmol), dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (XPhos, 0.034 mmol), palladium(II) acetate (0.023 mmol), and potassium fluoride (1.71 mmol) were added to a microwave vial, which was capped and purged three times with nitrogen/vacuum. A 1:1 mixture of degassed methanol:toluene (10 mL) was added, and the reaction was subjected to microwave irradiation at 130 °C for 30 min. The solvent was removed under reduced pressure, and the residue was partitioned between ethyl acetate and saturated aqueous sodium chloride solution. The aqueous layer was extracted with ethyl acetate (2 × 20 mL), and the organic layers were combined, dried over sodium sulfate, and filtered. The filtrate was concentrated under reduced pressure to a residue, which was purified by silica gel chromatography to afford <b>3</b> (58%) as a solid. LC-MS <i>m</i>/<i>z</i> 393.5 (M + 1). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.58 (d, <i>J</i> = 3.9 Hz, 1H), 7.55 (d, <i>J</i> = 8.8 Hz, 2H), 7.19 (d, <i>J</i> = 3.9 Hz, 1H), 6.95 (d, <i>J</i> = 8.8 Hz, 2H), 4.86 (ddd, <i>J</i> = 5.8, 4.4, 1.7 Hz, 1H), 4.76 (d, <i>J</i> = 9.8 Hz, 1H), 4.30–4.22 (m, 1H), 4.20 (dd, <i>J</i> = 10.7, 4.2 Hz, 1H), 4.17 (t, <i>J</i> = 8.0 Hz, 1H), 3.98 (dd, <i>J</i> = 10.7, 1.7 Hz, 1H), 3.72 (t, <i>J</i> = 8.8 Hz, 1H), 3.17 (sep, <i>J</i> = 6.8 Hz, 1H), 1.40 (d, <i>J</i> = 6.8 Hz, 3H), 1.37 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 157.5, 151.3, 138.4, 128.1, 126.5, 122.7, 116.3, 114.4, 107.7, 76.2, 72.0, 70.2, 55.6, 54.7, 16.7, 16.6. Elemental Analysis Calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>: C, 55.08; H, 5.14; N, 7.14. Found: C, 55.14; H, 4.99; N, 7.05. HRMS (ESI<sup>–</sup>) <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>S<sub>2</sub>, 393.0937; found, 393.0931; mp 102–104 °C; [α]<sup>20</sup><sub>D</sub> = −89.1° (<i>c</i> = 0.8, CHCl<sub>3</sub>).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Pharmacology</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> In Vitro</h4><div class="NLM_p last">Primary pharmacology assays assessed functional activity using mES cell-derived neuronal precursors,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and HEK293 cells stably expressing the Ca<sup>2+</sup>-permeable Q form human AMPAR subunits GluA2i and GluA2o<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> and binding affinity relative to [<sup>3</sup>H]<b>4</b><a onclick="showRef(event, 'cit13b'); return false;" href="javascript:void(0);" class="ref cit13b">(13b)</a> in rat cortical tissue homogenate.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> For <b>3</b>, its electrophysiological properties were characterized in cultures of rat cortical neurons as described.<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a></div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> In Vivo</h4><div class="NLM_p">Before in vivo pharmacology experiments, the pharmacokinetics (peripheral and/or central) of <b>3</b> were characterized in the appropriate species to determine: total plasma (<i>C</i><sub>p</sub>) and/or brain (<i>C</i><sub>b</sub>) compound concentrations at select times after a specific dose, pharmacokinetic parameters (particularly <i>C</i><sub>max</sub> and AUC) and their linearity at doses of pharmacological interest, which allowed the correlation of pharmacodynamics to <i>C</i><sub>p</sub> and/or <i>C</i><sub>b</sub>, <i>T</i><sub>max</sub>, which determined pretreatment time in certain assays, and <i>t</i><sub>1/2</sub> that dictated wash-out periods between doses in the rat RAM. For each species, the same vehicle and dosing route used in its pharmacokinetics study were employed in its pharmacodynamics experiment.</div><div class="NLM_p">Potentiator <b>3</b> was studied in select in vivo pharmacology models to understand the relationship between its <i>C</i><sub>b,u</sub> and a specific AMPAR-mediated effect, which together allowed comparison to its in vitro pharmacology values; this strategy<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> provided dose-dependent, temporally normalized, and assay-dependent <i>C</i><sub>b,u</sub> that could be directly compared across all in vivo models. For terminal assays in which brain tissue was collected from an animal undergoing pharmacodynamic assessment, <i>C</i><sub>b,u</sub> (nM units) was determined by measured <i>C</i><sub>b</sub>, compound molecular weight (MW, 392.5 g/mol), rat <i>f</i><sub>u,b</sub>, an assumed brain tissue density of 1 g/mL, and eq <a class="ref internalNav" href="#eq1" aria-label="1">1</a>:<span class="NLM_disp-formula" id="eq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/jm-2015-00300g_m001.gif" alt="" /></img><span class="labelSpan">(1)</span></span></div><div class="NLM_p">For the application to ultimate human dose projections and pharmacokinetic simulations, the <i>C</i><sub>b,u</sub> from any assay was converted to a human total plasma compound concentration (<i>C</i><sub>p</sub>, ng/mL units) using MW, rat <i>C</i><sub>b,u</sub>:<i>C</i><sub>p,u</sub> (0.59), human <i>f</i><sub>u,p</sub> (0.079) and eq <a class="ref internalNav" href="#eq2" aria-label="2">2</a>:<span class="NLM_disp-formula" id="eq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/jm-2015-00300g_m002.gif" alt="" /></img><span class="labelSpan">(2)</span></span></div><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> Mouse Cerebellum Cyclic Guanosine Monophosphate (cGMP) Assay</h5><div class="NLM_p last">A modified version<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a> of the procedure of Ryder et al.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> was used to determine the dose–response relationship of <b>3</b> (0.1, 0.32, 0.56, or 1.0 mg/kg, SC; <i>N</i> = 4–6/dose) to elevate cerebellar cGMP concentrations in CD-1 mice. For each dose group, data were reported as group means ± SEM using X-fold changes in tissue cGMP levels relative to the vehicle-treated group. Doses of <b>3</b> were compared to the concurrent vehicle control group using One-Way Analysis of Variance (ANOVA) followed by Dunnett’s <i>t</i> test (SigmaStat version 3.5; Systat Software, Inc., Chicago, IL). A value of <i>P</i> < 0.05 indicated a statistically significant effect.</div></div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> Mouse Rotarod Assay</h5><div class="NLM_p last">Employing the described procedure,<a onclick="showRef(event, 'cit13a'); return false;" href="javascript:void(0);" class="ref cit13a">(13a)</a><b>3</b> (0.1, 0.178, or 0.32 mg/kg, SC) was evaluated in C57BL/6J mice (<i>N</i> = 12/dose) on the accelerating rotarod.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> For testing, each mouse was subjected to three consecutive trials on the rods with a 10 s intertrial interval. The mean fall latency for three trials was calculated and data were reported as group means ± SEM. Doses of <b>3</b> were compared to the concurrent vehicle control group using One-Way ANOVA followed by Dunnett’s <i>t</i> test (SigmaStat version 3.5; Systat Software, Inc.). A value of <i>P</i> < 0.05 indicated a statistically significant effect. Upon completion of the last trial, a subset of animals (<i>N</i> = 2–3/dose) underwent blood and brain sample collection for <b>3</b> quantification.</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> Rat MK-801-Disrupted Cortical Oscillation and Paired-Pulse Facilitation (PPF) Assay</h5><div class="NLM_p last">This study quantified the effects of <b>3</b> on the disruption of cortical EEG and PPF by the NMDAR antagonist MK-801 (0.05 mg/kg, IV; Tocris Bioscience, Bristol, UK) in urethane-anesthetized rats.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This is a preclinical model, which evaluates the subiculum-medial PFC pathway, proposed for studying NMDAR hypofunction of schizophrenia. Experimental procedures were those published by Kiss et al.<a onclick="showRef(event, 'cit11b'); return false;" href="javascript:void(0);" class="ref cit11b">(11b)</a> using male Sprague–Dawley rats (250 to 320 g, <i>N</i> = 5) under urethane anesthesia (1.5 mg/kg, intraperitoneal). For the IV dose–response effects of <b>3</b>, control waveform averages were first computed using 60 consecutive paired-stimuli over a 10 min period. MK-801 was then administered, and after a 5 min waiting period, paired-pulse averaging was again conducted over the next two consecutive 5 min time bins. The total MK-801 response was then computed by combining these two averages. At the end of the second 5 min data collection time bin (i.e., 15 min after MK-801 injection), cumulative IV administration of <b>3</b> (0.001, 0.003, and 0.01 mg/kg) was initiated. Similar to how the data were handled following MK-801 dosing, 5 min were allowed between each successive injection of <b>3</b> and the start of the subsequent averaging. If no effect was observed before the end of the second 5 min averaging period, then the two 5 min averages were combined as a single value for that dose and the next IV dose was given. If an effect was observed at any point during the first two averages following a given dose, then two additional 5 min averages were combined as the data point for that dose. The reversal of the MK-801 effects by <b>3</b> did not occur in a typical cumulative dose–response manner, but rather as an all-or-none effect with variable threshold doses between animals. Because reversal was an all-or-none effect once the threshold dose in a particular animal was reached, no additional cumulative doses of <b>3</b> were given. Subsequently, a PPF time-course study was conducted with a single dose of <b>3</b> (0.01 mg/kg, IV; <i>N</i> = 3). In this experiment, responses to the paired-pulse stimulations were recorded continuously and averaged over each consecutive 10 min time-bin for 60 min to obtain the overall time-course of <b>3</b> activity. Mean effects in the doses of <b>3</b> (cumulative-dose study) or time-bins (single-dose study) were compared to both the control and MK-801 doses using a two-tailed Student’s <i>t</i> test (Microsoft Excel, Microsoft Corporation, Redmond, WA). A value of <i>P</i> < 0.05 indicated a statistically significant effect. For the cumulative-dose study, a Spearman–Karber analysis calculated an effective dose for 50% of animals (ED<sub>50</sub>) to provide an idea of a minimally effective dose.</div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Pharmacokinetic/Pharmacodynamic Modeling of the PPF Assay</h5><div class="NLM_p last">From the IV neuropharmacokinetics study, the <i>C</i><sub>p</sub> of <b>3</b> was characterized by an empirical two-compartment model; from the time-course PPF study, the MK-801-induced PPF disruption was modeled as a baseline. A link model was used to describe the slight hysteresis between the reversal of the MK-801-induced PPF disruption and <i>C</i><sub>p</sub>. Because the time-course study was only conducted at one dose (0.01 mg/kg, IV), a slope model was used to describe the pharmacodynamic interaction within the effect compartment. Final parameter estimates were obtained using nonlinear mixed-effect modeling with interanimal variability in baseline MK-801-induced PPF disruptions. Model characterization and parameter estimation procedures were performed using NONMEM version V (University of California at San Francisco, CA).</div></div><div id="sec4_3_2_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Rat Ketamine-Disrupted Spatial Working Memory Radial Arm Maze (RAM)</h5><div class="NLM_p last">This study’s goal was to quantify the ability of <b>3</b> to antagonize the ketamine-induced spatial working memory impairments in rats, a model of glutamatergic dysregulation hypothesized to underlie the cognitive deficits in schizophrenia.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Prior to RAM, <b>3</b> (0.01, 0.032, 0.1, 0.32, and 1 mg/kg, SC) was tested in unhabituated and habituated Long–Evans rats to evaluate its effects on basal locomotor activity and in psychomotor stimulant-induced hyperactivity tests to aid with dose selection in RAM experiments; <b>3</b> had no significant effects on locomotor activities under any condition. Briefly, Long–Evans rats were trained in a spatial working memory version of the RAM task until all animals had reached the training criterion. Performance on the maze was then evaluated 0.5 h after the administration of (±)-ketamine (10 mg/kg, SC; Ketaset, Zoetis, Florham Park, NJ) to animals (<i>N</i> = 12/dose) that had received either vehicle or <b>3</b> (0.0032, 0.01, 0.032, 0.1, or 0.32 mg/kg, SC) 0.5 h before (±)-ketamine. Working memory errors were reported as group means ± SEM. All dose groups were compared to the vehicle-treated ketamine-disrupted group using a generalized linear mixed model assuming an underlying Poisson distribution followed by a Hochberg’s test for multiple post hoc comparisons (SAS Software, SAS Institute, Inc., Cary NC). A value of <i>P</i> ≤ 0.05 indicated a statistically significant effect.</div></div><div id="sec4_3_2_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Rat 2-Deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose Positron Emission Tomography (FDG-PET)</h5><div class="NLM_p last">This study determined in rats the effect on central activity, as measured by changes in regional brain uptake of FDG, by <b>3</b> relative to vehicle. Thirty-six male Sprague–Dawley rats (<i>N</i> = 12/group) were deprived of food overnight to ensure fasted glucose levels at the time of PET scanning. A single injection (1 mL/kg, SC) of vehicle (2:98 (v/v) DMSO:30% hydroxypropyl-β-cyclodextrin) or <b>3</b> (0.027, 0.08, or 0.60 mg/kg) was administered to each animal within its respective dose group. After 0.5 h, rats were briefly anesthetized with isoflurane (5% and 2% (v/v) in oxygen for knock-down and maintenance, respectively, and given an IV bolus of FDG (ca. 1.8 mCi in 0.5 mL saline, followed by a flush of 0.5 mL saline) via the tail vein. Animals were then allowed to recover and kept awake in their home cage during a 0.75 h FDG-uptake phase. Subsequently, each rat was reanesthetized with isoflurane (1–2% in oxygen) and placed on an animal bed with its brain centered in the field of view of a Focus F220 microPET scanner (Siemens Molecular Imaging, Knoxville, TN). Its head was fixed in place by a tooth bar and ear canal holders for a 15 min static PET scan at 0.75–1 h after FDG injection. Animal breathing rate was monitored and maintained around 40–60 breaths per min using a small animal physiological monitoring system (SA Instruments Inc., Stony Brook, NY), and rats were sacrificed using CO<sub>2</sub> immediately after scanning. The PET images were reconstructed into standard uptake values (SUV) by applying corrections for detector normalization, decay, attenuation, and scatter using a hybrid 3D OSEM/MAP reconstruction algorithm (microPET Manager, Siemens Molecular Imaging) to a 128 × 128 × 95 matrix with a voxel size of 0.6 mm × 0.6 mm × 0.796 mm. Then, the images were coregistered and mapped to a standard rat brain atlas for identification of brain regions using a proprietary registration algorithm employing a rigid-body transform. The PET image of each animal was normalized by its mean whole brain uptake to remove the whole brain FDG uptake variations among animals. Subsequently, Analysis of Functional NeuroImages (AFNI) software<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> was applied to perform voxel-by-voxel statistical parametric mapping via an unpaired <i>t</i> test to look for significant changes in FDG uptake by comparing the two <b>3</b>-treated groups to the vehicle-treated group. For the AFNI analysis, the PET image voxel size was resampled to be 0.5 mm × 0.5 mm × 0.5 mm. A correction for multiple comparisons was made within the AFNI analysis package by selecting a voxel cluster size generated from a Monte Carlo simulation. Only voxels passing the <i>t</i> test (<i>P</i> < 0.05) and satisfying the cluster size constraints for connectivity were considered significant; only voxels that were significantly increased or decreased between animal groups were identified by the AFNI analysis. For the three groups receiving <b>3</b>, the number of voxels with significantly increased FDG uptake compared to the vehicle group within the entire volume of the cortex and cerebellum were counted.</div></div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Pharmacokinetics Studies</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Interspecies Binding Factors</h4><div class="NLM_p last">Using published procedures,<a onclick="showRef(event, 'cit16b ref21'); return false;" href="javascript:void(0);" class="ref cit16b ref21">(16b, 21)</a> the blood-to-plasma concentration ratio (B/P) and unbound fraction (<i>f</i><sub>u</sub>) in both plasma (<i>f</i><sub>u,p</sub>) and liver microsomes (<i>f</i><sub>u,LM</sub>) of <b>3</b> (0.05 and 0.5 μM, <i>N</i> = 4/species) were determined for rat, dog, NHP, and human; its (1 μM, <i>N</i> = 4) unbound fraction in rat brain homogenate (<i>f</i><sub>u,b</sub>) was ascertained similarly. The stability of <b>3</b> in each matrix and the optimal incubation/dialysis time were determined separately prior to actual studies.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> In Vitro Metabolism</h4><div class="NLM_p last">Incubations using interspecies (rat, dog, NHP, and human) liver (LM) and intestinal (IM) microsomes and hepatocytes (Hep) and recombinant human cytochrome P450s (rhCYP) were performed as described.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Using either the BioBook module in the E-Workbook Suite (IDBS Ltd., Guildford, Surrey, UK) or manual calculation in Microsoft Excel (Microsoft Corp., Redmond, WA), hepatic apparent intrinsic (<i>CL</i><sub>int,app</sub>), and blood (<i>CL</i><sub>H</sub>) clearances were calculated using the well-stirred model without (LM and Hep) and with (LM) all binding factors.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> In Vivo Pharmacokinetics</h4><div class="NLM_p">Individual animal doses were calculated based on respective dose solution concentrations (mg/mL), pretreatment body weights (kg), and dose volume (mL/kg). The actual amount of dose solution administered to each animal was determined by weighing the loaded syringe before and after it was dispensed. All study animals were fasted overnight and for ca. 4 h postdose.</div><div id="sec4_4_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Mouse</h5><div class="NLM_p last">A single dose (1.78 mg/kg) of <b>3</b> in 5:5:90 (v/v/v) DMSO:cremophor EL:H<sub>2</sub>O (0.178 mg/mL) was administered (10 mL/kg) subcutaneously (SC) to CD-1 (<i>N</i> = 3) mice. At 0.5 h postdose, animals were placed under isoflurane anesthesia for the collection of blood and brain samples.</div></div><div id="sec4_4_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i39" class="anchor-spacer"></div><h5 class="article-section__title" id="_i39"> Rat</h5><div class="NLM_p last"><i>Intravenous and Oral Dosing</i>. Jugular vein-cannulated rats (<i>N</i> = 2/dose) received <b>3</b> either as a single intravenous bolus (IV, 1 mL/kg, 0.2 mg/kg, 20% hydroxypropyl-β-cyclodextrin) or by oral gavage (PO, 10 mL/kg, 3 mg/kg, 0.5% methylcellulose). For the IV study, blood samples (0.2 mL) were serially collected just before dosing and at 0.083, 0.25, 0.5, 1, 2, 4, and 7 h postdose; for the PO study, identical sampling occurred at 0.25, 0.5, 1, and 2 h postdose. <i>Neuropharmacokinetics</i>. A single dose (1 mg/kg, SC) of <b>3</b> in 2:98 (v/v) DMSO:30% hydroxypropyl-β-cyclodextrin (1 mg/mL) was injected (1 mL/kg) into each rat. Blood, cerebrospinal fluid (CSF), and brain samples were collected from each animal after isoflurane anesthesia euthanasia at 0.25, 0.5, 1, 2, 4, and 8 h postdose (<i>N</i> = 2/time point). This study was conducted to determine both basic neuropharmacokinetic parameters<a onclick="showRef(event, 'cit16b'); return false;" href="javascript:void(0);" class="ref cit16b">(16b)</a> and to provide time point-specific <i>C</i><sub>b,u</sub> for extrapolating linearly <i>C</i><sub>b,u</sub> at a select time point for each dose tested in the rat RAM model. Separately, a single IV-dosed (0.01 mg/kg) rat neuropharmacokinetics study was performed in urethane-anesthetized animals using PPF assay conditions. Blood and brain samples were collected from each animal at 5, 10, 15, 30, and 60 min postdose (<i>N</i> = 2/time point) to parallel the full duration of a PPF experiment. The exposure-time data from this study was exclusively used for the PPF model experiments to linearly project <i>C</i><sub>b,u</sub> in dose–response studies and to establish from a single-dose study the temporal PK/PD relationship of <b>3</b>.</div></div><div id="sec4_4_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i40" class="anchor-spacer"></div><h5 class="article-section__title" id="_i40"> Dog</h5><div class="NLM_p last">A single dose (0.1 mg/kg, PO) of <b>3</b> in 0.5% methylcellulose was given (1 mL/kg) to each dog (<i>N</i> = 3/gender). Blood samples (2 mL) were obtained via the jugular vein just before dosing and at 0.25, 0.5, 1, 2, 6, and 24 h postdose. For the first 6 h following dosing, animals were continuously monitored by trained lab staff for any readily apparent adverse events.</div></div><div id="sec4_4_3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i41" class="anchor-spacer"></div><h5 class="article-section__title" id="_i41"> Nonhuman Primate (NHP)</h5><div class="NLM_p last">A single dose (0.032 mg/kg, SC) of <b>3</b> in 1:9 (v/v) cremophor EL:H<sub>2</sub>O (1 mL/kg) was administered to the dorsal thoracolumbar area of each NHP (<i>N</i> = 2). Blood samples (3 mL) were obtained via a vascular access port just before dosing and at 0.25, 0.5, 1, 2, 4, 6, and 24 h postdose. After remaining chaired for 2 h postdose, animals were returned to their home cage. They were again chaired just prior to blood collection at 4, 6, and 24 h postdose and released back to their home cage after each blood sampling. Trained lab staff constantly observed each NHP for any readily apparent adverse events for 6 h postdose.</div></div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Quantitative Analysis of <b>3</b> in Biological Matrices</h4><div class="NLM_p last">The quantification of <b>3</b> in interspecies plasma, rat CSF or rodent brain tissue samples was achieved using slightly modified versions of published LC-MS/MS methodologies<a onclick="showRef(event, 'cit16b ref21'); return false;" href="javascript:void(0);" class="ref cit16b ref21">(16b, 21)</a> with an appropriate internal standard. Mass spectral data were collected using negative ionization in multiple-reaction monitoring scanning mode tracking <i>m</i>/<i>z</i> 391.1 → 284.9 (<b>3</b>). Respective matrix lower (LLOQ) and upper limits of quantification were: 0.1–100 ng/mL for rodent, dog, and human plasma, 0.06–6 ng/mL for NHP plasma, 0.1–100 ng/mL for rat CSF, and 0.6– 60 ng/mL for rodent brain tissue. Analyst 1.4.2 (Applied Biosystems, Foster City, CA) software was used for the acquisition and processing of mass spectral data as well as analyte quantification performed via weighted (1/<i>x</i><sup>2</sup>) linear regression.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Pharmacokinetic Calculations</h4><div class="NLM_p last">Pharmacokinetic parameters were calculated by noncompartmental analyses using WinNonlin version 5.2 (Pharsight Corp., Mountain View, CA). The area under the matrix compound concentration–time curve (AUC<sub>0–Tlast</sub>) was calculated using the linear trapezoidal method, the elimination rate constant (<i>k</i><sub>el</sub>) was determined by linear regression of the log concentration versus time data during the last observable elimination phase, half-life (<i>t</i><sub>1/2</sub>) was calculated as 0.693/<i>k</i><sub>el</sub>, and AUC<sub>0–∞</sub> was calculated as the sum of AUC<sub>0–Tlast</sub> and AUC<sub>Tlast–∞</sub>, which was determined by dividing the plasma concentration at <i>T</i><sub>last</sub> by <i>k</i><sub>el</sub>. Both maximal total matrix drug concentration (<i>C</i><sub>max</sub>) and its time of first occurrence (<i>T</i><sub>max</sub>) were taken directly from the matrix compound concentration–time data. Means and standard deviations (SD) were computed when half or greater of the values exceeded the LLOQ; 0 was used if a measured value was <LLOQ. Volume of distribution (<i>V</i>) was calculated by the equation <i>V</i> = CL·(AUMC/AUC), where AUMC is the total area under the first moment–time curve and systemic clearance (<i>CL</i>) was determined by dividing the measured dose by plasma AUC<sub>0–Tlast</sub>. All AUC values were subject weight-normalized.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Biotransformation</h4><div class="NLM_p last">To gain a preliminary assessment of the metabolites of <b>3</b>, it underwent in vitro biotransformation studies and, subsequently, metabolite profiling of plasma (rat, dog) and brain samples (rat). Briefly, incubations with <b>3</b> (10 μM) were performed in interspecies LM (1 mg protein/mL, 30 min incubation) and human hepatocytes (0.75 × 10<sup>6</sup> viable cells/mL, 2.5 h incubation) using reported<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> experimental and bioanalytical procedures. Plasma and brain samples came from single-dose toxicology studies and were processed similarly to identical samples undergoing <b>3</b> quantification only.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Predicted Human Pharmacokinetics and Simcyp Simulations for <b>3</b></h4><div class="NLM_p last">Using precisely the same published<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> methodology and simulation criteria, clinical pharmacokinetic parameters were projected and a combination of these parameters and rhCYP <i>CL</i><sub>int,app</sub> were incorporated into Simcyp v8.10 SP1 (Certara, L.P., St. Louis, MO) to simulate human <i>C</i><sub>p</sub>-time profiles for a forecasted clinically relevant single or multiple oral dose(s) (0.3 mg) of <b>3</b>. The virtual population (<i>N</i> = 100) was constructed by 10 trials (<i>N</i> = 10/trial), 18–65 y old healthy volunteers (34% female), a fixed seed value of 1, fasted, 250 mL of fluid intake with dose, no contribution of renal clearance to <b>3</b> systemic clearance, and a coefficient of variation of 30%.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00300">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31720" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31720" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and characterization data for <b>3</b> and <b>6</b>–<b>28</b>, single X-ray crystallography data for <b>3</b>, X-ray data collection and refinement statistics for protein/ligand complexes, summary of electrophysiology experiments with <b>3</b> in rat primary cortical neurons, and preclinical pharmacokinetics and biotransformation data for <b>3</b>. The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b00300" class="ext-link">10.1021/acs.jmedchem.5b00300</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00300/suppl_file/jm5b00300_si_001.pdf">jm5b00300_si_001.pdf (553.55 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited to the Protein Data Bank for human GluA2o complexes of <b>5</b> (LY451646) (ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5">4LZ5</a>) and <b>3</b> (PF-04958242) (ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X48">4X48</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b00300" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05407" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05407" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher L. Shaffer</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#501338223923243f203835227e1c7e03383136363522102036392a35227e333f3d"><span class="__cf_email__" data-cfemail="c784afb5aeb4b3a8b7afa2b5e98be994afa6a1a1a2b587b7a1aebda2b5e9a4a8aa">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. O’Donnell</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#602308120913140f100805124e2a4e2f240f0e0e050c0c201006091a05124e030f0d"><span class="__cf_email__" data-cfemail="fcbf948e958f88938c94998ed2b6d2b3b8939292999090bc8c9a9586998ed29f9391">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nandini C. Patel</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob Schwarz</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Renato J. Scialis</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunjing Wei</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun J. Hou</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Longfei Xie</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kapil Karki</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dianne K. Bryce</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah M. Osgood</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William E. Hoffmann</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John T. Lazzaro</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Chang</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dina F. McGinnis</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan M. Lotarski</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">JianHua Liu</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">R. Scott Obach</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark L. Weber</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laigao Chen</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kenneth R. Zasadny</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patricia A. Seymour</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihály Hajós</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raymond S. Hurst</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jayvardhan Pandit</span> - <span class="hlFld-Affiliation affiliation">†Department of Pharmacokinetics, Dynamics and Metabolism, ‡Neuroscience Research
Unit, §Worldwide
Medicinal Chemistry and ||BioImaging Center, Worldwide
Research & Development, Groton Laboratories, Pfizer Inc., Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): At the time that this work was completed, all authors were full-time employees of Pfizer Inc. and owned and/or held options and/or restricted stock units for the company’s publicly traded shares.  At the time that this work was disclosed, only some authors were full-time employees of Pfizer Inc. and thus they maintained the aforementioned equity interest(s).<br /></br></div></li></ul></div><div class="ack" id="ACK-d4569e4780-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06522" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06522" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We acknowledge Roberta Dorow, Michael W. Fichtner, John M. Humphrey, Morgan Stewart, Don Wishka, and Kevin Witter for chemistry scale-up support, Eric S. Marr and Brian Samas for GluA2o protein purification and protein–ligand complex crystallization, Curt Christoffersen for performing the in-life portion of the NHP pharmacokinetics study, and Haojing Rong for conducting initial Simcyp simulations.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i58" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i58"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i59" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i59"> Abbreviations Used</h2><tr><td class="NLM_term">AMPA(R)</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (receptors)</p></td></tr><tr><td class="NLM_term">NMDAR</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors</p></td></tr><tr><td class="NLM_term">GluA2o</td><td class="NLM_def"><p class="first last">the flop splice form of the AMPAR subtype 2</p></td></tr><tr><td class="NLM_term">TI</td><td class="NLM_def"><p class="first last">therapeutic index</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>b,u</sub></td><td class="NLM_def"><p class="first last">unbound brain compound concentration</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand-binding domain</p></td></tr><tr><td class="NLM_term">PFC</td><td class="NLM_def"><p class="first last">prefrontal cortex</p></td></tr><tr><td class="NLM_term">AE</td><td class="NLM_def"><p class="first last">adverse event(s)</p></td></tr><tr><td class="NLM_term">mES</td><td class="NLM_def"><p class="first last">mouse embryonic stem</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term"><i>CL</i><sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">PPF</td><td class="NLM_def"><p class="first last">paired-pulse facilitation</p></td></tr><tr><td class="NLM_term">FDG</td><td class="NLM_def"><p class="first last">2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18714" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18714" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 49 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malinow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">AMPA receptor trafficking and synaptic plasticity</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1146%2Fannurev.neuro.25.112701.142758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12052905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=103-126&author=R.+Malinowauthor=R.+C.+Malenka&title=AMPA+receptor+trafficking+and+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor trafficking and synaptic plasticity</span></div><div class="casAuthors">Malinow, Roberto; Malenka, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-126</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Activity-dependent changes in synaptic function are believed to underlie the formation of memories.  Two prominent examples are long-term potentiation (LTP) and long-term depression (LTD), whose mechanisms have been the subject of considerable scrutiny over the past few decades.  Here we review the growing literature that supports a crit. role for AMPA receptor trafficking in LTP and LTD, focusing on the roles proposed for specific AMPA receptor subunits and their interacting proteins.  While much work remains to understand the mol. basis for synaptic plasticity, recent results on AMPA receptor trafficking provide a clear conceptual framework for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXbY4P375GeLVg90H21EOLACvtfcHk0ljLyIJ-JHox-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D&md5=bdf912ce2115da5d4cb87031d707d745</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.25.112701.142758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.25.112701.142758%26sid%3Dliteratum%253Aachs%26aulast%3DMalinow%26aufirst%3DR.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DAMPA%2520receptor%2520trafficking%2520and%2520synaptic%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D25%26spage%3D103%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huganir, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span> </span><span class="NLM_article-title">AMPARs and synaptic plasticity: the last 25 years</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2013&pages=704-717&author=R.+L.+Huganirauthor=R.+A.+Nicoll&title=AMPARs+and+synaptic+plasticity%3A+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuganir%26aufirst%3DR.%2BL.%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26atitle%3DAMPARs%2520and%2520synaptic%2520plasticity%253A%2520the%2520last%252025%2520years%26jtitle%3DNeuron%26date%3D2013%26volume%3D80%26spage%3D704%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">Memory enhancement: the search for mecahnism-based drugs</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1038%2Fnn935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12403980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1035-1038&author=G.+Lynch&title=Memory+enhancement%3A+the+search+for+mecahnism-based+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancement: the search for mechanism-based drugs</span></div><div class="casAuthors">Lynch, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1035-1038</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapid progress has been made in understanding the synaptic changes required for memory encoding.  Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs.  These efforts have produced novel compds. that improve retention scores across a broad range of tests and species.  Initial clin. results are encouraging.  Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN-gQ6I9ivB7Vg90H21EOLACvtfcHk0ljLyIJ-JHox-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D&md5=f391c93b5e05f4c8ba19a0bbbc05ee97</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnn935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn935%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DMemory%2520enhancement%253A%2520the%2520search%2520for%2520mecahnism-based%2520drugs%26jtitle%3DNature%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D1035%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Ampakines and the threefold path to cognitive enhancement</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=554-562&author=G.+Lynchauthor=C.+M.+Gall&title=Ampakines+and+the+threefold+path+to+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DAmpakines%2520and%2520the%2520threefold%2520path%2520to%2520cognitive%2520enhancement%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D554%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Morris, R. G. M.</span><span> </span><span class="NLM_article-title">Long-term potentiation and memory</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1098%2Frstb.2002.1230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12740109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=643-647&author=R.+G.+M.+Morris&title=Long-term+potentiation+and+memory"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term potentiation and memory</span></div><div class="casAuthors">Morris Richard G M</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">643-7</span>
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    </div><div class="casAbstract">The discovery of long-term potentiation (LTP) transformed research on the neurobiology of learning and memory.  This did not happen overnight, but the discovery of an experimentally demonstrable phenomenon reflecting activity-driven neuronal and synaptic plasticity changed discussions about what might underlie learning from speculation into something much more concrete.  Equally, however, the relationship between the discovery of LTP and research on the neurobiology of learning and memory has been reciprocal; for it is also true that studies of the psychological, anatomical and neurochemical basis of memory provided a developing and critical intellectual context for the physiological discovery.  The emerging concept of multiple memory systems, from 1970 onwards, paved the way for the development of new behavioural and cognitive tasks, including the watermaze described in this paper.  The use of this task in turn provided key evidence that pharmacological interference with an LTP induction mechanism would also interfere with learning, a finding that was by no means a foregone conclusion.  This reciprocal relationship between studies of LTP and the neurobiology of memory helped the physiological phenomenon to be recognized as a major discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRumjSaqwyW3lvAgqb2vdc5fW6udTcc2eZrBfK7WkZpybntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D&md5=b9975b00a2dba770a29a392832ba549a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1230%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DLong-term%2520potentiation%2520and%2520memory%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2003%26volume%3D358%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, M. E.</span><span> </span><span class="NLM_article-title">Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7342</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.4603-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16093384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7342-7351&author=X.+Sunauthor=Y.+Zhaoauthor=M.+E.+Wolf&title=Dopamine+receptor+stimulation+modulates+AMPA+receptor+synaptic+insertion+in+prefrontal+cortex+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons</span></div><div class="casAuthors">Sun, Xiu; Zhao, Yun; Wolf, Marina E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">7342-7351</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Addiction is believed to involve glutamate-dependent forms of synaptic plasticity that promote the formation of new habits focused on drug seeking.  The authors used primary cultures of rat prefrontal cortex (PFC) neurons to explore mechanisms by which dopamine-releasing psychomotor stimulants such as cocaine and amphetamine influence synaptic plasticity, focusing on AMPA receptor trafficking because of its key role in long-term potentiation (LTP).  Brief stimulation of D1 dopamine receptors increased surface expression of glutamate receptor 1 (GluR1)-contg. AMPA receptors through a protein kinase A-dependent mechanism, by increasing their rate of externalization at extrasynaptic sites.  Newly externalized GluR1 remained extrasynaptic under basal conditions but could be translocated into synapses by subsequent NMDA receptor activation.  These results suggest that D1 receptors may facilitate LTP by increasing the AMPA receptor pool available for synaptic insertion.  However, stimulation of D2 receptors decreased surface and synaptic GluR1 expression.  These findings are discussed in the context of evidence that D1 and D2 receptors act independently rather than antagonistically in the intact PFC.  D1 receptor facilitation of AMPA receptor synaptic insertion helps explain D1 receptor-dependent facilitation of LTP and learning in the normal brain.  Abnormal engagement of this mechanism during unregulated dopamine release may account for maladaptive plasticity after repeated exposure to cocaine or amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHWXErG4Fz1bVg90H21EOLACvtfcHk0lhLQafiFvGSqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGiur4%253D&md5=aa96d7798c1f400e4f67ce2920b81e7e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4603-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4603-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520receptor%2520stimulation%2520modulates%2520AMPA%2520receptor%2520synaptic%2520insertion%2520in%2520prefrontal%2520cortex%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7342%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Black, M. D.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=154-163&author=M.+D.+Black&title=Therapeutic+Potential+of+Positive+AMPA+Modulators+and+Their+Relationship+to+AMPA+Receptor+Subunits.+A+Review+of+Preclinical+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520Potential%2520of%2520Positive%2520AMPA%2520Modulators%2520and%2520Their%2520Relationship%2520to%2520AMPA%2520Receptor%2520Subunits.%2520A%2520Review%2520of%2520Preclinical%2520Data%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grove, S. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7271-7279&author=S.+J.+A.+Groveauthor=C.+Jamiesonauthor=J.+K.+F.+Macleanauthor=J.+A.+Morrowauthor=Z.+Rankovic&title=Positive+allosteric+modulators+of+the+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm1000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000419%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DS.%2BJ.%2BA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7271%26epage%3D7279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">AMPA Receptor Potentiators for the Treatment of CNS Disorders</span> <span class="citation_source-journal">Curr. Drug Targets CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.2174%2F1568007043337508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=15180479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=181-194&author=M.+J.+O%E2%80%99Neillauthor=D.+Bleakmanauthor=D.+M.+Zimmermanauthor=E.+S.+Nisenbaum&title=AMPA+Receptor+Potentiators+for+the+Treatment+of+CNS+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor potentiators for the treatment of CNS disorders</span></div><div class="casAuthors">O'Neill, Michael J.; Bleakman, David; Zimmerman, Dennis M.; Nisenbaum, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-194</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors mediate most of the excitatory neurotransmission in the mammalian central nervous system and also participate in forms of synaptic plasticity thought to underlie memory and learning, and the formation of neural networks during development.  Mol. cloning techniques have shown that the AMPA receptor family is composed of 4 different subunits named GluR1-4 or GluRA-D (newly termed as GluA1-GluA4) and native AMPA receptors are most likely tetramers generated by the assembly of 1 or more of these subunits, yielding homomeric or heteromeric receptors.  Addnl. complexity among AMPA receptors is conferred by alternative splicing of RNA for each subunit giving rise to flip and flop variants.  Clin. and exptl. data have suggested that pos. modulation of AMPA receptors may be therapeutically effective in the treatment of cognitive deficits.  Several classes of AMPA receptor potentiators were reported, including pyrrolidones (piracetam, aniracetam), benzothiazides (cyclothiazide), benzylpiperidines (CX-516, CX-546), and more recently biarylpropylsulfonamides (LY392098, LY404187 and LY503430).  These mols. enhance cognitive function in rodents, which appears to correlate with increased hippocampal activity.  In addn., clin. studies have suggested that AMPA receptor modulators enhance cognitive function in elderly subjects, as well as patients suffering from neurol. and psychiatric disorders.  Several independent studies have suggested that AMPA receptors can increase BDNF expression by both calcium-dependent and independent pathways.  For example, recent studies have shown that AMPA receptors interact with the protein Tyr kinase, Lyn.  Activation of Lyn can recruit the mitogen-activated protein kinase (MAPK) signalling pathway and increase the expression of BDNF.  Therefore, in addn. to directly enhancing glutamatergic synaptic transmission, AMPA receptor activation can increase the expression of BDNF in vitro and in vivo.  This may account for activity of AMPA receptor potentiators in rodent models predictive of antidepressant activity (forced swim and tail suspension tests).  The increase in neurotrophin expression also may contribute to the functional, neuroprotective, and neurotrophic actions of LY404187 and LY503430 after infusion of 6-OHDA into the substantia nigra.  In conclusion, several potent, selective and systematically active AMPA receptor potentiators were reported.  Data indicate that these mols. modulate glutamatergic transmission, enhance synaptic transmission, long-term potentiation (LTP), and increase neurotrophin expression.  Therefore, these AMPA receptor potentiators offer an exciting new class of drugs with potentials for treating (1) cognitive impairment assocd. with Alzheimer's disease and schizophrenia, (2) depression, (3) slowing the progression and potentially enhancing recovery from Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYMd0O34_SLVg90H21EOLACvtfcHk0liE2Qo66cLxSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D&md5=5d438c3c4cc13fa863608073601cc6a1</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1568007043337508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337508%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DAMPA%2520Receptor%2520Potentiators%2520for%2520the%2520Treatment%2520of%2520CNS%2520Disorders%26jtitle%3DCurr.%2520Drug%2520Targets%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D181%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zarate, C. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.expneurol.2008.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18291371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2qtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2008&pages=7-10&author=C.+A.+Zarateauthor=H.+K.+Manji&title=The+role+of+AMPA+receptor+modulation+in+the+treatment+of+neuropsychiatric+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases</span></div><div class="casAuthors">Zarate, Carlos A.; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-10</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acidglutamate receptor is the major contributors of excitatory neurotransmission, reconciling the fast, rapidly desensitizing excitation of many synapses, and is concerned in the early response to glutamate in the synaptic space.  The results of some early studies depicting the roles of AMPA receptors are shown.  AMPA receptors have important roles in long-term neurotrophic/neuroprotective effects, aging, treatment of severe psychiatric disorders, as well as mood disorders.  It also failed to demonstrate any improvement in neuropsychiatric symptoms and in cognitive deficits or psychotic symptoms.  Thus, a better understanding of the mol. cellular mechanisms involved in disease and the mechanism of action of AMPA receptor modulators will be of the utmost importance when boarding in proof-of-concept studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIf-9Au4U3b7Vg90H21EOLACvtfcHk0liE2Qo66cLxSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2qtbY%253D&md5=63825025e9b5a2c8bcde3b4ff8e48407</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2008.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2008.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DThe%2520role%2520of%2520AMPA%2520receptor%2520modulation%2520in%2520the%2520treatment%2520of%2520neuropsychiatric%2520diseases%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D211%26spage%3D7%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRubeis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jay, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansuy, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Lindenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolls, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saletu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=141-168&author=M.+J.+Millanauthor=Y.+Agidauthor=M.+Bruneauthor=E.+T.+Bullmoreauthor=C.+S.+Carterauthor=N.+S.+Claytonauthor=R.+Connorauthor=S.+Davisauthor=B.+Deakinauthor=R.+J.+DeRubeisauthor=B.+Duboisauthor=M.+A.+Geyerauthor=G.+M.+Goodwinauthor=P.+Gorwoodauthor=T.+M.+Jayauthor=M.+Joelsauthor=I.+M.+Mansuyauthor=A.+Meyer-Lindenbergauthor=D.+Murphyauthor=E.+Rollsauthor=B.+Saletuauthor=M.+Speddingauthor=J.+Sweeneyauthor=M.+Whittingtonauthor=L.+J.+Young&title=Cognitive+dysfunction+in+psychiatric+disorders%3A+characteristics%2C+causes+and+the+quest+for+improved+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DBrune%26aufirst%3DM.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DClayton%26aufirst%3DN.%2BS.%26aulast%3DConnor%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DDeakin%26aufirst%3DB.%26aulast%3DDeRubeis%26aufirst%3DR.%2BJ.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DGoodwin%26aufirst%3DG.%2BM.%26aulast%3DGorwood%26aufirst%3DP.%26aulast%3DJay%26aufirst%3DT.%2BM.%26aulast%3DJoels%26aufirst%3DM.%26aulast%3DMansuy%26aufirst%3DI.%2BM.%26aulast%3DMeyer-Lindenberg%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DRolls%26aufirst%3DE.%26aulast%3DSaletu%26aufirst%3DB.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DCognitive%2520dysfunction%2520in%2520psychiatric%2520disorders%253A%2520characteristics%252C%2520causes%2520and%2520the%2520quest%2520for%2520improved%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D141%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+C.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0ljc0kJsnI6RuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volianskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidball, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolotto, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Molnarauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMolnar%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">Glutamate receptor dysfunction and schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Farchpsyc.1995.03950240016004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7492260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=998-1007&author=J.+W.+Olneyauthor=N.+B.+Farber&title=Glutamate+receptor+dysfunction+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor dysfunction and schizophrenia</span></div><div class="casAuthors">Olney, John W.; Farber, Nuri B.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">998-1007</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review, with 120 refs., which advances a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights N-methyl-D-aspartate receptor hypofunction as a key mechanism that can help explain major clin. and pathophysiol. aspects of schizophrenia.  The following fundamental features of schizophrenia are accommodated by this hypothesis: (1) the occurrence of structural brain changes during early development that have the potential for producing subsequent clin. manifestations of schizophrenia, (2) a quiescent period in infancy and adolescence before clin. manifestations are expressed, (3) onset in early adulthood of psychotic symptoms, (4) involvement of dopamine (D2) receptors in some cases but not others that would explain why some but not all patients are responsive to typical neuroleptic therapy, and (5) ongoing neurodegenerative changes and cognitive deterioration in some patients.  We propose that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents (clozapine, olanzapine, fluperlapine), a better understanding of the N-methyl-D-aspartate receptor hypofunction mechanism and ways of preventing its neurodegenerative consequences in the rat brain may lead to improved pharmacotherapy in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jBCscao6LVg90H21EOLACvtfcHk0lg6OeNXjw79VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D&md5=ce668d3a1c911f6a0eab2488b0a14ad5</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950240016004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950240016004%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DGlutamate%2520receptor%2520dysfunction%2520and%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D998%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goff, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span> </span><span class="NLM_article-title">The emerging role of glutamate in the pathophysiology and treatment of schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fappi.ajp.158.9.1367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=11532718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3MvovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1367-1377&author=D.+C.+Goffauthor=J.+T.+Coyle&title=The+emerging+role+of+glutamate+in+the+pathophysiology+and+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of glutamate in the pathophysiology and treatment of schizophrenia</span></div><div class="casAuthors">Goff D C; Coyle J T</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1367-77</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Research has implicated dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia.  This review evaluates evidence from preclinical and clinical studies that brain glutamatergic neurotransmission is altered in schizophrenia, may affect symptom expression, and is modulated by antipsychotic drugs.  METHOD:  A comprehensive review of scientific articles published over the last decade that address the role of glutamate in the pathophysiology of schizophrenia was carried out.  RESULTS:  Glutamatergic neurons are the major excitatory pathways linking the cortex, limbic system, and thalamus, regions that have been implicated in schizophrenia.  Postmortem studies have revealed alterations in pre- and postsynaptic markers for glutamatergic neurons in several brain regions in schizophrenia.  The N-methyl-D-aspartic acid (NMDA) subtype of glutamate receptor may be particularly important as blockade of this receptor by the dissociative anesthetics reproduces in normal subjects the symptomatic manifestations of schizophrenia, including negative symptoms and cognitive impairments, and increases dopamine release in the mesolimbic system.  Agents that indirectly enhance NMDA receptor function via the glycine modulatory site reduce negative symptoms and variably improve cognitive functioning in schizophrenic subjects receiving typical antipsychotics.  CONCLUSIONS:  Dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia, especially of the negative symptoms and cognitive impairments associated with the disorder, and is a promising target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQp5GLn-Koh8_h3YQQtAhNufW6udTcc2ebCaTVV4_ERqbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvovFKktw%253D%253D&md5=1ca16492e57ea93d117bbbb7a40dbc60</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.9.1367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.9.1367%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BC.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520emerging%2520role%2520of%2520glutamate%2520in%2520the%2520pathophysiology%2520and%2520treatment%2520of%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1367%26epage%3D1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Glutamate and schizophrenia: phencyclidine, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors, and dopamine–glutamate interactions</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2FS0074-7742%2806%2978003-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=17349858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2007&pages=69-108&author=D.+C.+Javitt&title=Glutamate+and+schizophrenia%3A+phencyclidine%2C+N-methyl-d-aspartate+receptors%2C+and+dopamine%E2%80%93glutamate+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions</span></div><div class="casAuthors">Javitt, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Integrating the Neurobiology of Schizophrenia</span>),
    <span class="NLM_cas:pages">69-108,, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a serious mental disorder that affects up to 1% of the population worldwide.  As of yet, neurochem. mechanisms underlying schizophrenia remain unknown.  To date, the most widely considered neurochem. hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia may result from excess dopaminergic neurotransmission particularly in striatal brain regions, along with dopaminergic deficits in prefrontal brain regions.  Alternative neurochem. models of schizophrenia, however, have been proposed involving glutamatergic mechanisms in general and N-methyl-D-aspartate (NMDA) receptors in particular.  A potential role for glutamatergic mechanisms in schizophrenia was first proposed ∼15 years ago based on the observation that the psychotomimetic agents phencyclidine (PCP) and ketamine induce psychotic symptoms and neurocognitive disturbances similar to those of schizophrenia by blocking neurotransmission at NMDA-type glutamate receptors.  Since that time, significant addnl. evidence has accumulated supporting a role for NMDA hypofunction in the pathophysiol. of schizophrenia.  Clin. challenge studies with PCP and ketamine have confirmed the close resemblance between NMDA antagonist-induced symptoms and neurocognitive deficits and those obsd. in schizophrenia, and suggest that NMDA dysfunction may lead to secondary dopaminergic dysregulation in striatal and prefrontal brain regions.  As compared to dopaminergic agents, NMDA antagonists induce neg. and cognitive symptoms of schizophrenia, as well as pos. symptoms.  Treatment studies with NMDA modulators, such as glycine, D-serine, and glycine transport inhibitors (GTIs), have yielded encouraging findings, although results remain controversial.  Finally, genetic linkage and in vivo neurochem. studies in schizophrenia highlight potential etiol. mechanisms giving rise to glutamatergic/NMDA dysfunction in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ZhuFfD0tJ7Vg90H21EOLACvtfcHk0lg6OeNXjw79VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Gmt74%253D&md5=dd081e288a66cdc6e3a98d0cfb49fa50</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2806%2978003-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252806%252978003-5%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlutamate%2520and%2520schizophrenia%253A%2520phencyclidine%252C%2520N-methyl-d-aspartate%2520receptors%252C%2520and%2520dopamine%25E2%2580%2593glutamate%2520interactions%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2007%26volume%3D78%26spage%3D69%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Krystal, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karper, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibyl, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heninger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Farchpsyc.1994.03950030035004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=8122957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=199-214&author=J.+H.+Krystalauthor=L.+P.+Karperauthor=J.+P.+Seibylauthor=G.+K.+Freemanauthor=R.+Delaneyauthor=J.+D.+Bremnerauthor=G.+R.+Heningerauthor=M.+B.+Bowersauthor=D.+S.+Charney&title=Subanesthetic+effects+of+the+noncompetitive+NMDA+antagonist%2C+ketamine%2C+in+humans.+Psychotomimetic%2C+perceptual%2C+cognitive%2C+and+neuroendocrine+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span></div><div class="casAuthors">Krystal, John H.; Karper, Laurence P.; Seibyl, John P.; Freeman, Glenna K.; Delaney, Richard; Bremner, J. Douglas; Heninger, George R.; Bowers, Malcolm B., Jr.; Charney, Dennis S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-214</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">When given at subanesthetic doses to healthy subjects, the N-methyl-D-aspartate (NMDA) agonist ketamine: (1) produced behaviors similar to the pos. and neg. symptoms of schizophrenia; (2) elicited alterations in perception; (3) impaired performance on tests of vigilance, verbal fluency, and the Wisconsin Card Sorting Test; (4) evoked symptoms similar to those of dissociative states; and (5) preferentially disrupted delayed word recall, sparing immediate recall and postdistraction recall.  Ketamine had no effect on the Mini-Mental State Examn.  Ketamine also had no effect on plasma 3-methoxy-4-hydroxyphenethylene glycol levels, although it blunted a test day decline in plasma homovanillic acid levels at the higher dose tested.  It also dose-dependently increased plasma cortisol and prolactin levels.  Ketamine produced small dose-dependent increases in blood pressure.  These data indicate that NMDA antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWxsI3lz_fbVg90H21EOLACvtfcHk0lhiaWZBCQbxtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D&md5=6554b88d3fd5f747a925fe5ffaf49cd6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030035004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030035004%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BK.%26aulast%3DDelaney%26aufirst%3DR.%26aulast%3DBremner%26aufirst%3DJ.%2BD.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DSubanesthetic%2520effects%2520of%2520the%2520noncompetitive%2520NMDA%2520antagonist%252C%2520ketamine%252C%2520in%2520humans.%2520Psychotomimetic%252C%2520perceptual%252C%2520cognitive%252C%2520and%2520neuroendocrine%2520responses%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D199%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+ketamine-induced+working+memory+impairments+by+AMPA+potentiators+in+a+nonhuman+primate+model+of+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0lhiaWZBCQbxtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520ketamine-induced%2520working%2520memory%2520impairments%2520by%2520AMPA%2520potentiators%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520cognitive%2520dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+oscillation+and+short-term+plasticity+in+the+rat+medial+prefrontal+cortex%3A+modelling+NMDA+hypofunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0ljsqin0POmJxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520oscillation%2520and%2520short-term%2520plasticity%2520in%2520the%2520rat%2520medial%2520prefrontal%2520cortex%253A%2520modelling%2520NMDA%2520hypofunction%2520of%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Marenco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.2165%2F00023210-200620030-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16529524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=173-185&author=S.+Marencoauthor=D.+R.+Weinberger&title=Therapeutic+Potential+of+Positive+AMPA+Receptor+Modulators+in+the+Treatment+of+Neuropsychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span></div><div class="casAuthors">Marenco, Stefano; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that potentiate the activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor cause a complex cascade of consequences in exptl. models, ranging from enhancement of long-term potentiation to induction of neurotrophic factors.  Animal studies characterizing the pharmacol. and behavioral effects of these substances have provided the rationale for several initial attempts to use these drugs in neuropsychiatric clin. settings.  Applications in schizophrenia, Alzheimer's disease and mild cognitive impairment have been initiated.  Other trials with these compds. include the treatment of Fragile X syndrome, and possible future applications may be in the field of Parkinson's disease.  The literature published to date is limited mostly to small phase I or II trials, so there is no conclusive evidence for or against the use of these drugs.  Substantial questions remain concerning which compds. to use, in what dose, for what condition and for how long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEIFzk9iLjHLVg90H21EOLACvtfcHk0ljsqin0POmJxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D&md5=09378aa20043ab2a78cd6bcd0787af16</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620030-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620030-00001%26sid%3Dliteratum%253Aachs%26aulast%3DMarenco%26aufirst%3DS.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520Potential%2520of%2520Positive%2520AMPA%2520Receptor%2520Modulators%2520in%2520the%2520Treatment%2520of%2520Neuropsychiatric%2520Disorders%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure–response continuum of the novel potentiator PF-4778574</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fjpet.113.204735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=23899905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=212-224&author=C.+L.+Shafferauthor=R.+S.+Hurstauthor=R.+J.+Scialisauthor=S.+M.+Osgoodauthor=D.+K.+Bryceauthor=W.+E.+Hoffmannauthor=J.+T.+Lazzaroauthor=A.+N.+Hanksauthor=S.+Lotarskiauthor=M.+L.+Weberauthor=J.+Liuauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Haj%C3%B3s&title=Positive+allosteric+modulation+of+AMPA+receptors+from+efficacy+to+toxicity%3A+the+interspecies+exposure%E2%80%93response+continuum+of+the+novel+potentiator+PF-4778574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span></div><div class="casAuthors">Shaffer, Christopher L.; Hurst, Raymond S.; Scialis, Renato J.; Osgood, Sarah M.; Bryce, Dianne K.; Hoffmann, William E.; Lazzaro, John T.; Hanks, Ashley N.; Lotarski, Susan; Weber, Mark L.; Liu, Jian Hua; Menniti, Frank S.; Schmidt, Christopher J.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-224</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) pos. allosteric modulation (i.e., "potentiation") has been proposed to overcome cognitive impairments in schizophrenia, but AMPAR overstimulation can be excitotoxic.  Thus, it is crit. to define carefully a potentiator's mechanism-based therapeutic index (TI) and to det. confidently its translatability from rodents to higher-order species.  Accordingly, the novel AMPAR potentiator N-{(3R,4S)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2H-pyran-4-yl}propane-2-sulfonamide (PF-4778574) was characterized in a series of in vitro assays and single-dose animal studies evaluating AMPAR-mediated activities related to cognition and safety to afford an unbound brain compd. concn. (Cb,u)-normalized interspecies exposure-response relationship.  Because it is unknown which AMPAR subtype(s) may be selectively potentiated for an optimal TI, PF-4778574 binding affinity and functional potency were detd. in rodent tissues expected to express a native mixt. of AMPAR subunits and their assocd. proteins to afford composite pharmacol. values.  Functional activity was also quantified in recombinant cell lines stably expressing human GluA2 flip or flop homotetramers.  Procognitive effects of PF-4778574 were evaluated in both rat electrophysiol. and nonhuman primate (nhp) behavioral models of pharmacol. induced N-methyl-D-aspartate receptor hypofunction.  Safety studies assessed carebellum-based AMPAR activation (mouse) and motor coordination disruptions (mouse, dog, and nhp), as well as convulsion (mouse, rat, and dog).  The resulting empirically derived exposure-response continuum for PF-4778574 defines a single-dose-based TI of 8- to 16-fold for self-limiting tremor, a readily monitorable clin. adverse event.  Importantly, the Cb,u mediating each physiol. effect were highly consistent across species, with efficacy and convulsion occurring at just fractions of the in vitro-derived pharmacol. values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5MdXGBbRYrVg90H21EOLACvtfcHk0lgaAoSGnhpYfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE&md5=8fead71db7d49812f68c25f603132679</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.204735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.204735%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulation%2520of%2520AMPA%2520receptors%2520from%2520efficacy%2520to%2520toxicity%253A%2520the%2520interspecies%2520exposure%25E2%2580%2593response%2520continuum%2520of%2520the%2520novel%2520potentiator%2520PF-4778574%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliri, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallaschun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9180</span><span class="NLM_x">–</span> <span class="NLM_lpage">9191</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401274b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9180-9191&author=N.+C.+Patelauthor=J.+Schwarzauthor=X.+J.+Houauthor=D.+J.+Hooverauthor=L.+Xieauthor=A.+J.+Fliriauthor=R.+J.+Gallaschunauthor=J.+T.+Lazzaroauthor=D.+K.+Bryceauthor=W.+E.+Hoffmanauthor=A.+N.+Hanksauthor=D.+McGinnisauthor=E.+S.+Marrauthor=J.+L.+Gazardauthor=M.+Hajosauthor=R.+J.+Scialisauthor=R.+S.+Hurstauthor=C.+L.+Shafferauthor=J.+Panditauthor=C.+J.+O%E2%80%99Donnell&title=Discovery+and+characterization+of+a+novel+dihydroisoxazole+class+of+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm401274b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401274b%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DFliri%26aufirst%3DA.%2BJ.%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DGazard%26aufirst%3DJ.%2BL.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520dihydroisoxazole%2520class%2520of%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%2520potentiators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9180%26epage%3D9191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garthwaite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span> </span><span class="NLM_article-title">Mechanisms of AMPA neurotoxicity in rat brain slices</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1111%2Fj.1460-9568.1991.tb01669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12106459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=729-736&author=G.+Garthwaiteauthor=J.+Garthwaite&title=Mechanisms+of+AMPA+neurotoxicity+in+rat+brain+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1991.tb01669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1991.tb01669.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarthwaite%26aufirst%3DG.%26aulast%3DGarthwaite%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520AMPA%2520neurotoxicity%2520in%2520rat%2520brain%2520slices%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1991%26volume%3D3%26spage%3D729%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brorson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzolillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">AMPA receptor desensitization predicts the selective vulnerability of cerebellar purkinje cells to excitotoxicity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7540678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1aqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=4515-4524&author=J.+R.+Brorsonauthor=P.+A.+Manzolilloauthor=S.+J.+Gibbonsauthor=R.+J.+Miller&title=AMPA+receptor+desensitization+predicts+the+selective+vulnerability+of+cerebellar+purkinje+cells+to+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity</span></div><div class="casAuthors">Brorson, James R.; Manzolillo, Patricia A.; Gibbons, Simon J.; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4515-24</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cerebellar Purkinje cells are selectively vulnerable to ischemia, although the reasons for this are unknown.  In cultured embryonic rat cerebellar neurons, the steady state responses to the desensitizing agonist AMPA (α-amino-3- hydroxy-5-methyl-4-isoxazole propionic acid) relative to responses to the nondesensitizing agonist kainate were greater in Purkinje cells compared to other cells, as measured by whole cell voltage clamp studies.  Fluorimetric [Ca2+]i imaging expts. similarly found greater responses to AMPA relative to kainate in Purkinje cells than in other cerebellar neurons.  In toxicity expts., measuring cell survival 24 h following agonist exposure, AMPA and glutamate produced Ca2+-dependent toxicity which was selective for the Purkinje cell fraction of the neurons, whereas kainate produced nonselective toxicity, and NMDA selectively spared the mature Purkinje cells.  Cyclothiazide, which inhibits AMPA receptor desensitization, enhanced steady state current responses to AMPA and increased the toxicity of AMPA.  Thus, the vulnerability of cerebellar neurons in culture to glutamate agonist-induced toxicity parallels the magnitude of the steady state currents produced, and that Purkinje cells may be selectively vulnerable because they express AMPA receptors which undergo less complete desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosGWfViNuLPLVg90H21EOLACvtfcHk0lhSJGMV26v7NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1aqtbc%253D&md5=1fc628fd3b70b92ca24c0efcf5ad0e07</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrorson%26aufirst%3DJ.%2BR.%26aulast%3DManzolillo%26aufirst%3DP.%2BA.%26aulast%3DGibbons%26aufirst%3DS.%2BJ.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DAMPA%2520receptor%2520desensitization%2520predicts%2520the%2520selective%2520vulnerability%2520of%2520cerebellar%2520purkinje%2520cells%2520to%2520excitotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D4515%26epage%3D4524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, K. A.</span><span> </span><span class="NLM_article-title">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1006%2Fnbdi.1998.0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9746904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=67-80&author=K.+A.+Yamada&title=Modulating+excitatory+synaptic+neurotransmission%3A+potential+treatment+for+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span></div><div class="casAuthors">Yamada, Kelvin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.  Excitatory neurotransmission at many CNS synapses depends upon AMPA-type glutamate receptors.  Derangements in AMPA receptor-mediated synaptic transmission may be a contributing factor in neurol. and neurodegenerative diseases and could be a target for therapeutic intervention.  Drugs that pos. modulate AMPA receptors by reducing AMPA receptor desensitization and/or slowing AMPA receptor deactivation, such as thiazide derivs. (cyclothiazide, diazoxide, IDRA 21) and benzoylpiperidine derivs. (1-BCP, CX516, aniracetam), facilitate AMPA receptor-mediated processes and may have beneficial therapeutic effects.  For example, AMPA modulators facilitate long-term potentiation, which may be important for memory storage, and facilitate memory encoding in behavioral expts.  Thus, AMPA modulators might ameliorate memory deficits that occur in dementia, such as Alzheimer's disease.  However, AMPA receptor-mediated excitotoxicity may occur with excessive AMPA receptor activation such as in seizures or ischemia, and pos. AMPA modulators would promote neuronal injury under those conditions.  Regardless of the ultimate clin. utility of pos. AMPA modulators, their discovery and study have already provided significant insight into the physiol. and structural determinants of important AMPA receptor properties.  This review attempts to synthesize a variety of studies that have utilized these AMPA modulators to gain insight into fundamental as well as clin. relevant AMPA receptor-mediated processes.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjdGogGo9LLVg90H21EOLACvtfcHk0lhSJGMV26v7NA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D&md5=5f8211686883cffc773c302d8ef24877</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0190%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BA.%26atitle%3DModulating%2520excitatory%2520synaptic%2520neurotransmission%253A%2520potential%2520treatment%2520for%2520neurological%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span> </span><span class="NLM_article-title">Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">571</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1113%2Fjphysiol.2005.103812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16423850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVCkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=571&publication_year=2006&pages=605-618&author=J.+Qiauthor=Y.+Wangauthor=M.+Jiangauthor=P.+Warrenauthor=G.+Chen&title=Cyclothiazide+induces+robust+epileptiform+activity+in+rat+hippocampal+neurons+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo</span></div><div class="casAuthors">Qi, Jinshun; Wang, Yun; Jiang, Min; Warren, Philippa; Chen, Gong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">571</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">605-618</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cyclothiazide (CTZ) is a potent blocker of AMPA receptor desensitization.  We have recently demonstrated that CTZ also inhibits GABAA receptors.  Here we report that CTZ induces robust epileptiform activity in hippocampal neurons both in vitro and in vivo.  We first found that chronic treatment of hippocampal cultures with CTZ (5 μM, 48 h) results in epileptiform activity in the majority of neurons (80%).  The epileptiform activity lasts more than 48 h after washing off CTZ, suggesting a permanent change of the neural network properties after CTZ treatment.  We then demonstrated in in vivo recordings that injection of CTZ (5 μmol in 5 μl) into the lateral ventricles of anesthetized rats also induces spontaneous epileptiform activity in the hippocampal CA1 region.  The epileptogenic effect of CTZ is probably due to its enhancing glutamatergic neurotransmission as shown by increasing the frequency and decay time of mEPSCs, and simultaneously inhibiting GABAergic neurotransmission by reducing the frequency of mIPSCs.  Comparing to a well-known epileptogenic agent kainic acid (KA), CTZ affects neuronal activity mainly through modulating synaptic transmission without significant change of the intrinsic membrane excitability.  Unlike KA, which induces significant cell death in hippocampal cultures, CTZ treatment does not result in any apparent neuronal death.  Therefore, the CTZ-induced epilepsy model may provide a novel research tool to elucidate the mol. and cellular mechanisms of epileptogenesis without any complication from drug-induced cell death.  The long-lasting epileptiform activity after CTZ washout may also make it a very useful model in screening antiepileptic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdYudVEld6LVg90H21EOLACvtfcHk0lhLvYbRCiig0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVCkuro%253D&md5=b67d0b87e6cd40109a18dcd372c514ae</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2005.103812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2005.103812%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DCyclothiazide%2520induces%2520robust%2520epileptiform%2520activity%2520in%2520rat%2520hippocampal%2520neurons%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D571%26spage%3D605%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0lhLvYbRCiig0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2162</span><span class="NLM_x">–</span> <span class="NLM_lpage">2173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2162-2173&author=A.+C.+Doranauthor=S.+M.+Osgoodauthor=J.+Y.+Mancusoauthor=C.+L.+Shaffer&title=An+evaluation+of+using+rat-derived+single-dose+neuropharmacokinetic+parameters+to+project+accurately+large+animal+unbound+brain+drug+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DAn%2520evaluation%2520of%2520using%2520rat-derived%2520single-dose%2520neuropharmacokinetic%2520parameters%2520to%2520project%2520accurately%2520large%2520animal%2520unbound%2520brain%2520drug%2520concentrations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2162%26epage%3D2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarotsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toublanc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutant, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span> </span><span class="NLM_article-title">Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1177%2F0091270006286899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16554450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslWhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=424-432&author=S.+S.+Jheeauthor=A.+S.+Chappellauthor=V.+Zarotskyauthor=S.+V.+Moranauthor=M.+Rosenthalauthor=E.+Kimauthor=S.+Chalonauthor=N.+Toublancauthor=J.+Brandtauthor=D.+E.+Coutantauthor=L.+Ereshefsky&title=Multiple-dose+plasma+pharmacokinetic+and+safety+study+of+LY450108+and+LY451395+%28AMPA+receptor+potentiators%29+and+their+concentration+in+cerebrospinal+fluid+in+healthy+human+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects</span></div><div class="casAuthors">Jhee, S. S.; Chappell, A. S.; Zarotsky, V.; Moran, S. V.; Rosenthal, M.; Kim, E.; Chalon, S.; Toublanc, N.; Brandt, J.; Coutant, D. E.; Ereshefsky, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The objective of this study was to measure the steady-state cerebrospinal fluid (CSF) concn. of LY450108 and LY451395 (pos. modulators of AMPA receptors) in healthy subjects after the administration of 1 mg and 5 mg.  Secondary objectives included the evaluation of safety, pharmacokinetics, and steady-state ratio of plasma:CSF concns. of LY450108 and LY451395 after multiple dosing.  This study was an open-label, multiple oral dose study evaluating 1 mg and 5 mg LY450108 and 1 mg and 5 mg LY451395 in 12 (3 subjects per dosing group) healthy subjects, aged 18 to 49 years.  Twelve healthy male subjects completed the study.  LY450108 and LY451395 were quantifiable in CSF after 1-mg and 5-mg multiple-dose administrations with plasma:CSF ratio of 82:1 and 44:1, resp.  LY450108 and LY451395 1 mg and 5 mg were measured in the CSF.  Single and multiple oral doses of LY450108 and LY451395 were detd. to be safe and well tolerated in healthy subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcTZEPsQAabVg90H21EOLACvtfcHk0li77W8UlEIdpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslWhurk%253D&md5=cbb4725f14502afea7b51b27c816c85c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1177%2F0091270006286899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006286899%26sid%3Dliteratum%253Aachs%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DChappell%26aufirst%3DA.%2BS.%26aulast%3DZarotsky%26aufirst%3DV.%26aulast%3DMoran%26aufirst%3DS.%2BV.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DChalon%26aufirst%3DS.%26aulast%3DToublanc%26aufirst%3DN.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCoutant%26aufirst%3DD.%2BE.%26aulast%3DEreshefsky%26aufirst%3DL.%26atitle%3DMultiple-dose%2520plasma%2520pharmacokinetic%2520and%2520safety%2520study%2520of%2520LY450108%2520and%2520LY451395%2520%2528AMPA%2520receptor%2520potentiators%2529%2520and%2520their%2520concentration%2520in%2520cerebrospinal%2520fluid%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D424%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chappell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span> </span><span class="NLM_article-title">AMPA potentiator treatment of cognitive deficits in Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=1008-1012&author=A.+S.+Chappellauthor=C.+Gonzalesauthor=J.+Williamsauthor=M.+M.+Witteauthor=R.+C.+Mohsauthor=R.+Sperling&title=AMPA+potentiator+treatment+of+cognitive+deficits+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChappell%26aufirst%3DA.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DWitte%26aufirst%3DM.%2BM.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DSperling%26aufirst%3DR.%26atitle%3DAMPA%2520potentiator%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2007%26volume%3D68%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trzepacz, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konechnik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennehy, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabas, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C.</span><span> </span><span class="NLM_article-title">Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer’s disease</span> <span class="citation_source-journal">Int. Psychogeriatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1017%2FS1041610212002141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=23257314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BC3s3js1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=707-719&author=P.+T.+Trzepaczauthor=J.+Cummingsauthor=T.+Konechnikauthor=T.+D.+Forresterauthor=C.+Changauthor=E.+B.+Dennehyauthor=B.+A.+Willisauthor=C.+Shulerauthor=L.+B.+Tabasauthor=C.+Lyketsos&title=Mibampator+%28LY451395%29+randomized+clinical+trial+for+agitation%2Faggression+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease</span></div><div class="casAuthors">Trzepacz Paula T; Cummings Jeffrey; Konechnik Thomas; Forrester Tammy D; Chang Curtis; Dennehy Ellen B; Willis Brian A; Shuler Catherine; Tabas Linda B; Lyketsos Constantine</div><div class="citationInfo"><span class="NLM_cas:title">International psychogeriatrics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">707-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Mibampator, an amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor potentiator, was evaluated for treatment of agitation and aggression (A/A) in Alzheimer's disease (AD).  METHODS:  Outpatients (n = 132) with probable AD and A/A randomized to 12 weeks of double-blind treatment with 3-mg po mibampator or placebo were assessed using the 4-domain A/A subscale of the Neuropsychiatric Inventory (NPI-4-A/A) derived from the Neuropsychiatric Inventory.  Secondary measures included the Cohen-Mansfield Agitation Inventory, Cornell Scale for Depression in Dementia, Frontal Systems Behavior Inventory (FrSBe), and Alzheimer's Disease Assessment Scale-Cognitive.  Efficacy was analyzed using mixed-effects model repeated measures from baseline to endpoint.  Adverse events (AEs), labs, vital signs, and electrocardiograms were monitored.  RESULTS:  Baseline characteristics were comparable between groups.  Both groups improved on the NPI-4-A/A, but without group differences.  Among secondaries, mibampator was significantly better (p = 0.007) than placebo only on the FrSBe.  AEs were similar between groups.  One death occurred in the placebo group.  CONCLUSION:  Possible explanations for no significant group differences include caregiver, drug target engagement, and design issues.  This trial is registered on ClinicalTrials.gov; ID: NCT00843518.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9rGUvPivaH-2qxNLjzXe8fW6udTcc2eb8lRAkEE1CS7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3js1GqtQ%253D%253D&md5=d709ce625fff2b2f017074a981f495f1</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1017%2FS1041610212002141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1041610212002141%26sid%3Dliteratum%253Aachs%26aulast%3DTrzepacz%26aufirst%3DP.%2BT.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DKonechnik%26aufirst%3DT.%26aulast%3DForrester%26aufirst%3DT.%2BD.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDennehy%26aufirst%3DE.%2BB.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DShuler%26aufirst%3DC.%26aulast%3DTabas%26aufirst%3DL.%2BB.%26aulast%3DLyketsos%26aufirst%3DC.%26atitle%3DMibampator%2520%2528LY451395%2529%2520randomized%2520clinical%2520trial%2520for%2520agitation%252Faggression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520Psychogeriatr.%26date%3D2013%26volume%3D25%26spage%3D707%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2<i>S</i>)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fleming, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, P. M.</span><span> </span><span class="NLM_article-title">Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1381-1387&author=J.+J.+Flemingauthor=P.+M.+England&title=Developing+a+complete+pharmacology+for+AMPA+receptors%3A+a+perspective+on+subtype-selective+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DJ.%2BJ.%26aulast%3DEngland%26aufirst%3DP.%2BM.%26atitle%3DDeveloping%2520a%2520complete%2520pharmacology%2520for%2520AMPA%2520receptors%253A%2520a%2520perspective%2520on%2520subtype-selective%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1381%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Harms, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span> </span><span class="NLM_article-title">Functional analysis of a novel allosteric modulator of AMPA receptors derived from a structure-based drug design strategy</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=45-52&author=J.+E.+Harmsauthor=M.+Benvenisteauthor=J.+K.+F.+Macleanauthor=K.+M.+Partinauthor=C.+Jamieson&title=Functional+analysis+of+a+novel+allosteric+modulator+of+AMPA+receptors+derived+from+a+structure-based+drug+design+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarms%26aufirst%3DJ.%2BE.%26aulast%3DBenveniste%26aufirst%3DM.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26aulast%3DJamieson%26aufirst%3DC.%26atitle%3DFunctional%2520analysis%2520of%2520a%2520novel%2520allosteric%2520modulator%2520of%2520AMPA%2520receptors%2520derived%2520from%2520a%2520structure-based%2520drug%2520design%2520strategy%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D45%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1002%2Fbdd.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=22213407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=72-84&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=H.+Rongauthor=R.+S.+Obach&title=Using+Simcyp+to+project+human+oral+pharmacokinetic+variability+in+early+drug+research+to+mitigate+mechanism-based+adverse+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsProjecting Human Cmax Variability after an Oral Dose via PBPK ModelingC.L. SHAFFER ET AL.</span></div><div class="casAuthors">Shaffer, Christopher L.; Scialis, Renato J.; Rong, Haojing; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pos. allosteric modulators ( potentiators') of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) have been shown to display a mechanism-based exposure-response continuum in preclin. species with procognitive electrophysiol. and behavioral effects ( efficacy') at low exposures and motor coordination disruptions at progressively higher exposures.  Due to the dose-capping nature of such motor coordination deficits, an exposure threshold-mediated adverse event (CAE), the adequacy of sepn. between the maximal total plasma compd. concn. (Cmax) at a predicted clin. efficacious oral dose and this adverse event (AE) was explored in early drug research with three AMPAR potentiators considered potential candidates for clin. trials.  In vitro metab. studies in human liver microsomes and human hepatocytes demonstrated the metabolic clearance for each compd. was predominately due to cytochromes P 450 (CYP).  Thus, for each compd.'s anticipated clin. efficacious dose, human Cmax variability following oral administration was assessed using Simcyp software, which combines its virtual human populations database using extensive demog., physiol. and genomic information with routinely collected compd.-specific in vitro biochem. data to simulate and predict drug disposition.  Using a combination of exptl. detd. recombinant human CYP intrinsic clearances for CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4, human binding factors, expected fraction absorbed and estd. steady-state vol. of distribution, Simcyp simulations demonstrated that two of the three potentiators had acceptable projected Cmax variability (i.e. the 95th percentile Cmax did not breach CAE).  This evaluation aided in the selection of compds. for preclin. progression, and represents a novel application of pharmacol. based pharmacokinetic (PBPK) software approaches to predict interpatient variability.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHYc71vaExbVg90H21EOLACvtfcHk0liPz3L8riaC1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D&md5=0ff126a5b34085f42606277651aa40e2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1768%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DUsing%2520Simcyp%2520to%2520project%2520human%2520oral%2520pharmacokinetic%2520variability%2520in%2520early%2520drug%2520research%2520to%2520mitigate%2520mechanism-based%2520adverse%2520events%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2012%26volume%3D33%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Defining the mechanism-mediated exposure–response continuum of a novel AMPA receptor potentiator (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">883</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=883&publication_year=2009&pages=17&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=S.+Lotarskiauthor=D.+K.+Bryceauthor=J.+Liuauthor=M.+J.+Majchrzakauthor=C.+Christoffersenauthor=W.+E.+Hoffmannauthor=B.+Campbellauthor=R.+S.+Hurstauthor=S.+McLeanauthor=A.+H.+Ganongauthor=M.+Hajosauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidt&title=Defining+the+mechanism-mediated+exposure%E2%80%93response+continuum+of+a+novel+AMPA+receptor+potentiator+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DDefining%2520the%2520mechanism-mediated%2520exposure%25E2%2580%2593response%2520continuum%2520of%2520a%2520novel%2520AMPA%2520receptor%2520potentiator%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2009%26volume%3D883%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machacek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R.</span><span> </span><span class="NLM_article-title">High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">17209</span><span class="NLM_x">–</span> <span class="NLM_lpage">17217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17209-17217&author=J.+McNeishauthor=M.+Roachauthor=J.+Hamborauthor=R.+J.+Matherauthor=L.+Weibleyauthor=J.+Lazzaroauthor=J.+Gazardauthor=J.+Schwarzauthor=R.+Volkmannauthor=D.+Machacekauthor=S.+Sticeauthor=L.+Zawadzkeauthor=C.+O%E2%80%99Donnellauthor=R.+Hurst&title=High-throughput+screening+in+embryonic+stem+cell-derived+neurons+identifies+potentiators+of+%CE%B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DWeibley%26aufirst%3DL.%26aulast%3DLazzaro%26aufirst%3DJ.%26aulast%3DGazard%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DVolkmann%26aufirst%3DR.%26aulast%3DMachacek%26aufirst%3DD.%26aulast%3DStice%26aufirst%3DS.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DR.%26atitle%3DHigh-throughput%2520screening%2520in%2520embryonic%2520stem%2520cell-derived%2520neurons%2520identifies%2520potentiators%2520of%2520%25CE%25B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type%2520glutamate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17209%26epage%3D17217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span> </span><span class="NLM_article-title">Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic Acid (AMPA) Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4354-4358&author=P.+L.+Ornsteinauthor=D.+M.+Zimmermanauthor=M.+B.+Arnoldauthor=T.+J.+Bleischauthor=B.+Cantrellauthor=R.+Simonauthor=H.+Zarrinmayehauthor=S.+R.+Bakerauthor=M.+Gatesauthor=J.+P.+Tizzanoauthor=D.+Bleakman&title=Biarylpropylsulfonamides+as+Novel%2C+Potent+Potentiators+of+2-Amino-3-%285-methyl-3-hydroxyisoxazol-4-yl%29-propanoic+Acid+%28AMPA%29+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)propanoicacid (AMPA) Receptors</span></div><div class="casAuthors">Ornstein, Paul L.; Zimmerman, Dennis M.; Arnold, M. Brian; Bleisch, Thomas J.; Cantrell, Buddy; Simon, Richard; Zarrinmayeh, Hamideh; Baker, S. Richard; Gates, Mary; Tizzano, Joseph P.; Bleakman, David; Mandelzys, Allan; Jarvie, Kieth R.; Ho, Ken; Deverill, Michelle; Kamboj, Rajender K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4354-4358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biarylpropyl sulfonamides that are very potent potentiators of responses mediated through AMPA receptors are presented.  Structure-activity studies demonstrated significant changes in potency when the methylsulfonamide was changed to an propylsulfonamide in the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkGeRcI8km7Vg90H21EOLACvtfcHk0lhXDdGXBxbZxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKns7k%253D&md5=35f2071cc486af8212d8308ed4608d21</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm0002836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002836%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DCantrell%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DBleakman%26aufirst%3DD.%26atitle%3DBiarylpropylsulfonamides%2520as%2520Novel%252C%2520Potent%2520Potentiators%2520of%25202-Amino-3-%25285-methyl-3-hydroxyisoxazol-4-yl%2529-propanoic%2520Acid%2520%2528AMPA%2529%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Quirk, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">LY404187: A novel positive allosteric modulator of AMPA receptors</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=255-282&author=J.+C.+Quirkauthor=E.+S.+Nisenbaum&title=LY404187%3A+A+novel+positive+allosteric+modulator+of+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuirk%26aufirst%3DJ.%2BC.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DLY404187%253A%2520A%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520AMPA%2520receptors%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2002%26volume%3D8%26spage%3D255%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liXcb2m90lDNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0liXcb2m90lDNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cram, D. J.</span><span> </span><span class="NLM_article-title">Preorganization—from solvents to spherands</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=1039-1134&author=D.+J.+Cram&title=Preorganization%E2%80%94from+solvents+to+spherands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCram%26aufirst%3DD.%2BJ.%26atitle%3DPreorganization%25E2%2580%2594from%2520solvents%2520to%2520spherands%26jtitle%3DAngew.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D1039%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cram, D. J.</span><span> </span><span class="NLM_article-title">The design of molecular hosts, guests, and their complexes (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=1009-1112&author=D.+J.+Cram&title=The+design+of+molecular+hosts%2C+guests%2C+and+their+complexes+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCram%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520design%2520of%2520molecular%2520hosts%252C%2520guests%252C%2520and%2520their%2520complexes%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D1009%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lehn, J.-M.</span><span> </span><span class="NLM_article-title">Supramolecular chemistry—scope and perspectives. Molecules, supermolecules, and molecular devices (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=89-112&author=J.-M.+Lehn&title=Supramolecular+chemistry%E2%80%94scope+and+perspectives.+Molecules%2C+supermolecules%2C+and+molecular+devices+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehn%26aufirst%3DJ.-M.%26atitle%3DSupramolecular%2520chemistry%25E2%2580%2594scope%2520and%2520perspectives.%2520Molecules%252C%2520supermolecules%252C%2520and%2520molecular%2520devices%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D89%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lehn, J.-M.</span><span> </span><span class="NLM_article-title">Perspectives in supramolecular chemistry—from molecular recognition towards molecular information processing and self-organization</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=1304-1319&author=J.-M.+Lehn&title=Perspectives+in+supramolecular+chemistry%E2%80%94from+molecular+recognition+towards+molecular+information+processing+and+self-organization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehn%26aufirst%3DJ.-M.%26atitle%3DPerspectives%2520in%2520supramolecular%2520chemistry%25E2%2580%2594from%2520molecular%2520recognition%2520towards%2520molecular%2520information%2520processing%2520and%2520self-organization%26jtitle%3DAngew.%2520Chem.%26date%3D1990%26volume%3D29%26spage%3D1304%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Pedersen, C. J.</span><span> </span><span class="NLM_article-title">The discovery of crown ethers (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=1021-1027&author=C.+J.+Pedersen&title=The+discovery+of+crown+ethers+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520crown%2520ethers%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D1021%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wolfe, S.</span><span> </span><span class="NLM_article-title">The gauche effect. Some stereochemical consequences of adjacent electron pairs and polar bonds</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar50051a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaE38Xht1KhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=102-111&author=S.+Wolfe&title=The+gauche+effect.+Some+stereochemical+consequences+of+adjacent+electron+pairs+and+polar+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Gauche effect.  Stereochemical consequences of adjacent electron pairs and polar bonds</span></div><div class="casAuthors">Wolfe, Saul</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    </div><div class="casAbstract">The gauche effect is a term proposed to describe the tendency of species contg. adjacent electron pairs or polar bonds to exist preferentially in that structure which has the max. no. of gauche interactions between these electron pairs and polar bonds.  Organosulfur stereochemistry, esp. sulfonium ylides, and bimol. elimination reactions are discussed in terms of the effect.  The effect is reproduced and, therefore, explained by non-empirical MO calcns.  The explanation requires recognition of the fact that the stable structure of a mol. is not simply the result of a minimization of repulsive interactions, but is rather a subtle balance of attractive as well as repulsive forces.  For the specific cases of 2 adjacent electron pairs or 2 electron pairs adjacent to a polar bond the balance is between attraction and repulsion involving bonded electron pairs and the nuclei.  The notion that non-bonding electron pairs behave as directed ligands is not supported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUy1sB5iAG0bVg90H21EOLACvtfcHk0lh7Qm6fbyfxOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xht1KhtLw%253D&md5=2598a509adb1d341188744f1c2ab87c7</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Far50051a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far50051a003%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DS.%26atitle%3DThe%2520gauche%2520effect.%2520Some%2520stereochemical%2520consequences%2520of%2520adjacent%2520electron%2520pairs%2520and%2520polar%2520bonds%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1972%26volume%3D5%26spage%3D102%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Juaristi, E.</span><span> </span><span class="NLM_article-title">The attractive and repulsive gauche effects</span> <span class="citation_source-journal">J. Chem. Educ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/ed056p438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1979&pages=438-441&author=E.+Juaristi&title=The+attractive+and+repulsive+gauche+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fed056p438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed056p438%26sid%3Dliteratum%253Aachs%26aulast%3DJuaristi%26aufirst%3DE.%26atitle%3DThe%2520attractive%2520and%2520repulsive%2520gauche%2520effects%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D1979%26volume%3D56%26spage%3D438%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Burke, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Cyclic hydropyran oligolides as preorganized ligand arrays: cumulative effects of structural elements on shape and cation binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">12649</span><span class="NLM_x">–</span> <span class="NLM_lpage">12650</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00155a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=12649-12650&author=S.+D.+Burkeauthor=C.+J.+O%E2%80%99Donnellauthor=W.+J.+Porterauthor=Y.+Song&title=Cyclic+hydropyran+oligolides+as+preorganized+ligand+arrays%3A+cumulative+effects+of+structural+elements+on+shape+and+cation+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fja00155a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00155a035%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCyclic%2520hydropyran%2520oligolides%2520as%2520preorganized%2520ligand%2520arrays%253A%2520cumulative%2520effects%2520of%2520structural%2520elements%2520on%2520shape%2520and%2520cation%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D12649%26epage%3D12650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span> </span><span class="NLM_article-title">N-Substituted pyrollidones and tetrahydrofurans as novel AMPAR positive modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7116</span><span class="NLM_x">–</span> <span class="NLM_lpage">7119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7116-7119&author=K.+M.+Thewlisauthor=L.+Aldegheriauthor=M.+H.+Harriesauthor=C.+Mookherjeeauthor=B.+Oliosiauthor=S.+E.+Ward&title=N-Substituted+pyrollidones+and+tetrahydrofurans+as+novel+AMPAR+positive+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DHarries%26aufirst%3DM.%2BH.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DWard%26aufirst%3DS.%2BE.%26atitle%3DN-Substituted%2520pyrollidones%2520and%2520tetrahydrofurans%2520as%2520novel%2520AMPAR%2520positive%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7116%26epage%3D7119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+J.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhI0PT9i0tYIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9027</span><span class="NLM_x">–</span> <span class="NLM_lpage">9036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.2567-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16192394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9027-9036&author=R.+Jinauthor=S.+Clarkauthor=A.+M.+Weeksauthor=J.+T.+Dudmanauthor=E.+Gouauxauthor=K.+M.+Partin&title=Mechanism+of+Positive+Allosteric+Modulators+Acting+on+AMPA+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of positive allosteric modulators acting on AMPA receptors</span></div><div class="casAuthors">Jin, Rongsheng; Clark, Suzanne; Weeks, Autumn M.; Dudman, Joshua T.; Gouaux, Eric; Partin, Kathryn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9027-9036</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ligand-gated ion channels involved in the modulation of synaptic strength are the AMPA, kainate, and NMDA glutamate receptors.  Small mols. that potentiate AMPA receptor currents relieve cognitive deficits caused by neurodegenerative diseases such as Alzheimer's disease and show promise in the treatment of depression.  Previously, there has been limited understanding of the mol. mechanism of action for AMPA receptor potentiators.  Here the authors present cocrystal structures of the glutamate receptor GluR2 S1S2 ligand-binding domain in complex with aniracetam [1-(4-methoxybenzoyl)-2-pyrrolidinone] or CX614 (pyrrolidino-1,3-oxazino benzo-1,4-dioxan-10-one), two AMPA receptor potentiators that preferentially slow AMPA receptor deactivation.  Both potentiators bind within the dimer interface of the nondesensitized receptor at a common site located on the twofold axis of mol. symmetry.  Importantly, the potentiator binding site is adjacent to the "hinge" in the ligand-binding core "clamshell" that undergoes conformational rearrangement after glutamate binding.  Using rapid soln. exchange, patch-clamp electrophysiol. expts., the authors show that point mutations of residues that interact with potentiators in the cocrystal disrupt potentiator function.  The authors suggest that the potentiators slow deactivation by stabilizing the clamshell in its closed-cleft, glutamate-bound conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo15HIwmBGNTrVg90H21EOLACvtfcHk0liX7vvaiZt6Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP&md5=d035b142e3911e5e44a0ec4a825dc0a8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2567-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2567-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DDudman%26aufirst%3DJ.%2BT.%26aulast%3DGouaux%26aufirst%3DE.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DMechanism%2520of%2520Positive%2520Allosteric%2520Modulators%2520Acting%2520on%2520AMPA%2520Receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9027%26epage%3D9036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2ebOsbwMInlygrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span> </span><span class="NLM_article-title">Modulation of NMDA receptor function by inhibition of <span class="smallcaps smallerCapital">d</span>-amino acid oxidase in rodent brain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=1001-1015&author=C.+A.+Strickauthor=C.+Liauthor=L.+Scottauthor=B.+Harveyauthor=M.+Hajosauthor=S.+J.+Steynauthor=M.+A.+Piotrowskiauthor=L.+C.+Jamesauthor=J.+T.+Downsauthor=B.+Ragoauthor=S.+L.+Beckerauthor=A.+El-Kattanauthor=Y.+Xuauthor=A.+H.+Ganongauthor=F.+D.+Tingleyauthor=A.+D.+Ramirezauthor=P.+A.+Seymourauthor=V.+Guanowskyauthor=M.+J.+Majchrzakauthor=C.+B.+Foxauthor=C.+J.+Schmidtauthor=A.+J.+Duplantier&title=Modulation+of+NMDA+receptor+function+by+inhibition+of+d-amino+acid+oxidase+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DB.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DPiotrowski%26aufirst%3DM.%2BA.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DDowns%26aufirst%3DJ.%2BT.%26aulast%3DRago%26aufirst%3DB.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DRamirez%26aufirst%3DA.%2BD.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26atitle%3DModulation%2520of%2520NMDA%2520receptor%2520function%2520by%2520inhibition%2520of%2520d-amino%2520acid%2520oxidase%2520in%2520rodent%2520brain%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D1001%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kozak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dounay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Reduction of brain kynurenic acid improves cognitive function</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">10592</span><span class="NLM_x">–</span> <span class="NLM_lpage">10602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.1107-14.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=25100593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ertbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=10592-10602&author=R.+Kozakauthor=B.+M.+Campbellauthor=C.+A.+Strickauthor=W.+E.+Hornerauthor=W.+E.+Hoffmanauthor=T.+Kissauthor=D.+S.+Chapinauthor=D.+McGinnisauthor=A.+L.+Abbottauthor=B.+M.+Robertsauthor=K.+Fonsecaauthor=V.+Guanowskyauthor=D.+A.+Youngauthor=P.+A.+Seymourauthor=A.+Dounayauthor=M.+Hajosauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Reduction+of+brain+kynurenic+acid+improves+cognitive+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of brain kynurenic acid improves cognitive function</span></div><div class="casAuthors">Kozak, Rouba; Campbell, Brian M.; Strick, Christine A.; Horner, Weldon; Hoffmann, William E.; Kiss, Tamas; Chapin, Douglas S.; McGinnis, Dina; Abbott, Amanda L.; Roberts, Brooke M.; Fonseca, Kari; Guanowsky, Victor; Young, Damon A.; Seymour, Patricia A.; Dounay, Amy; Hajos, Mihaly; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10592-10602, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The elevation of kynurenic acid (KYNA) obsd. in schizophrenic patients may contribute to core symptoms arising from glutamate hypofunction, including cognitive impairments.  Although increased KYNA levels reduce excitatory neurotransmission, KYNA has been proposed to act as an endogenous antagonist at the glycine site of the glutamate NMDA receptor (NMDAR) and as a neg. allosteric modulator at the α7 nicotinic acetylcholine receptor.  Levels of KYNA are elevated in CSF and the postmortem brain of schizophrenia patients, and these elevated levels of KYNA could contribute to NMDAR hypofunction and the cognitive deficits and neg. symptoms assocd. with this disease.  However, the impact of endogenously produced KYNA on brain function and behavior is less well understood due to a paucity of pharmacol. tools.  To address this issue, we identified PF-04859989, a brain-penetrable inhibitor of kynurenine aminotransferase II (KAT II), the enzyme responsible for most brain KYNA synthesis.  In rats, systemic administration of PF-04859989 dose-dependently reduced brain KYNA to as little as 28% of basal levels, and prevented amphetamine- and ketamine-induced disruption of auditory gating and improved performance in a sustained attention task.  It also prevented ketamine-induced disruption of performance in a working memory task and a spatial memory task in rodents and nonhuman primates, resp.  Together, these findings support the hypotheses that endogenous KYNA impacts cognitive function and that inhibition of KAT II, and consequent lowering of endogenous brain KYNA levels, improves cognitive performance under conditions considered relevant for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVW5CSu94ClLVg90H21EOLACvtfcHk0lhpt7MVe0NUwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ertbfP&md5=537ed93c7548a6968c8a6599b6be69b8</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1107-14.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1107-14.2014%26sid%3Dliteratum%253Aachs%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DAbbott%26aufirst%3DA.%2BL.%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DDounay%26aufirst%3DA.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DReduction%2520of%2520brain%2520kynurenic%2520acid%2520improves%2520cognitive%2520function%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D10592%26epage%3D10602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. M.</span><span> </span><span class="NLM_article-title">CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=171-176&author=F.+S.+Mennitiauthor=A.+M.+Buchanauthor=B.+L.+Chenardauthor=D.+J.+Critchettauthor=A.+H.+Ganongauthor=V.+Guanowskyauthor=P.+A.+Seymourauthor=W.+M.+Welch&title=CP-465%2C022%2C+a+selective+noncompetitive+AMPA+receptor+antagonist%2C+blocks+AMPA+receptors+but+is+not+neuroprotective+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DBuchan%26aufirst%3DA.%2BM.%26aulast%3DChenard%26aufirst%3DB.%2BL.%26aulast%3DCritchett%26aufirst%3DD.%2BJ.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DWelch%26aufirst%3DW.%2BM.%26atitle%3DCP-465%252C022%252C%2520a%2520selective%2520noncompetitive%2520AMPA%2520receptor%2520antagonist%252C%2520blocks%2520AMPA%2520receptors%2520but%2520is%2520not%2520neuroprotective%2520in%2520vivo%26jtitle%3DStroke%26date%3D2003%26volume%3D34%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">Working memory dysfunction in schizophrenia</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fjnp.6.4.348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7841806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=348-357&author=P.+S.+Goldman-Rakic&title=Working+memory+dysfunction+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Working memory dysfunction in schizophrenia</span></div><div class="casAuthors">Goldman-Rakic P S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-57</span>
        ISSN:<span class="NLM_cas:issn">0895-0172</span>.
    </div><div class="casAbstract">Recent advances in anatomical, behavioral, and physiological techniques have produced new information about the nature of prefrontal function, its cellular basis, and its anatomical underpinnings in nonhuman primates.  These findings are changing our views of prefrontal function and providing insight into possible bases for human mental disorder.  A major advance is the recognition that various prefrontal areas are engaged in holding information "on line" and updating past and current information on a moment-to-moment basis.  Studies of animals and of cognitive function in normal, brain-injured, and schizophrenic subjects support the theory that a defect in working memory--the ability to guide behavior by representations--may be the fundamental impairment leading to schizophrenic thought disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyESdDKBz6etTiMd2aNQVUfW6udTcc2eZBWAZxaJvXzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D&md5=4a864a3c0cf5268f35615668e11246c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1176%2Fjnp.6.4.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fjnp.6.4.348%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DWorking%2520memory%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci%26date%3D1994%26volume%3D6%26spage%3D348%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. D.</span><span> </span><span class="NLM_article-title">The hippocampal formation in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fappi.ajp.2010.09081187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20810471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BC3cfms1Snug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2010&pages=1178-1193&author=C.+A.+Tammingaauthor=A.+D.+Stanauthor=A.+D.+Wagner&title=The+hippocampal+formation+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">The hippocampal formation in schizophrenia</span></div><div class="casAuthors">Tamminga Carol A; Stan Ana D; Wagner Anthony D</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1178-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The hippocampal formation is one of the most extensively studied regions of the brain, with well-described anatomy and basic physiology; moreover, aspects of human memory mediated by the hippocampus are well characterized.  In schizophrenia, alterations in hippocampal anatomy, perfusion, and activation are consistently reported; impairments in declarative memory function, especially in the flexible use of event memories (e.g., in the service of memory-based inference), are common.  Postmortem molecular changes suggest a selective reduction in glutamate transmission in the dentate gyrus and in its efferent fibers, the mossy fiber pathway.  A reduction in dentate gyrus glutamatergic output and in its information processing functions could generate two co-occurring outcomes in the hippocampus: 1) a change in homeostatic plasticity processes in cornu ammonis 3 (CA3), accompanied by increased activity due to reduced afferent stimulation from the dentate gyrus onto CA3 neurons, a process that could increase the pattern completion functions of CA3, and 2) the loss of mnemonic functions specific to the dentate gyrus, namely pattern separation, a change that could increase the prevalence of illusory pattern completion and reduce discrimination between present and past experiences in memory.  The resulting increase in "runaway" CA3-mediated pattern completion could result in cognitive "mistakes," generating psychotic associations and resulting in memories with psychotic content.  Tests of this model could result in novel approaches to the treatment of psychosis and declarative memory alterations and in novel animal preparations for basic schizophrenia research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9GNGZ90AjCxpyrDyM_m9cfW6udTcc2eZBWAZxaJvXzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfms1Snug%253D%253D&md5=741343d58ac33cf03c4e74859553d6ca</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2010.09081187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2010.09081187%26sid%3Dliteratum%253Aachs%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26aulast%3DStan%26aufirst%3DA.%2BD.%26aulast%3DWagner%26aufirst%3DA.%2BD.%26atitle%3DThe%2520hippocampal%2520formation%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatr.%26date%3D2010%26volume%3D167%26spage%3D1178%26epage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lisman, J.</span><span> </span><span class="NLM_article-title">Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=537-544&author=J.+Lisman&title=Excitation%2C+inhibition%2C+local+oscillations%2C+or+large-scale+loops%3A+what+causes+the+symptoms+of+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLisman%26aufirst%3DJ.%26atitle%3DExcitation%252C%2520inhibition%252C%2520local%2520oscillations%252C%2520or%2520large-scale%2520loops%253A%2520what%2520causes%2520the%2520symptoms%2520of%2520schizophrenia%253F%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2012%26volume%3D22%26spage%3D537%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lidow, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">The cerebral cortex: a case for a common site of action of antipsychotics</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=136-140&author=M.+S.+Lidowauthor=G.+V.+Williamsauthor=P.+S.+Goldman-Rakic&title=The+cerebral+cortex%3A+a+case+for+a+common+site+of+action+of+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLidow%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DThe%2520cerebral%2520cortex%253A%2520a%2520case%2520for%2520a%2520common%2520site%2520of%2520action%2520of%2520antipsychotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D136%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Calabrese, E. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drugs: an application of the hormetic dose–response model</span> <span class="citation_source-journal">Crit. Rev. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1080%2F10408440802003991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18568864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=419-451&author=E.+J.+Calabrese&title=Alzheimer%E2%80%99s+disease+drugs%3A+an+application+of+the+hormetic+dose%E2%80%93response+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Drugs: An Application of the Hormetic Dose-Response Model</span></div><div class="casAuthors">Calabrese, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-451</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This article provides an evaluation of the dose-response features of drugs that are intended to improve memory, some of which have been used in the treatment of Alzheimer's disease (AD).  A common feature of these drugs is that they act via an inverted U-shaped dose response, consistent with the hormetic dose response model.  This article assesses historical foundations that lead to the development of AD drugs, their dose-response features and how the quant. features of such dose responses affected drug discovery and development, and the successes and possible failures of such agents in preclin. and clin. settings.  This story begins about 150 years ago with the discovery of an active agent in the Calabar bean plant called physostigmine, its unfolding medical applications, and its implications for dose-response relationships, memory enhancement, and improved drug discovery activities.  The article also demonstrates the occurrence of U-shaped dose responses for memory with numerous endogenous agonists including neurosteroids, various peptides (e.g., vasopressin, CCK-8, neuropeptide Y), and other agents (e.g., epinephrine, antagonists for platelet activity factor and nicotinic receptors), supporting the generalizability of the hormetic biphasic dose response.  Finally, the significance of the U-shaped dose response is crit. for successful clin. application, since it defines the therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_PWZvojlALVg90H21EOLACvtfcHk0liqFsauI3OsZw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFahu7k%253D&md5=b1590655a2d50950decdf417cf72ceae</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1080%2F10408440802003991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440802003991%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DE.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drugs%253A%2520an%2520application%2520of%2520the%2520hormetic%2520dose%25E2%2580%2593response%2520model%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2008%26volume%3D38%26spage%3D419%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B3S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B3S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Zasadny, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszpit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Proctor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span> </span><span class="NLM_article-title">FDG-PET imaging provides insights into efficacy and safety for an AMPA receptor potentiator (Abstract)</span> <span class="citation_source-journal">World Mol. Imaging Soc. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=909&author=K.+Zasadnyauthor=M.+J.+Callahanauthor=K.+Kuszpitauthor=L.+Chenauthor=M.+Skaddanauthor=C.+Brown-Proctorauthor=R.+Harrisauthor=A.+Zhuauthor=C.+L.+Shafferauthor=R.+J.+Scialis&title=FDG-PET+imaging+provides+insights+into+efficacy+and+safety+for+an+AMPA+receptor+potentiator+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DCallahan%26aufirst%3DM.%2BJ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DBrown-Proctor%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26atitle%3DFDG-PET%2520imaging%2520provides%2520insights%2520into%2520efficacy%2520and%2520safety%2520for%2520an%2520AMPA%2520receptor%2520potentiator%2520%2528Abstract%2529%26jtitle%3DWorld%2520Mol.%2520Imaging%2520Soc.%2520Abstr.%26date%3D2009%26spage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandiego, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Cerebral metabolic correlates of ketamine-induced cognitive deficits and their reversal by a positive allosteric modulator of the AMPA receptor: a functional imaging study in the nonhuman primate using FDG-PET (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">883</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=883&publication_year=2009&pages=17&author=G.+V.+Williamsauthor=B.+M.+Robertsauthor=D.+E.+Holdenauthor=D.+W.+Campbellauthor=C.+L.+Shafferauthor=R.+J.+Scialisauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=C.+M.+Sandiegoauthor=R.+E.+Carsonauthor=S.+A.+Castner&title=Cerebral+metabolic+correlates+of+ketamine-induced+cognitive+deficits+and+their+reversal+by+a+positive+allosteric+modulator+of+the+AMPA+receptor%3A+a+functional+imaging+study+in+the+nonhuman+primate+using+FDG-PET+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DCampbell%26aufirst%3DD.%2BW.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSandiego%26aufirst%3DC.%2BM.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DCerebral%2520metabolic%2520correlates%2520of%2520ketamine-induced%2520cognitive%2520deficits%2520and%2520their%2520reversal%2520by%2520a%2520positive%2520allosteric%2520modulator%2520of%2520the%2520AMPA%2520receptor%253A%2520a%2520functional%2520imaging%2520study%2520in%2520the%2520nonhuman%2520primate%2520using%2520FDG-PET%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2009%26volume%3D883%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honey, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandiego, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Investigation of the dose-dependent effect of the AMPA potentiator PF-04958242 on cerebral glucose metabolism: significance for development of a PET biomarker for efficacy of procognitive agents in schizophrenia (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">899</span><span class="NLM_x">, </span> <span class="NLM_fpage">07</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=899&publication_year=2011&pages=07&author=G.+V.+Williamsauthor=A.+L.+Abbottauthor=D.+W.+Campbellauthor=G.+D.+Honeyauthor=C.+L.+Shafferauthor=S.+M.+Osgoodauthor=P.+A.+Seymourauthor=C.+J.+Schmidtauthor=C.+M.+Sandiegoauthor=R.+E.+Carsonauthor=S.+A.+Castner&title=Investigation+of+the+dose-dependent+effect+of+the+AMPA+potentiator+PF-04958242+on+cerebral+glucose+metabolism%3A+significance+for+development+of+a+PET+biomarker+for+efficacy+of+procognitive+agents+in+schizophrenia+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DAbbott%26aufirst%3DA.%2BL.%26aulast%3DCampbell%26aufirst%3DD.%2BW.%26aulast%3DHoney%26aufirst%3DG.%2BD.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSandiego%26aufirst%3DC.%2BM.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520dose-dependent%2520effect%2520of%2520the%2520AMPA%2520potentiator%2520PF-04958242%2520on%2520cerebral%2520glucose%2520metabolism%253A%2520significance%2520for%2520development%2520of%2520a%2520PET%2520biomarker%2520for%2520efficacy%2520of%2520procognitive%2520agents%2520in%2520schizophrenia%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2011%26volume%3D899%26spage%3D07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Jamei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marciniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostami-Hodjegan, A.</span><span> </span><span class="NLM_article-title">The Simcyp population-based ADME simulator</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1517%2F17425250802691074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=19199378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1elu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=211-223&author=M.+Jameiauthor=S.+Marciniakauthor=K.+Fengauthor=A.+Barnettauthor=G.+Tuckerauthor=A.+Rostami-Hodjegan&title=The+Simcyp+population-based+ADME+simulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Simcyp Population-based ADME Simulator</span></div><div class="casAuthors">Jamei, Masoud; Marciniak, Steve; Feng, Kairui; Barnett, Adrian; Tucker, Geoffrey; Rostami-Hodjegan, Amin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-223</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The Simcyp population-based absorption, distribution, metab. and excretion simulator is a platform and database for bottom-up' mechanistic modeling and simulation of the processes of oral absorption, tissue distribution, metab. and excretion of drugs and drug candidates in healthy and disease populations.  It combines exptl. data generated routinely during preclin. drug discovery and development from in vitro enzyme and cellular systems and relevant physicochem. attributes of compd. and dosage form with demog., physiol. and genetic information on different patient populations.  The mechanistic approach implemented in the Simcyp Simulator allows simulation of complex absorption, distribution, metab. and excretion outcomes, particularly those involving multiple drug interactions, parent drug and metabolite profiles and time- and dose-dependent phenomena such as auto-induction and auto-inhibition.  This review describes the framework and organization of the simulator and how it combines the different categories of information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbau4KimjnBLVg90H21EOLACvtfcHk0lhH17ySlDhdRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1elu7c%253D&md5=11548b35c66fe6f07a917f0718421427</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17425250802691074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250802691074%26sid%3Dliteratum%253Aachs%26aulast%3DJamei%26aufirst%3DM.%26aulast%3DMarciniak%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DBarnett%26aufirst%3DA.%26aulast%3DTucker%26aufirst%3DG.%26aulast%3DRostami-Hodjegan%26aufirst%3DA.%26atitle%3DThe%2520Simcyp%2520population-based%2520ADME%2520simulator%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D211%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bednar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartinis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowditch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudreault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumpano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. R.</span><span> </span><span class="NLM_article-title">The safety and efficacy of PF-04958242 in age-related sensorineural hearing loss: a randomized, double-blind, placebo-controlled, single-dose, crossover study</span> <span class="citation_source-journal">JAMA Otolaryngol.—Head Neck Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">in press</span><span class="refDoi"> DOI: 10.1001/jamaoto.2015.0791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Fjamaoto.2015.0791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=in+press&author=M.+M.+Bednarauthor=N.+DeMartinisauthor=A.+Banerjeeauthor=S.+Bowditchauthor=F.+Gaudreaultauthor=L.+Zumpanoauthor=F.+R.+Lin&title=The+safety+and+efficacy+of+PF-04958242+in+age-related+sensorineural+hearing+loss%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+single-dose%2C+crossover+study&doi=10.1001%2Fjamaoto.2015.0791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1001%2Fjamaoto.2015.0791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaoto.2015.0791%26sid%3Dliteratum%253Aachs%26aulast%3DBednar%26aufirst%3DM.%2BM.%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBowditch%26aufirst%3DS.%26aulast%3DGaudreault%26aufirst%3DF.%26aulast%3DZumpano%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DF.%2BR.%26atitle%3DThe%2520safety%2520and%2520efficacy%2520of%2520PF-04958242%2520in%2520age-related%2520sensorineural%2520hearing%2520loss%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%252C%2520single-dose%252C%2520crossover%2520study%26jtitle%3DJAMA%2520Otolaryngol.%25E2%2580%2594Head%2520Neck%2520Surg.%26date%3D2015%26spage%3Din%2520press%26doi%3D10.1001%2Fjamaoto.2015.0791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span>Guide for the Care and Use of Laboratory Animals, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">Institute of Laboratory Animal Resources, National Research Council</span>, <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guide+for+the+Care+and+Use+of+Laboratory+Animals%2C+7th+ed.%3B+Institute+of+Laboratory+Animal+Resources%2C+National+Research+Council%2C+Washington%2C+DC%2C+1996."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DGuide%2520for%2520the%2520Care%2520and%2520Use%2520of%2520Laboratory%2520Animals%26pub%3DInstitute%2520of%2520Laboratory%2520Animal%2520Resources%252C%2520National%2520Research%2520Council%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fjpet.106.105734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=293-298&author=J.+W.+Ryderauthor=J.+F.+Falconeauthor=J.+R.+Manroauthor=K.+A.+Svenssonauthor=K.+M.+Merchant&title=Pharmacological+Characterization+of+cGMP+Regulation+by+the+Biarylpropylsulfonamide+Class+of+Positive%2C+Allosteric+Modulators+of+%CE%B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic+Acid+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span></div><div class="casAuthors">Ryder, John W.; Falcone, Julie F.; Manro, Jason R.; Svensson, Kjell A.; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biarylpropylsulfonamide class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) potentiators represented by N-2-(4-(4-cyanophenol)phenol)propyl-2-propanesulfonamide (LY404187) and (R)-4'-[1-fluoro-1-methyl-2-(propane-2-sulfonylamino)-ethyl]-biphenyl-4-carboxylic acid methylamide (LY503430) are pos., allosteric AMPA receptor activators, which enhance AMPA receptor-mediated neurotransmission by reducing desensitization of the ion channel.  Although these compds. have efficacy in in vivo rodent models of cognition, depression, and Parkinson's disease, little is known about biochem. pathways activated by these agents.  Given the well established regulation of the nitric oxide/cGMP pathway by excitatory neurotransmission, the current study characterized AMPA receptor potentiator-mediated cGMP response in mouse cerebellum.  Acute treatment by both LY404187 and LY503430 [2.0, 5.0, or 10 mg/kg s.c.] elevated basal cerebellar cGMP levels in a dose-dependent manner.  Pretreatment with the noncompetitive, allosteric AMPA receptor-selective antagonist 7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-N,8-dimethyl-monohydrochloride-(9CI) (GYKI 53655) [3.0 mg/kg i.p.], completely blocked the effect of LY404187, demonstrating that activation of AMPA receptors induces cGMP levels.  Interestingly, pretreatment with the N-methyl-D-aspartate (NMDA) open channel blocker dizocilpine (0.3 and 1.0 mg/kg i.p.) also abolished the AMPA receptor potentiator-mediated cGMP accumulation, indicating that activation of AMPA receptors leads to NMDA receptor-mediated transmission involved in cGMP regulation.  Pharmacol. augmentation of the endogenous glutamate tone via the alkaloid harmaline (20-60 mg/kg i.p.) synergized with AMPA potentiator activity and provided further direct evidence of in vivo allosteric activation of AMPA receptors by LY404187.  The synergism between harmaline and LY404187 was specific, since cGMP accumulation induced by foot-shock stress was not augmented by the AMPA receptor potentiator.  Taken together, these data indicate that the cGMP system may play an important role in pharmacol. efficacy of the biarylpropylsulfonamide class of AMPA receptor potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZVDKiSOi7LVg90H21EOLACvtfcHk0lgv62fk5XwPVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO&md5=e1fff3ab717a74321b389e96ea575889</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.105734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.105734%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DPharmacological%2520Characterization%2520of%2520cGMP%2520Regulation%2520by%2520the%2520Biarylpropylsulfonamide%2520Class%2520of%2520Positive%252C%2520Allosteric%2520Modulators%2520of%2520%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520Acid%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Dunham, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miya, T. S.</span><span> </span><span class="NLM_article-title">A note on a simple apparatus for detecting neurological deficit in rats and mice</span> <span class="citation_source-journal">J. Am. Pharm. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">XLVI</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=XLVI&publication_year=1957&pages=208-209&author=N.+W.+Dunhamauthor=T.+S.+Miya&title=A+note+on+a+simple+apparatus+for+detecting+neurological+deficit+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunham%26aufirst%3DN.%2BW.%26aulast%3DMiya%26aufirst%3DT.%2BS.%26atitle%3DA%2520note%2520on%2520a%2520simple%2520apparatus%2520for%2520detecting%2520neurological%2520deficit%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%26date%3D1957%26volume%3DXLVI%26spage%3D208%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milici, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.3389%2Ffpsyt.2011.00014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1-12&author=T.+Kissauthor=W.+E.+Hoffmanauthor=L.+Scottauthor=T.+T.+Kawabeauthor=A.+J.+Miliciauthor=E.+A.+Nilsenauthor=M.+Haj%C3%B3s&title=Role+of+thalamic+projection+in+NMDA+receptor-induced+disruption+of+cortical+slow+oscillation+and+short-term+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2011.00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2011.00014%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DNilsen%26aufirst%3DE.%2BA.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DRole%2520of%2520thalamic%2520projection%2520in%2520NMDA%2520receptor-induced%2520disruption%2520of%2520cortical%2520slow%2520oscillation%2520and%2520short-term%2520plasticity%26jtitle%3DFront.%2520Psychiatry%26date%3D2011%26volume%3D2%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Cox, R. W.</span><span> </span><span class="NLM_article-title">AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</span> <span class="citation_source-journal">Comput. Biomed. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1006%2Fcbmr.1996.0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=8812068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADyaK28vgvVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1996&pages=162-173&author=R.+W.+Cox&title=AFNI%3A+software+for+analysis+and+visualization+of+functional+magnetic+resonance+neuroimages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</span></div><div class="casAuthors">Cox R W</div><div class="citationInfo"><span class="NLM_cas:title">Computers and biomedical research, an international journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-73</span>
        ISSN:<span class="NLM_cas:issn">0010-4809</span>.
    </div><div class="casAbstract">A package of computer programs for analysis and visualization of three-dimensional human brain functional magnetic resonance imaging (FMRI) results is described.  The software can color overlay neural activation maps onto higher resolution anatomical scans.  Slices in each cardinal plane can be viewed simultaneously.  Manual placement of markers on anatomical landmarks allows transformation of anatomical and functional scans into stereotaxic (Talairach-Tournoux) coordinates.  The techniques for automatically generating transformed functional data sets from manually labeled anatomical data sets are described.  Facilities are provided for several types of statistical analyses of multiple 3D functional data sets.  The programs are written in ANSI C and Motif 1.2 to run on Unix workstations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpCKGKbuk0ozToTC3aBaesfW6udTcc2eZlTUPkRe_hYLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vgvVChug%253D%253D&md5=23dbf7895a72f130092406163664ed25</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1006%2Fcbmr.1996.0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fcbmr.1996.0014%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DR.%2BW.%26atitle%3DAFNI%253A%2520software%2520for%2520analysis%2520and%2520visualization%2520of%2520functional%2520magnetic%2520resonance%2520neuroimages%26jtitle%3DComput.%2520Biomed.%2520Res.%26date%3D1996%26volume%3D29%26spage%3D162%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+from+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0ljvWSPYEDK8gA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520from%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=293-301&author=H.+S.+Brownauthor=M.+Griffinauthor=J.+B.+Houston&title=Evaluation+of+cryopreserved+human+hepatocytes+as+an+alternative+in+vitro+system+to+microsomes+for+the+prediction+of+metabolic+clearance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DGriffin%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520cryopreserved%2520human%2520hepatocytes%2520as%2520an%2520alternative%2520in%2520vitro%2520system%2520to%2520microsomes%2520for%2520the%2520prediction%2520of%2520metabolic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c'],'ref9':['cit9a','cit9b','cit9c'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14a','cit14b'],'ref15':['cit15a','cit15b'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18a','cit18b'],'ref19':['cit19'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24a','cit24b'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b','cit27c','cit27d','cit27e'],'ref28':['cit28a','cit28b','cit28c'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34a','cit34b'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37a','cit37b'],'ref38':['cit38a','cit38b','cit38c'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49a','cit49b']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 17 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Simone Brogi, Giuseppe Campiani, Margherita Brindisi, <span class="NLM_string-name hlFld-ContribAuthor">Stefania Butini</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (3)
                                     , 228-236. <a href="https://doi.org/10.1021/acsmedchemlett.8b00450" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00450</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00450&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00450%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAllosteric%252BModulation%252Bof%252BIonotropic%252BGlutamate%252BReceptors%25253A%252BAn%252BOutlook%252Bon%252BNew%252BTherapeutic%252BApproaches%252BTo%252BTreat%252BCentral%252BNervous%252BSystem%252BDisorders%26aulast%3DBrogi%26aufirst%3DSimone%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D30092018%26date%3D23012019%26date%3D05022019%26date%3D23012019%26volume%3D10%26issue%3D3%26spage%3D228%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hualong Fu, Zhen Chen, Lee Josephson, Zijing Li, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Positron Emission Tomography (PET) Ligand Development for Ionotropic Glutamate Receptors: Challenges and Opportunities for Radiotracer Targeting N-Methyl-d-aspartate (NMDA), α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA), and Kainate Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 403-419. <a href="https://doi.org/10.1021/acs.jmedchem.8b00714" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPositron%252BEmission%252BTomography%252B%252528PET%252529%252BLigand%252BDevelopment%252Bfor%252BIonotropic%252BGlutamate%252BReceptors%25253A%252BChallenges%252Band%252BOpportunities%252Bfor%252BRadiotracer%252BTargeting%252BN-Methyl-d-aspartate%252B%252528NMDA%252529%25252C%252B%2525CE%2525B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%252BAcid%252B%252528AMPA%252529%25252C%252Band%252BKainate%252BReceptors%26aulast%3DFu%26aufirst%3DHualong%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D04052018%26date%3D27082018%26date%3D15082018%26volume%3D62%26issue%3D2%26spage%3D403%26epage%3D419" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Eric  Arnold</span>, <span class="hlFld-ContribAuthor ">Tracey  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Ethan  Fisher</span>, <span class="hlFld-ContribAuthor ">Mihaly  Hajos</span>, <span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffman</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Zhijun  Kang</span>, <span class="hlFld-ContribAuthor ">Robin J.  Kleiman</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Jiemin  Lu</span>, <span class="hlFld-ContribAuthor ">Noha  Maklad</span>, <span class="hlFld-ContribAuthor ">Laura  McDowell</span>, <span class="hlFld-ContribAuthor ">Dina  McGinnis</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>, <span class="hlFld-ContribAuthor ">Adam  Ogden</span>, <span class="hlFld-ContribAuthor ">Mary  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Patricia A.  Seymour</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Ueno</span>, <span class="hlFld-ContribAuthor ">Nichole  Vansell</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1001-1018. <a href="https://doi.org/10.1021/acs.jmedchem.7b01466" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01466%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252Ba%252BPotent%25252C%252BHighly%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BPhosphodiesterase%252B2A%252BInhibitor%252BClinical%252BCandidate%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D02102017%26date%3D16012018%26date%3D08022018%26date%3D02012018%26volume%3D61%26issue%3D3%26spage%3D1001%26epage%3D1018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Akiyoshi  Kunugi</span>, <span class="hlFld-ContribAuthor ">Yasukazu  Tajima</span>, <span class="hlFld-ContribAuthor ">Noriko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Motohisa  Suzuki</span>, <span class="hlFld-ContribAuthor ">Masashi  Toyofuku</span>, <span class="hlFld-ContribAuthor ">Haruhiko  Kuno</span>, <span class="hlFld-ContribAuthor ">Satoshi  Sogabe</span>, <span class="hlFld-ContribAuthor ">Yohei  Kosugi</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Awasaki</span>, <span class="hlFld-ContribAuthor ">Tomohiro  Kaku</span>, <span class="hlFld-ContribAuthor ">Haruhide  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-93888-0" title="DOI URL">https://doi.org/10.1038/s41598-021-93888-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-93888-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-93888-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DStrictly%252Bregulated%252Bagonist-dependent%252Bactivation%252Bof%252BAMPA-R%252Bis%252Bthe%252Bkey%252Bcharacteristic%252Bof%252BTAK-653%252Bfor%252Brobust%252Bsynaptic%252Bresponses%252Band%252Bcognitive%252Bimprovement%26aulast%3DSuzuki%26aufirst%3DAtsushi%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bashkim  Kadriu</span>, <span class="hlFld-ContribAuthor ">Laura  Musazzi</span>, <span class="hlFld-ContribAuthor ">Jenessa N.  Johnston</span>, <span class="hlFld-ContribAuthor ">Lisa E.  Kalynchuk</span>, <span class="hlFld-ContribAuthor ">Hector J.  Caruncho</span>, <span class="hlFld-ContribAuthor ">Maurizio  Popoli</span>, <span class="hlFld-ContribAuthor ">Carlos A.  Zarate Jr</span>. </span><span class="cited-content_cbyCitation_article-title">Positive AMPA receptor modulation in the treatment of neuropsychiatric disorders: a long and winding road. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2021,</strong> <em>46 </em><a href="https://doi.org/10.1016/j.drudis.2021.07.027" title="DOI URL">https://doi.org/10.1016/j.drudis.2021.07.027</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2021.07.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2021.07.027%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DPositive%252BAMPA%252Breceptor%252Bmodulation%252Bin%252Bthe%252Btreatment%252Bof%252Bneuropsychiatric%252Bdisorders%25253A%252Ba%252Blong%252Band%252Bwinding%252Broad%26aulast%3DKadriu%26aufirst%3DBashkim%26date%3D2021%26volume%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karla  Frydenvang</span>, <span class="hlFld-ContribAuthor ">Darryl S.  Pickering</span>, <span class="hlFld-ContribAuthor ">Jette Sandholm  Kastrup</span>. </span><span class="cited-content_cbyCitation_article-title">Structural basis for positive allosteric modulation of AMPA and kainate receptors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physiology</span><span> <strong>2021,</strong> <em>53 </em><a href="https://doi.org/10.1113/JP280873" title="DOI URL">https://doi.org/10.1113/JP280873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1113/JP280873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1113%2FJP280873%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physiology%26atitle%3DStructural%252Bbasis%252Bfor%252Bpositive%252Ballosteric%252Bmodulation%252Bof%252BAMPA%252Band%252Bkainate%252Breceptors%26aulast%3DFrydenvang%26aufirst%3DKarla%26date%3D2021%26date%3D2021%26volume%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toshiyuki  Ishii</span>, <span class="hlFld-ContribAuthor ">Jacob R.  Stolz</span>, <span class="hlFld-ContribAuthor ">Geoffrey T.  Swanson</span>. </span><span class="cited-content_cbyCitation_article-title">Auxiliary Proteins are the Predominant Determinants of Differential Efficacy of Clinical Candidates Acting as AMPA Receptor Positive Allosteric Modulators. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2020,</strong> <em>97 </em>
                                    (5)
                                     , 336-350. <a href="https://doi.org/10.1124/mol.119.118554" title="DOI URL">https://doi.org/10.1124/mol.119.118554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.119.118554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.119.118554%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DAuxiliary%252BProteins%252Bare%252Bthe%252BPredominant%252BDeterminants%252Bof%252BDifferential%252BEfficacy%252Bof%252BClinical%252BCandidates%252BActing%252Bas%252BAMPA%252BReceptor%252BPositive%252BAllosteric%252BModulators%26aulast%3DIshii%26aufirst%3DToshiyuki%26date%3D2020%26date%3D2020%26volume%3D97%26issue%3D5%26spage%3D336%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiahui  Chen</span>, <span class="hlFld-ContribAuthor ">Jiefeng  Gan</span>, <span class="hlFld-ContribAuthor ">Jiyun  Sun</span>, <span class="hlFld-ContribAuthor ">Zhen  Chen</span>, <span class="hlFld-ContribAuthor ">Hualong  Fu</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Jingjie  Shang</span>, <span class="hlFld-ContribAuthor ">Jian  Gong</span>, <span class="hlFld-ContribAuthor ">Tuo  Shao</span>, <span class="hlFld-ContribAuthor ">Lee  Collier</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Xu</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and preliminary evaluation of 11C-labeled 4-cyclopropyl-7-(3-methoxyphenoxy)-3,4-dihydro-2H-benzo[e] [1,2,4] thiadiazine 1,1-dioxide for PET imaging AMPA receptors. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2020,</strong> <em>61 </em>
                                    (12)
                                     , 151635. <a href="https://doi.org/10.1016/j.tetlet.2020.151635" title="DOI URL">https://doi.org/10.1016/j.tetlet.2020.151635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2020.151635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2020.151635%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DRadiosynthesis%252Band%252Bpreliminary%252Bevaluation%252Bof%252B11C-labeled%252B4-cyclopropyl-7-%2525283-methoxyphenoxy%252529-3%25252C4-dihydro-2H-benzo%25255Be%25255D%252B%25255B1%25252C2%25252C4%25255D%252Bthiadiazine%252B1%25252C1-dioxide%252Bfor%252BPET%252Bimaging%252BAMPA%252Breceptors%26aulast%3DChen%26aufirst%3DJiahui%26date%3D2020%26volume%3D61%26issue%3D12%26spage%3D151635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atsushi  Suzuki</span>, <span class="hlFld-ContribAuthor ">Yasukazu  Tajima</span>, <span class="hlFld-ContribAuthor ">Akiyoshi  Kunugi</span>, <span class="hlFld-ContribAuthor ">Haruhide  Kimura</span>. </span><span class="cited-content_cbyCitation_article-title">Electrophysiological characterization of a novel AMPA receptor potentiator, TAK-137, in rat hippocampal neurons. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Letters</span><span> <strong>2019,</strong> <em>712 </em>, 134488. <a href="https://doi.org/10.1016/j.neulet.2019.134488" title="DOI URL">https://doi.org/10.1016/j.neulet.2019.134488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neulet.2019.134488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neulet.2019.134488%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Letters%26atitle%3DElectrophysiological%252Bcharacterization%252Bof%252Ba%252Bnovel%252BAMPA%252Breceptor%252Bpotentiator%25252C%252BTAK-137%25252C%252Bin%252Brat%252Bhippocampal%252Bneurons%26aulast%3DSuzuki%26aufirst%3DAtsushi%26date%3D2019%26volume%3D712%26spage%3D134488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna A.  Nazarova</span>, <span class="hlFld-ContribAuthor ">Kseniya N.  Sedenkova</span>, <span class="hlFld-ContribAuthor ">Dmitry S.  Karlov</span>, <span class="hlFld-ContribAuthor ">Mstislav I.  Lavrov</span>, <span class="hlFld-ContribAuthor ">Yuri K.  Grishin</span>, <span class="hlFld-ContribAuthor ">Tamara S.  Kuznetsova</span>, <span class="hlFld-ContribAuthor ">Vladimir L.  Zamoyski</span>, <span class="hlFld-ContribAuthor ">Vladimir V.  Grigoriev</span>, <span class="hlFld-ContribAuthor ">Elena B.  Averina</span>, <span class="hlFld-ContribAuthor ">Vladimir A.  Palyulin</span>. </span><span class="cited-content_cbyCitation_article-title">Bivalent AMPA receptor positive allosteric modulators of the bis(pyrimidine) series. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 1615-1619. <a href="https://doi.org/10.1039/C9MD00262F" title="DOI URL">https://doi.org/10.1039/C9MD00262F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00262F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00262F%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DBivalent%252BAMPA%252Breceptor%252Bpositive%252Ballosteric%252Bmodulators%252Bof%252Bthe%252Bbis%252528pyrimidine%252529%252Bseries%26aulast%3DNazarova%26aufirst%3DAnna%2BA.%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D9%26spage%3D1615%26epage%3D1619" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Shaffer</span>, <span class="hlFld-ContribAuthor ">Jason K.  Dutra</span>, <span class="hlFld-ContribAuthor ">Wei Chou  Tseng</span>, <span class="hlFld-ContribAuthor ">Mark L.  Weber</span>, <span class="hlFld-ContribAuthor ">Luke J.  Bogart</span>, <span class="hlFld-ContribAuthor ">Katherine  Hales</span>, <span class="hlFld-ContribAuthor ">Jincheng  Pang</span>, <span class="hlFld-ContribAuthor ">Dmitri  Volfson</span>, <span class="hlFld-ContribAuthor ">Christopher W.  am Ende</span>, <span class="hlFld-ContribAuthor ">Michael E.  Green</span>, <span class="hlFld-ContribAuthor ">Derek L.  Buhl</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>153 </em>, 73-81. <a href="https://doi.org/10.1016/j.neuropharm.2019.04.019" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.04.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.04.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.04.019%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DPharmacological%252Bevaluation%252Bof%252Bclinically%252Brelevant%252Bconcentrations%252Bof%252B%2525282R%25252C6R%252529-hydroxynorketamine%26aulast%3DShaffer%26aufirst%3DChristopher%2BL.%26date%3D2019%26volume%3D153%26spage%3D73%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven M.  Wales</span>, <span class="hlFld-ContribAuthor ">Elena G.  Merisor</span>, <span class="hlFld-ContribAuthor ">Holly V.  Adcock</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Pearce</span>, <span class="hlFld-ContribAuthor ">Ian R.  Strutt</span>, <span class="hlFld-ContribAuthor ">William  Lewis</span>, <span class="hlFld-ContribAuthor ">Daniel  Hamza</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Moody</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Synthesis of Highly Substituted, Amino- and Pyrrolidino-Tetrahydrofurans as Lead-Like Molecular Scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (32)
                                     , 8233-8239. <a href="https://doi.org/10.1002/chem.201801046" title="DOI URL">https://doi.org/10.1002/chem.201801046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201801046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201801046%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DDiastereoselective%252BSynthesis%252Bof%252BHighly%252BSubstituted%25252C%252BAmino-%252Band%252BPyrrolidino-Tetrahydrofurans%252Bas%252BLead-Like%252BMolecular%252BScaffolds%26aulast%3DWales%26aufirst%3DSteven%2BM.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D32%26spage%3D8233%26epage%3D8239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher L.  Shaffer</span>. </span><span class="cited-content_cbyCitation_article-title">Reverse and Forward Translational Neuropharmacology in Psychiatric Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2018,</strong> <em>103 </em>
                                    (2)
                                     , 193-195. <a href="https://doi.org/10.1002/cpt.901" title="DOI URL">https://doi.org/10.1002/cpt.901</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.901%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DReverse%252Band%252BForward%252BTranslational%252BNeuropharmacology%252Bin%252BPsychiatric%252BDrug%252BDiscovery%26aulast%3DShaffer%26aufirst%3DChristopher%2BL.%26date%3D2018%26date%3D2017%26volume%3D103%26issue%3D2%26spage%3D193%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M  Ranganathan</span>, <span class="hlFld-ContribAuthor ">N  DeMartinis</span>, <span class="hlFld-ContribAuthor ">B  Huguenel</span>, <span class="hlFld-ContribAuthor ">F  Gaudreault</span>, <span class="hlFld-ContribAuthor ">M M  Bednar</span>, <span class="hlFld-ContribAuthor ">C L  Shaffer</span>, <span class="hlFld-ContribAuthor ">S  Gupta</span>, <span class="hlFld-ContribAuthor ">J  Cahill</span>, <span class="hlFld-ContribAuthor ">M A  Sherif</span>, <span class="hlFld-ContribAuthor ">J  Mancuso</span>, <span class="hlFld-ContribAuthor ">L  Zumpano</span>, <span class="hlFld-ContribAuthor ">D C  D’Souza</span>. </span><span class="cited-content_cbyCitation_article-title">Attenuation of ketamine-induced impairment in verbal learning and memory in healthy volunteers by the AMPA receptor potentiator PF-04958242. </span><span class="cited-content_cbyCitation_journal-name">Molecular Psychiatry</span><span> <strong>2017,</strong> <em>22 </em>
                                    (11)
                                     , 1633-1640. <a href="https://doi.org/10.1038/mp.2017.6" title="DOI URL">https://doi.org/10.1038/mp.2017.6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/mp.2017.6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fmp.2017.6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Psychiatry%26atitle%3DAttenuation%252Bof%252Bketamine-induced%252Bimpairment%252Bin%252Bverbal%252Blearning%252Band%252Bmemory%252Bin%252Bhealthy%252Bvolunteers%252Bby%252Bthe%252BAMPA%252Breceptor%252Bpotentiator%252BPF-04958242%26aulast%3DRanganathan%26aufirst%3DM%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D11%26spage%3D1633%26epage%3D1640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon E  Ward</span>, <span class="hlFld-ContribAuthor ">Paul  Beswick</span>, <span class="hlFld-ContribAuthor ">Novella  Calcinaghi</span>, <span class="hlFld-ContribAuthor ">Lee A  Dawson</span>, <span class="hlFld-ContribAuthor ">Jane  Gartlon</span>, <span class="hlFld-ContribAuthor ">Francesca  Graziani</span>, <span class="hlFld-ContribAuthor ">Declan N C  Jones</span>, <span class="hlFld-ContribAuthor ">Laurent  Lacroix</span>, <span class="hlFld-ContribAuthor ">M H  Selina Mok</span>, <span class="hlFld-ContribAuthor ">Beatrice  Oliosi</span>, <span class="hlFld-ContribAuthor ">Joanne  Pardoe</span>, <span class="hlFld-ContribAuthor ">Kathryn  Starr</span>, <span class="hlFld-ContribAuthor ">Marie L  Woolley</span>, <span class="hlFld-ContribAuthor ">Mark H  Harries</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological characterization of
              N
              -[(2
              S
              )-5-(6-fluoro-3-pyridinyl)-2, 3-dihydro-1
              H
              -inden-2-yl]-2-propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2017,</strong> <em>174 </em>
                                    (5)
                                     , 370-385. <a href="https://doi.org/10.1111/bph.13696" title="DOI URL">https://doi.org/10.1111/bph.13696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.13696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.13696%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DPharmacological%252Bcharacterization%252Bof%252BN%252B-%25255B%2525282%252BS%252B%252529-5-%2525286-fluoro-3-pyridinyl%252529-2%25252C%252B3-dihydro-1%252BH%252B-inden-2-yl%25255D-2-propanesulfonamide%25253A%252Ba%252Bnovel%25252C%252Bclinical%252BAMPA%252Breceptor%252Bpositive%252Ballosteric%252Bmodulator%26aulast%3DWard%26aufirst%3DSimon%2BE%26date%3D2017%26date%3D2017%26volume%3D174%26issue%3D5%26spage%3D370%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tristan  Reuillon</span>, <span class="hlFld-ContribAuthor ">Simon E.  Ward</span>, <span class="hlFld-ContribAuthor ">Paul  Beswick</span>. </span><span class="cited-content_cbyCitation_article-title">Modulating AMPA Receptors for the Treatment of CNS Disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 447-480. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12654-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12654-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12654-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12654-X%26sid%3Dliteratum%253Aachs%26atitle%3DModulating%252BAMPA%252BReceptors%252Bfor%252Bthe%252BTreatment%252Bof%252BCNS%252BDisorders%26aulast%3DReuillon%26aufirst%3DTristan%26date%3D2017%26spage%3D447%26epage%3D480%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative compounds of the tetrahydropyran (<b>1</b>), dihydroisoxazole (<b>2</b> and <b>4</b>), tetrahydrofuran ether (<b>3</b>), and biarylpropylsulfonamide (<b>5</b>) structural classes of AMPAR potentiators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Visualization of the design hypotheses explored to discover a unique chemotype from the biarylpropylsulfonamide structural class of AMPAR potentiators (exemplified by <b>5</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Model of <b>7</b> (cyan) docked onto the X-ray cocrystal structure of <b>5</b> (magenta) in the symmetrical binding pocket of the human GluA2o LBD. Only one binding pose of symmetric poses for each compound is shown for clarity. The sulfonamide of <b>5</b> forms a hydrogen bond with the backbone carbonyl oxygen of Pro-494; assuming an identical interaction, the sulfonamide of <b>7</b> was overlaid onto that of <b>5</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Visualization of the heterocycle design hypothesis from <b>7</b>. (A) Newman projection of the structural conformation of the energy-minimized model of <b>7</b> projected to bind to the GluA2o LBD. (B) Design hypotheses based on the ring-construction strategy to constrain the GluA2o LBD-bound conformation of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, BnNEt<sub>3</sub>Cl, dioxane, reflux, 18 h, quant; (b) MsCl, Et<sub>3</sub>N, DCM, 0 °C to rt, 18 h, quant; (c) NaN<sub>3</sub>, DMF, 110 °C, 66 h, 85%; (d) PPh<sub>3</sub>, THF, 0 °C to rt, 18 h, 78%; (e) (+)-CSA, IPA/H<sub>2</sub>O, 18 h, 30–35%; (f) <i>i</i>PrSO<sub>2</sub>Cl, DBU, DCM, 0 °C to rt, 20 h, quant; (g) boronic acid or boronate ester (<b>16</b>), XPhos, Pd(OAc)<sub>2</sub>, KF, 1:1 MeOH/toluene, 40–75%.</p></p></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. X-ray cocrystal structure of <b>3</b> in the symmetrical binding pocket of the human GluA2o LBD; only one binding pose is shown for clarity. The sulfonamide of <b>3</b> interacts with Pro-494 when its 2-cyano moiety accesses a flip isoform-selective pocket. The flip vs flop GluA2 isoforms are differentiated by a Ser vs Asn, respectively, at amino acid 754.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Compound <b>3</b> dose-dependently increased CD-1 mouse cerebellum cGMP (A) and decreased fall latency in C57BL/6J mice traversing an accelerating rotarod (B). For both assays, single doses were administered subcutaneously with a 0.5 h pretreatment time; for each dose, the projected mean <i>C</i><sub>b,u</sub> at 0.5 h after administration of <b>3</b> is shown within brackets. The data are expressed as the mean ± SEM with <i>N</i> = 5–6/dose (cGMP) or <i>N</i> = 12/dose (rotarod). *<i>P</i> < 0.05 (one-way ANOVA followed by posthoc Dunnett’s <i>t</i> test).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. In rats, <b>3</b> reversed the MK-801-mediated reduction in PPF after cumulative (A) or a single (B; 0.01 mg/kg) intravenous dose(s). Each column represents PPF values (mean ± SEM, <i>N</i> = 3–5) collected over a 10 min period following administration of <b>3</b>, and the projected mean <i>C</i><sub>b,u</sub> for each period is shown within brackets. (A) *<i>P</i> < 0.01 vs vehicle–vehicle condition, <sup>#</sup><i>P</i> < 0.01 vs MK-801-vehicle condition (two-tailed Student’s <i>t</i> test). (B) *<i>P</i> < 0.05 vs pre-MK-801-administration (−10 min period), <sup>#</sup><i>P</i> < 0.05 vs post-MK-801/pre-<b>3</b>-administration (0 min period) (two-tailed Student’s <i>t</i> test); arrows designate compound administration, the mean onset of the <b>3</b>-mediated effect was 8 ± 3 min, and <b>3</b> reversed the MK-801-disruption through 50 min postdose.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Compound <b>3</b> attenuated ketamine-induced working memory disruptions in rats as determined by mean errors in a radial arm maze. Single doses were administered subcutaneously with 1 and 0.5 h pretreatment times for <b>3</b> or the positive control (PC) and (±)-ketamine (10 mg/kg), respectively; for each dose, the projected mean <i>C</i><sub>b,u</sub> at 1 h after <b>3</b> administration is shown within brackets. The data are expressed as the mean ± SEM with <i>N</i> = 12/dose. *, **<i>P</i> = 0.05, 0.01 vs vehicle-ketamine condition (using a generalized linear mixed model assuming an underlying Poisson distribution followed by a Hochberg’s test for multiple post hoc comparisons).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. In rats, <b>3</b> dose-dependently affected the regional brain uptake of FDG. (A) Representative slices at bregma coordinates (−0.50 (top row) and −11.00 mm (bottom row)) overlaid onto rat brain histological slices with color indicating brain regions with significantly (<i>P</i> < 0.05, unpaired one-tailed <i>t</i> test) increased (yellow-to-red) or decreased (blue) FDG uptake in rats (<i>N</i> = 12/group) receiving <b>3</b> (0.027, 0.08, or 0.60 mg/kg, SC) vs vehicle. The color bar represents both the direction and relative magnitude of the uptake change. (B) Number of voxels with significantly (<i>P</i> < 0.05, unpaired one-tailed <i>t</i> test) increased FDG uptake in rats (<i>N</i> = 12/group) receiving <b>3</b> (0.027, 0.08, or 0.60 mg/kg, SC) vs vehicle within the entire volume of the cortex and cerebellum. Each voxel size is 0.5 mm × 0.5 mm × 0.5 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/medium/jm-2015-00300g_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Simulated human total plasma <b>3</b> concentration–time profiles following a single (A) or multiple (B; BID for 7 d) oral dose(s) of 0.3 mg. In both plots, the mean (solid line), 5th percentile (lower dashed line) and 95th percentile (upper dashed line) plasma drug concentration–time curves are shown to capture the intersubject pharmacokinetic variability projected by Simcyp for a virtual population of 100 healthy volunteers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-10/acs.jmedchem.5b00300/20150521/images/large/jm-2015-00300g_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b00300&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i60">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 49 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malinow, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malenka, R. C.</span><span> </span><span class="NLM_article-title">AMPA receptor trafficking and synaptic plasticity</span> <span class="citation_source-journal">Annu. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">103</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1146%2Fannurev.neuro.25.112701.142758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12052905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2002&pages=103-126&author=R.+Malinowauthor=R.+C.+Malenka&title=AMPA+receptor+trafficking+and+synaptic+plasticity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor trafficking and synaptic plasticity</span></div><div class="casAuthors">Malinow, Roberto; Malenka, Robert C.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-126</span>CODEN:
                <span class="NLM_cas:coden">ARNSD5</span>;
        ISSN:<span class="NLM_cas:issn">0147-006X</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Activity-dependent changes in synaptic function are believed to underlie the formation of memories.  Two prominent examples are long-term potentiation (LTP) and long-term depression (LTD), whose mechanisms have been the subject of considerable scrutiny over the past few decades.  Here we review the growing literature that supports a crit. role for AMPA receptor trafficking in LTP and LTD, focusing on the roles proposed for specific AMPA receptor subunits and their interacting proteins.  While much work remains to understand the mol. basis for synaptic plasticity, recent results on AMPA receptor trafficking provide a clear conceptual framework for future studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXbY4P375GeLVg90H21EOLACvtfcHk0liW5z-cZeOWnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtF2hsLw%253D&md5=bdf912ce2115da5d4cb87031d707d745</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1146%2Fannurev.neuro.25.112701.142758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.neuro.25.112701.142758%26sid%3Dliteratum%253Aachs%26aulast%3DMalinow%26aufirst%3DR.%26aulast%3DMalenka%26aufirst%3DR.%2BC.%26atitle%3DAMPA%2520receptor%2520trafficking%2520and%2520synaptic%2520plasticity%26jtitle%3DAnnu.%2520Rev.%2520Neurosci.%26date%3D2002%26volume%3D25%26spage%3D103%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Huganir, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoll, R. A.</span><span> </span><span class="NLM_article-title">AMPARs and synaptic plasticity: the last 25 years</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">704</span><span class="NLM_x">–</span> <span class="NLM_lpage">717</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2013&pages=704-717&author=R.+L.+Huganirauthor=R.+A.+Nicoll&title=AMPARs+and+synaptic+plasticity%3A+the+last+25+years"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuganir%26aufirst%3DR.%2BL.%26aulast%3DNicoll%26aufirst%3DR.%2BA.%26atitle%3DAMPARs%2520and%2520synaptic%2520plasticity%253A%2520the%2520last%252025%2520years%26jtitle%3DNeuron%26date%3D2013%26volume%3D80%26spage%3D704%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Lynch, G.</span><span> </span><span class="NLM_article-title">Memory enhancement: the search for mecahnism-based drugs</span> <span class="citation_source-journal">Nature Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1035</span><span class="NLM_x">–</span> <span class="NLM_lpage">1038</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1038%2Fnn935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12403980" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2002&pages=1035-1038&author=G.+Lynch&title=Memory+enhancement%3A+the+search+for+mecahnism-based+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancement: the search for mechanism-based drugs</span></div><div class="casAuthors">Lynch, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">Suppl.</span>),
    <span class="NLM_cas:pages">1035-1038</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rapid progress has been made in understanding the synaptic changes required for memory encoding.  Several companies are now attempting to use information about the induction and consolidation phases of this process to build memory-enhancing drugs.  These efforts have produced novel compds. that improve retention scores across a broad range of tests and species.  Initial clin. results are encouraging.  Issues now arise about appropriate applications of candidate drugs and optimal cellular targets for future development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN-gQ6I9ivB7Vg90H21EOLACvtfcHk0liW5z-cZeOWnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1entLk%253D&md5=f391c93b5e05f4c8ba19a0bbbc05ee97</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnn935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn935%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26atitle%3DMemory%2520enhancement%253A%2520the%2520search%2520for%2520mecahnism-based%2520drugs%26jtitle%3DNature%2520Neurosci.%26date%3D2002%26volume%3D5%26spage%3D1035%26epage%3D1038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Lynch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gall, C. M.</span><span> </span><span class="NLM_article-title">Ampakines and the threefold path to cognitive enhancement</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">554</span><span class="NLM_x">–</span> <span class="NLM_lpage">562</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=554-562&author=G.+Lynchauthor=C.+M.+Gall&title=Ampakines+and+the+threefold+path+to+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLynch%26aufirst%3DG.%26aulast%3DGall%26aufirst%3DC.%2BM.%26atitle%3DAmpakines%2520and%2520the%2520threefold%2520path%2520to%2520cognitive%2520enhancement%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26spage%3D554%26epage%3D562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Morris, R. G. M.</span><span> </span><span class="NLM_article-title">Long-term potentiation and memory</span> <span class="citation_source-journal">Philos. Trans. R. Soc., B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">647</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1098%2Frstb.2002.1230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12740109" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2003&pages=643-647&author=R.+G.+M.+Morris&title=Long-term+potentiation+and+memory"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Long-term potentiation and memory</span></div><div class="casAuthors">Morris Richard G M</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical transactions of the Royal Society of London. Series B, Biological sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">1432</span>),
    <span class="NLM_cas:pages">643-7</span>
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    </div><div class="casAbstract">The discovery of long-term potentiation (LTP) transformed research on the neurobiology of learning and memory.  This did not happen overnight, but the discovery of an experimentally demonstrable phenomenon reflecting activity-driven neuronal and synaptic plasticity changed discussions about what might underlie learning from speculation into something much more concrete.  Equally, however, the relationship between the discovery of LTP and research on the neurobiology of learning and memory has been reciprocal; for it is also true that studies of the psychological, anatomical and neurochemical basis of memory provided a developing and critical intellectual context for the physiological discovery.  The emerging concept of multiple memory systems, from 1970 onwards, paved the way for the development of new behavioural and cognitive tasks, including the watermaze described in this paper.  The use of this task in turn provided key evidence that pharmacological interference with an LTP induction mechanism would also interfere with learning, a finding that was by no means a foregone conclusion.  This reciprocal relationship between studies of LTP and the neurobiology of memory helped the physiological phenomenon to be recognized as a major discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRumjSaqwyW3lvAgqb2vdc5fW6udTcc2eaB9zh2GMhjzLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3hvFCrtA%253D%253D&md5=b9975b00a2dba770a29a392832ba549a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1098%2Frstb.2002.1230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2002.1230%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DR.%2BG.%2BM.%26atitle%3DLong-term%2520potentiation%2520and%2520memory%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%252C%2520B%26date%3D2003%26volume%3D358%26spage%3D643%26epage%3D647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, M. E.</span><span> </span><span class="NLM_article-title">Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">7342</span><span class="NLM_x">–</span> <span class="NLM_lpage">7351</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.4603-04.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16093384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2MXpsFGiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=7342-7351&author=X.+Sunauthor=Y.+Zhaoauthor=M.+E.+Wolf&title=Dopamine+receptor+stimulation+modulates+AMPA+receptor+synaptic+insertion+in+prefrontal+cortex+neurons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons</span></div><div class="casAuthors">Sun, Xiu; Zhao, Yun; Wolf, Marina E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">7342-7351</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Addiction is believed to involve glutamate-dependent forms of synaptic plasticity that promote the formation of new habits focused on drug seeking.  The authors used primary cultures of rat prefrontal cortex (PFC) neurons to explore mechanisms by which dopamine-releasing psychomotor stimulants such as cocaine and amphetamine influence synaptic plasticity, focusing on AMPA receptor trafficking because of its key role in long-term potentiation (LTP).  Brief stimulation of D1 dopamine receptors increased surface expression of glutamate receptor 1 (GluR1)-contg. AMPA receptors through a protein kinase A-dependent mechanism, by increasing their rate of externalization at extrasynaptic sites.  Newly externalized GluR1 remained extrasynaptic under basal conditions but could be translocated into synapses by subsequent NMDA receptor activation.  These results suggest that D1 receptors may facilitate LTP by increasing the AMPA receptor pool available for synaptic insertion.  However, stimulation of D2 receptors decreased surface and synaptic GluR1 expression.  These findings are discussed in the context of evidence that D1 and D2 receptors act independently rather than antagonistically in the intact PFC.  D1 receptor facilitation of AMPA receptor synaptic insertion helps explain D1 receptor-dependent facilitation of LTP and learning in the normal brain.  Abnormal engagement of this mechanism during unregulated dopamine release may account for maladaptive plasticity after repeated exposure to cocaine or amphetamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHWXErG4Fz1bVg90H21EOLACvtfcHk0lgj8JZjjau1Ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXpsFGiur4%253D&md5=aa96d7798c1f400e4f67ce2920b81e7e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4603-04.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4603-04.2005%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DWolf%26aufirst%3DM.%2BE.%26atitle%3DDopamine%2520receptor%2520stimulation%2520modulates%2520AMPA%2520receptor%2520synaptic%2520insertion%2520in%2520prefrontal%2520cortex%2520neurons%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D7342%26epage%3D7351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Black, M. D.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">179</span><span class="NLM_x">, </span> <span class="NLM_fpage">154</span><span class="NLM_x">–</span> <span class="NLM_lpage">163</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=179&publication_year=2005&pages=154-163&author=M.+D.+Black&title=Therapeutic+Potential+of+Positive+AMPA+Modulators+and+Their+Relationship+to+AMPA+Receptor+Subunits.+A+Review+of+Preclinical+Data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlack%26aufirst%3DM.%2BD.%26atitle%3DTherapeutic%2520Potential%2520of%2520Positive%2520AMPA%2520Modulators%2520and%2520Their%2520Relationship%2520to%2520AMPA%2520Receptor%2520Subunits.%2520A%2520Review%2520of%2520Preclinical%2520Data%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D179%26spage%3D154%26epage%3D163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grove, S. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rankovic, Z.</span><span> </span><span class="NLM_article-title">Positive allosteric modulators of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7271</span><span class="NLM_x">–</span> <span class="NLM_lpage">7279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1000419" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7271-7279&author=S.+J.+A.+Groveauthor=C.+Jamiesonauthor=J.+K.+F.+Macleanauthor=J.+A.+Morrowauthor=Z.+Rankovic&title=Positive+allosteric+modulators+of+the+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm1000419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000419%26sid%3Dliteratum%253Aachs%26aulast%3DGrove%26aufirst%3DS.%2BJ.%2BA.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DRankovic%26aufirst%3DZ.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520the%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7271%26epage%3D7279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Neill, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">AMPA Receptor Potentiators for the Treatment of CNS Disorders</span> <span class="citation_source-journal">Curr. Drug Targets CNS Neurol. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.2174%2F1568007043337508" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=15180479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=181-194&author=M.+J.+O%E2%80%99Neillauthor=D.+Bleakmanauthor=D.+M.+Zimmermanauthor=E.+S.+Nisenbaum&title=AMPA+Receptor+Potentiators+for+the+Treatment+of+CNS+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor potentiators for the treatment of CNS disorders</span></div><div class="casAuthors">O'Neill, Michael J.; Bleakman, David; Zimmerman, Dennis M.; Nisenbaum, Eric S.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: CNS & Neurological Disorders</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-194</span>CODEN:
                <span class="NLM_cas:coden">CDTCCC</span>;
        ISSN:<span class="NLM_cas:issn">1568-007X</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors mediate most of the excitatory neurotransmission in the mammalian central nervous system and also participate in forms of synaptic plasticity thought to underlie memory and learning, and the formation of neural networks during development.  Mol. cloning techniques have shown that the AMPA receptor family is composed of 4 different subunits named GluR1-4 or GluRA-D (newly termed as GluA1-GluA4) and native AMPA receptors are most likely tetramers generated by the assembly of 1 or more of these subunits, yielding homomeric or heteromeric receptors.  Addnl. complexity among AMPA receptors is conferred by alternative splicing of RNA for each subunit giving rise to flip and flop variants.  Clin. and exptl. data have suggested that pos. modulation of AMPA receptors may be therapeutically effective in the treatment of cognitive deficits.  Several classes of AMPA receptor potentiators were reported, including pyrrolidones (piracetam, aniracetam), benzothiazides (cyclothiazide), benzylpiperidines (CX-516, CX-546), and more recently biarylpropylsulfonamides (LY392098, LY404187 and LY503430).  These mols. enhance cognitive function in rodents, which appears to correlate with increased hippocampal activity.  In addn., clin. studies have suggested that AMPA receptor modulators enhance cognitive function in elderly subjects, as well as patients suffering from neurol. and psychiatric disorders.  Several independent studies have suggested that AMPA receptors can increase BDNF expression by both calcium-dependent and independent pathways.  For example, recent studies have shown that AMPA receptors interact with the protein Tyr kinase, Lyn.  Activation of Lyn can recruit the mitogen-activated protein kinase (MAPK) signalling pathway and increase the expression of BDNF.  Therefore, in addn. to directly enhancing glutamatergic synaptic transmission, AMPA receptor activation can increase the expression of BDNF in vitro and in vivo.  This may account for activity of AMPA receptor potentiators in rodent models predictive of antidepressant activity (forced swim and tail suspension tests).  The increase in neurotrophin expression also may contribute to the functional, neuroprotective, and neurotrophic actions of LY404187 and LY503430 after infusion of 6-OHDA into the substantia nigra.  In conclusion, several potent, selective and systematically active AMPA receptor potentiators were reported.  Data indicate that these mols. modulate glutamatergic transmission, enhance synaptic transmission, long-term potentiation (LTP), and increase neurotrophin expression.  Therefore, these AMPA receptor potentiators offer an exciting new class of drugs with potentials for treating (1) cognitive impairment assocd. with Alzheimer's disease and schizophrenia, (2) depression, (3) slowing the progression and potentially enhancing recovery from Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHYMd0O34_SLVg90H21EOLACvtfcHk0lhmK3o4llK-nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXltFCgu7g%253D&md5=5d438c3c4cc13fa863608073601cc6a1</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.2174%2F1568007043337508&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568007043337508%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DBleakman%26aufirst%3DD.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DAMPA%2520Receptor%2520Potentiators%2520for%2520the%2520Treatment%2520of%2520CNS%2520Disorders%26jtitle%3DCurr.%2520Drug%2520Targets%2520CNS%2520Neurol.%2520Disord.%26date%3D2004%26volume%3D3%26spage%3D181%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zarate, C. A.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases</span> <span class="citation_source-journal">Exp. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">211</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.expneurol.2008.01.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18291371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsF2qtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=211&publication_year=2008&pages=7-10&author=C.+A.+Zarateauthor=H.+K.+Manji&title=The+role+of+AMPA+receptor+modulation+in+the+treatment+of+neuropsychiatric+diseases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases</span></div><div class="casAuthors">Zarate, Carlos A.; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Neurology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">211</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-10</span>CODEN:
                <span class="NLM_cas:coden">EXNEAC</span>;
        ISSN:<span class="NLM_cas:issn">0014-4886</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acidglutamate receptor is the major contributors of excitatory neurotransmission, reconciling the fast, rapidly desensitizing excitation of many synapses, and is concerned in the early response to glutamate in the synaptic space.  The results of some early studies depicting the roles of AMPA receptors are shown.  AMPA receptors have important roles in long-term neurotrophic/neuroprotective effects, aging, treatment of severe psychiatric disorders, as well as mood disorders.  It also failed to demonstrate any improvement in neuropsychiatric symptoms and in cognitive deficits or psychotic symptoms.  Thus, a better understanding of the mol. cellular mechanisms involved in disease and the mechanism of action of AMPA receptor modulators will be of the utmost importance when boarding in proof-of-concept studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIf-9Au4U3b7Vg90H21EOLACvtfcHk0lhmK3o4llK-nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsF2qtbY%253D&md5=63825025e9b5a2c8bcde3b4ff8e48407</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1016%2Fj.expneurol.2008.01.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.expneurol.2008.01.011%26sid%3Dliteratum%253Aachs%26aulast%3DZarate%26aufirst%3DC.%2BA.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DThe%2520role%2520of%2520AMPA%2520receptor%2520modulation%2520in%2520the%2520treatment%2520of%2520neuropsychiatric%2520diseases%26jtitle%3DExp.%2520Neurol.%26date%3D2008%26volume%3D211%26spage%3D7%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Millan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brune, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullmore, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deakin, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeRubeis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geyer, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodwin, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorwood, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jay, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joels, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansuy, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer-Lindenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rolls, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saletu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spedding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, L. J.</span><span> </span><span class="NLM_article-title">Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">168</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=141-168&author=M.+J.+Millanauthor=Y.+Agidauthor=M.+Bruneauthor=E.+T.+Bullmoreauthor=C.+S.+Carterauthor=N.+S.+Claytonauthor=R.+Connorauthor=S.+Davisauthor=B.+Deakinauthor=R.+J.+DeRubeisauthor=B.+Duboisauthor=M.+A.+Geyerauthor=G.+M.+Goodwinauthor=P.+Gorwoodauthor=T.+M.+Jayauthor=M.+Joelsauthor=I.+M.+Mansuyauthor=A.+Meyer-Lindenbergauthor=D.+Murphyauthor=E.+Rollsauthor=B.+Saletuauthor=M.+Speddingauthor=J.+Sweeneyauthor=M.+Whittingtonauthor=L.+J.+Young&title=Cognitive+dysfunction+in+psychiatric+disorders%3A+characteristics%2C+causes+and+the+quest+for+improved+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DAgid%26aufirst%3DY.%26aulast%3DBrune%26aufirst%3DM.%26aulast%3DBullmore%26aufirst%3DE.%2BT.%26aulast%3DCarter%26aufirst%3DC.%2BS.%26aulast%3DClayton%26aufirst%3DN.%2BS.%26aulast%3DConnor%26aufirst%3DR.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DDeakin%26aufirst%3DB.%26aulast%3DDeRubeis%26aufirst%3DR.%2BJ.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DGoodwin%26aufirst%3DG.%2BM.%26aulast%3DGorwood%26aufirst%3DP.%26aulast%3DJay%26aufirst%3DT.%2BM.%26aulast%3DJoels%26aufirst%3DM.%26aulast%3DMansuy%26aufirst%3DI.%2BM.%26aulast%3DMeyer-Lindenberg%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DD.%26aulast%3DRolls%26aufirst%3DE.%26aulast%3DSaletu%26aufirst%3DB.%26aulast%3DSpedding%26aufirst%3DM.%26aulast%3DSweeney%26aufirst%3DJ.%26aulast%3DWhittington%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DL.%2BJ.%26atitle%3DCognitive%2520dysfunction%2520in%2520psychiatric%2520disorders%253A%2520characteristics%252C%2520causes%2520and%2520the%2520quest%2520for%2520improved%2520therapy%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D141%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Moghaddam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1038%2Fnpp.2011.181" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=21956446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=4-15&author=B.+Moghaddamauthor=D.+C.+Javitt&title=From+revolution+to+evolution%3A+the+glutamate+hypothesis+of+schizophrenia+and+its+implication+for+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment</span></div><div class="casAuthors">Moghaddam, Bita; Javitt, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-15</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Glutamate is the primary excitatory neurotransmitter in mammalian brain.  Disturbances in glutamate-mediated neurotransmission have been increasingly documented in a range of neuropsychiatric disorders including schizophrenia, substance abuse, mood disorders, Alzheimer's disease, and autism-spectrum disorders.  Glutamatergic theories of schizophrenia are based on the ability of N-methyl--aspartate receptor (NMDAR) antagonists to induce schizophrenia-like symptoms, as well as emergent literature documenting disturbances of NMDAR-related gene expression and metabolic pathways in schizophrenia.  Research over the past two decades has highlighted promising new targets for drug development based on potential pre- and postsynaptic, and glial mechanisms leading to NMDAR dysfunction.  Reduced NMDAR activity on inhibitory neurons leads to disinhibition of glutamate neurons increasing synaptic activity of glutamate, esp. in the prefrontal cortex.  Based on this mechanism, normalizing excess glutamate levels by metabotropic glutamate group 2/3 receptor agonists has led to potential identification of the first non-monoaminergic target with comparable efficacy as conventional antipsychotic drugs for treating pos. and neg. symptoms of schizophrenia.  In addn., NMDAR has intrinsic modulatory sites that are active targets for drug development, several of which show promise in preclin./early clin. trials targeting both symptoms and cognition.  To date, most studies have been done with orthosteric agonists and/or antagonists at specific sites.  However, allosteric modulators, both pos. and neg., may offer superior efficacy with less danger of downregulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeNMlez-A7MbVg90H21EOLACvtfcHk0lhS4s7azq07xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ejs77N&md5=0bf82fc0e3cb5c3ad2bed91414672e6f</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2011.181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2011.181%26sid%3Dliteratum%253Aachs%26aulast%3DMoghaddam%26aufirst%3DB.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DFrom%2520revolution%2520to%2520evolution%253A%2520the%2520glutamate%2520hypothesis%2520of%2520schizophrenia%2520and%2520its%2520implication%2520for%2520treatment%26jtitle%3DNeuropsychopharmacology%26date%3D2012%26volume%3D37%26spage%3D4%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Collingridge, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volianskis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannister, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">France, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanna, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tidball, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Irvine, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bortolotto, Z. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molnar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lodge, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jane, D. E.</span><span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Molnarauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMolnar%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">Glutamate receptor dysfunction and schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">998</span><span class="NLM_x">–</span> <span class="NLM_lpage">1007</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Farchpsyc.1995.03950240016004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7492260" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=1995&pages=998-1007&author=J.+W.+Olneyauthor=N.+B.+Farber&title=Glutamate+receptor+dysfunction+and+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor dysfunction and schizophrenia</span></div><div class="casAuthors">Olney, John W.; Farber, Nuri B.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">998-1007</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">A review, with 120 refs., which advances a unified hypothesis pertaining to combined dysfunction of dopamine and N-methyl-D-aspartate glutamate receptors that highlights N-methyl-D-aspartate receptor hypofunction as a key mechanism that can help explain major clin. and pathophysiol. aspects of schizophrenia.  The following fundamental features of schizophrenia are accommodated by this hypothesis: (1) the occurrence of structural brain changes during early development that have the potential for producing subsequent clin. manifestations of schizophrenia, (2) a quiescent period in infancy and adolescence before clin. manifestations are expressed, (3) onset in early adulthood of psychotic symptoms, (4) involvement of dopamine (D2) receptors in some cases but not others that would explain why some but not all patients are responsive to typical neuroleptic therapy, and (5) ongoing neurodegenerative changes and cognitive deterioration in some patients.  We propose that since N-methyl-D-aspartate receptor hypofunction can cause psychosis in humans and corticolimbic neurodegenerative changes in the rat brain, and since these changes are prevented by certain antipsychotic drugs, including atypical neuroleptic agents (clozapine, olanzapine, fluperlapine), a better understanding of the N-methyl-D-aspartate receptor hypofunction mechanism and ways of preventing its neurodegenerative consequences in the rat brain may lead to improved pharmacotherapy in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8_jBCscao6LVg90H21EOLACvtfcHk0liyEahgY11xMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XotF2rtA%253D%253D&md5=ce668d3a1c911f6a0eab2488b0a14ad5</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1995.03950240016004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1995.03950240016004%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DGlutamate%2520receptor%2520dysfunction%2520and%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1995%26volume%3D52%26spage%3D998%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Goff, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coyle, J. T.</span><span> </span><span class="NLM_article-title">The emerging role of glutamate in the pathophysiology and treatment of schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">158</span><span class="NLM_x">, </span> <span class="NLM_fpage">1367</span><span class="NLM_x">–</span> <span class="NLM_lpage">1377</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fappi.ajp.158.9.1367" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=11532718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3MvovFKktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=158&publication_year=2001&pages=1367-1377&author=D.+C.+Goffauthor=J.+T.+Coyle&title=The+emerging+role+of+glutamate+in+the+pathophysiology+and+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9bR"><div class="casContent"><span class="casTitleNuber">9b</span><div class="casTitle"><span class="NLM_cas:atitle">The emerging role of glutamate in the pathophysiology and treatment of schizophrenia</span></div><div class="casAuthors">Goff D C; Coyle J T</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">158</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1367-77</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Research has implicated dysfunction of glutamatergic neurotransmission in the pathophysiology of schizophrenia.  This review evaluates evidence from preclinical and clinical studies that brain glutamatergic neurotransmission is altered in schizophrenia, may affect symptom expression, and is modulated by antipsychotic drugs.  METHOD:  A comprehensive review of scientific articles published over the last decade that address the role of glutamate in the pathophysiology of schizophrenia was carried out.  RESULTS:  Glutamatergic neurons are the major excitatory pathways linking the cortex, limbic system, and thalamus, regions that have been implicated in schizophrenia.  Postmortem studies have revealed alterations in pre- and postsynaptic markers for glutamatergic neurons in several brain regions in schizophrenia.  The N-methyl-D-aspartic acid (NMDA) subtype of glutamate receptor may be particularly important as blockade of this receptor by the dissociative anesthetics reproduces in normal subjects the symptomatic manifestations of schizophrenia, including negative symptoms and cognitive impairments, and increases dopamine release in the mesolimbic system.  Agents that indirectly enhance NMDA receptor function via the glycine modulatory site reduce negative symptoms and variably improve cognitive functioning in schizophrenic subjects receiving typical antipsychotics.  CONCLUSIONS:  Dysfunction of glutamatergic neurotransmission may play an important role in the pathophysiology of schizophrenia, especially of the negative symptoms and cognitive impairments associated with the disorder, and is a promising target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQp5GLn-Koh8_h3YQQtAhNufW6udTcc2eYEGwZp34idxbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvovFKktw%253D%253D&md5=1ca16492e57ea93d117bbbb7a40dbc60</span></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.158.9.1367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.158.9.1367%26sid%3Dliteratum%253Aachs%26aulast%3DGoff%26aufirst%3DD.%2BC.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DThe%2520emerging%2520role%2520of%2520glutamate%2520in%2520the%2520pathophysiology%2520and%2520treatment%2520of%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2001%26volume%3D158%26spage%3D1367%26epage%3D1377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Glutamate and schizophrenia: phencyclidine, <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors, and dopamine–glutamate interactions</span> <span class="citation_source-journal">Int. Rev. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2FS0074-7742%2806%2978003-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=17349858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmt1Gmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2007&pages=69-108&author=D.+C.+Javitt&title=Glutamate+and+schizophrenia%3A+phencyclidine%2C+N-methyl-d-aspartate+receptors%2C+and+dopamine%E2%80%93glutamate+interactions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9cR"><div class="casContent"><span class="casTitleNuber">9c</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions</span></div><div class="casAuthors">Javitt, Daniel C.</div><div class="citationInfo"><span class="NLM_cas:title">International Review of Neurobiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Integrating the Neurobiology of Schizophrenia</span>),
    <span class="NLM_cas:pages">69-108,, 1 plate</span>CODEN:
                <span class="NLM_cas:coden">IRNEAE</span>;
        ISSN:<span class="NLM_cas:issn">0074-7742</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Schizophrenia is a serious mental disorder that affects up to 1% of the population worldwide.  As of yet, neurochem. mechanisms underlying schizophrenia remain unknown.  To date, the most widely considered neurochem. hypothesis of schizophrenia is the dopamine hypothesis, which postulates that symptoms of schizophrenia may result from excess dopaminergic neurotransmission particularly in striatal brain regions, along with dopaminergic deficits in prefrontal brain regions.  Alternative neurochem. models of schizophrenia, however, have been proposed involving glutamatergic mechanisms in general and N-methyl-D-aspartate (NMDA) receptors in particular.  A potential role for glutamatergic mechanisms in schizophrenia was first proposed ∼15 years ago based on the observation that the psychotomimetic agents phencyclidine (PCP) and ketamine induce psychotic symptoms and neurocognitive disturbances similar to those of schizophrenia by blocking neurotransmission at NMDA-type glutamate receptors.  Since that time, significant addnl. evidence has accumulated supporting a role for NMDA hypofunction in the pathophysiol. of schizophrenia.  Clin. challenge studies with PCP and ketamine have confirmed the close resemblance between NMDA antagonist-induced symptoms and neurocognitive deficits and those obsd. in schizophrenia, and suggest that NMDA dysfunction may lead to secondary dopaminergic dysregulation in striatal and prefrontal brain regions.  As compared to dopaminergic agents, NMDA antagonists induce neg. and cognitive symptoms of schizophrenia, as well as pos. symptoms.  Treatment studies with NMDA modulators, such as glycine, D-serine, and glycine transport inhibitors (GTIs), have yielded encouraging findings, although results remain controversial.  Finally, genetic linkage and in vivo neurochem. studies in schizophrenia highlight potential etiol. mechanisms giving rise to glutamatergic/NMDA dysfunction in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_ZhuFfD0tJ7Vg90H21EOLACvtfcHk0liyEahgY11xMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmt1Gmt74%253D&md5=dd081e288a66cdc6e3a98d0cfb49fa50</span></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2806%2978003-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252806%252978003-5%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DGlutamate%2520and%2520schizophrenia%253A%2520phencyclidine%252C%2520N-methyl-d-aspartate%2520receptors%252C%2520and%2520dopamine%25E2%2580%2593glutamate%2520interactions%26jtitle%3DInt.%2520Rev.%2520Neurobiol.%26date%3D2007%26volume%3D78%26spage%3D69%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Krystal, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karper, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seibyl, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delaney, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bremner, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heninger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">199</span><span class="NLM_x">–</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Farchpsyc.1994.03950030035004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=8122957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=199-214&author=J.+H.+Krystalauthor=L.+P.+Karperauthor=J.+P.+Seibylauthor=G.+K.+Freemanauthor=R.+Delaneyauthor=J.+D.+Bremnerauthor=G.+R.+Heningerauthor=M.+B.+Bowersauthor=D.+S.+Charney&title=Subanesthetic+effects+of+the+noncompetitive+NMDA+antagonist%2C+ketamine%2C+in+humans.+Psychotomimetic%2C+perceptual%2C+cognitive%2C+and+neuroendocrine+responses"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span></div><div class="casAuthors">Krystal, John H.; Karper, Laurence P.; Seibyl, John P.; Freeman, Glenna K.; Delaney, Richard; Bremner, J. Douglas; Heninger, George R.; Bowers, Malcolm B., Jr.; Charney, Dennis S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-214</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">When given at subanesthetic doses to healthy subjects, the N-methyl-D-aspartate (NMDA) agonist ketamine: (1) produced behaviors similar to the pos. and neg. symptoms of schizophrenia; (2) elicited alterations in perception; (3) impaired performance on tests of vigilance, verbal fluency, and the Wisconsin Card Sorting Test; (4) evoked symptoms similar to those of dissociative states; and (5) preferentially disrupted delayed word recall, sparing immediate recall and postdistraction recall.  Ketamine had no effect on the Mini-Mental State Examn.  Ketamine also had no effect on plasma 3-methoxy-4-hydroxyphenethylene glycol levels, although it blunted a test day decline in plasma homovanillic acid levels at the higher dose tested.  It also dose-dependently increased plasma cortisol and prolactin levels.  Ketamine produced small dose-dependent increases in blood pressure.  These data indicate that NMDA antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWxsI3lz_fbVg90H21EOLACvtfcHk0lifeRB9MeF88w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D&md5=6554b88d3fd5f747a925fe5ffaf49cd6</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030035004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030035004%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BK.%26aulast%3DDelaney%26aufirst%3DR.%26aulast%3DBremner%26aufirst%3DJ.%2BD.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DSubanesthetic%2520effects%2520of%2520the%2520noncompetitive%2520NMDA%2520antagonist%252C%2520ketamine%252C%2520in%2520humans.%2520Psychotomimetic%252C%2520perceptual%252C%2520cognitive%252C%2520and%2520neuroendocrine%2520responses%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D199%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">212</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="NLM_x">–</span> <span class="NLM_lpage">48</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.bbr.2010.03.039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20347881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=212&publication_year=2010&pages=41-48&author=B.+M.+Robertsauthor=D.+E.+Holdenauthor=C.+L.+Shafferauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Prevention+of+ketamine-induced+working+memory+impairments+by+AMPA+potentiators+in+a+nonhuman+primate+model+of+cognitive+dysfunction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction</span></div><div class="casAuthors">Roberts, Brooke M.; Holden, Daniel E.; Shaffer, Christopher L.; Seymour, Patricia A.; Menniti, Frank S.; Schmidt, Christopher J.; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">212</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Working memory impairments are a core aspect of schizophrenia, yet current medicines do not address such cognitive dysfunction.  We have developed a model of these working memory deficits by acutely disrupting glutamatergic synaptic transmission by administration of the N-methyl-3-aspartate (NMDA) antagonist ketamine in the nonhuman primate.  The current studies evaluated the effect of pos. allosteric modulators ("potentiators") of the α-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors on the working memory and behavioral effects of ketamine.  AMPA receptors mediate fast excitatory synaptic transmission throughout the brain and play a crit. role in the activity-dependent regulation of NMDA receptors.  We find that pos. modulation of AMPA receptors with LY451646 (0.1-1.0 mg/kg, SC) and structurally distinct PF-4778574 (0.01 mg/kg, SC) robustly ameliorates ketamine-induced working memory impairments without altering behavioral effects of acute ketamine we consider related to pos.- and neg.-like symptoms.  These results support AMPA receptor potentiators as a potential adjunctive treatment for cognitive impairment assocd. with schizophrenia (CIAS).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ3Id6D1EeSrVg90H21EOLACvtfcHk0lifeRB9MeF88w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtFWrsb8%253D&md5=a7e67cfd3027b0013e4ab448503219dc</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2010.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2010.03.039%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DPrevention%2520of%2520ketamine-induced%2520working%2520memory%2520impairments%2520by%2520AMPA%2520potentiators%2520in%2520a%2520nonhuman%2520primate%2520model%2520of%2520cognitive%2520dysfunction%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2010%26volume%3D212%26spage%3D41%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span> </span><span class="NLM_article-title">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">29</span><span class="NLM_x">–</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1017%2FS1461145710000271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20334724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=29-42&author=T.+Kissauthor=W.+E.+Hoffmannauthor=M.+Hajos&title=Delta+oscillation+and+short-term+plasticity+in+the+rat+medial+prefrontal+cortex%3A+modelling+NMDA+hypofunction+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia</span></div><div class="casAuthors">Kiss, Tamas; Hoffmann, William E.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-42</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Dysfunction of the prefrontal cortex (PFC) is considered to be an important factor contributing to a decrease in cognitive performance of schizophrenia patients.  The medial PFC (mPFC) is innervated by the hippocampus/subiculum, and the subiculum-mPFC pathway is known to be involved in various cognitive processes.  Glutamate-contg. subicular axons innervate cortical pyramidal neurons and interneurons where AMPA and NMDA receptors are implicated in synaptic transmission.  In our expts., properties of subiculum-mPFC interactions were studied using pathway stimulation and local field potential (LFP) recordings of the mPFC in urethane-anesthetized rats.  Changes in paired-pulse facilitation (PPF) and LFP oscillations, effects of the NMDA receptor antagonist MK-801, and the AMPAkine LY451395 were evaluated.  Effects of disruption of the thalamo-cortical loop with local microinjection of lidocaine into the mediodorsal thalamic nucleus (MD) were also studied.  Our findings demonstrate that both systemic administration of MK-801 and local MD lidocaine microinjection produce similar changes in LFP oscillations and redn. in PPF.  Specifically, it was obsd. that MK-801 (0.05 mg/kg i.v.) and intra-thalamic lidocaine changed regular, 2 Hz delta oscillation to a less regular 0.5-1.5 Hz delta rhythm.  Concurrently, PPF in response to elec. stimulation of the subiculum was significantly attenuated.  Administration of the AMPAkine LY451395 (0.01 mg/kg i.v.) reversed the MK-801- and lidocaine-induced changes, and was itself blocked by the AMPA receptor antagonist CP-465022.  Anal. of our findings suggests a crit. role of cortical interneurons in NMDA/AMPA receptor-mediated changes in thalamo-cortical oscillations and PPF, and contributes to our understanding of the NMDA hypofunction model of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5APr_ncoDP7Vg90H21EOLACvtfcHk0lggWJnRx7hGyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsV2gtLnO&md5=5cf78907f9690c37011f8d3e39f7b110</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000271%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26atitle%3DDelta%2520oscillation%2520and%2520short-term%2520plasticity%2520in%2520the%2520rat%2520medial%2520prefrontal%2520cortex%253A%2520modelling%2520NMDA%2520hypofunction%2520of%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D14%26spage%3D29%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Marenco, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberger, D. R.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Positive AMPA Receptor Modulators in the Treatment of Neuropsychiatric Disorders</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.2165%2F00023210-200620030-00001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16529524" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=173-185&author=S.+Marencoauthor=D.+R.+Weinberger&title=Therapeutic+Potential+of+Positive+AMPA+Receptor+Modulators+in+the+Treatment+of+Neuropsychiatric+Disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic potential of positive AMPA receptor modulators in the treatment of neuropsychiatric disorders</span></div><div class="casAuthors">Marenco, Stefano; Weinberger, Daniel R.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">173-185</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Drugs that potentiate the activity of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor cause a complex cascade of consequences in exptl. models, ranging from enhancement of long-term potentiation to induction of neurotrophic factors.  Animal studies characterizing the pharmacol. and behavioral effects of these substances have provided the rationale for several initial attempts to use these drugs in neuropsychiatric clin. settings.  Applications in schizophrenia, Alzheimer's disease and mild cognitive impairment have been initiated.  Other trials with these compds. include the treatment of Fragile X syndrome, and possible future applications may be in the field of Parkinson's disease.  The literature published to date is limited mostly to small phase I or II trials, so there is no conclusive evidence for or against the use of these drugs.  Substantial questions remain concerning which compds. to use, in what dose, for what condition and for how long.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEIFzk9iLjHLVg90H21EOLACvtfcHk0lggWJnRx7hGyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XkvF2mtb4%253D&md5=09378aa20043ab2a78cd6bcd0787af16</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2165%2F00023210-200620030-00001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00023210-200620030-00001%26sid%3Dliteratum%253Aachs%26aulast%3DMarenco%26aufirst%3DS.%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DTherapeutic%2520Potential%2520of%2520Positive%2520AMPA%2520Receptor%2520Modulators%2520in%2520the%2520Treatment%2520of%2520Neuropsychiatric%2520Disorders%26jtitle%3DCNS%2520Drugs%26date%3D2006%26volume%3D20%26spage%3D173%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure–response continuum of the novel potentiator PF-4778574</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">224</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fjpet.113.204735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=23899905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=212-224&author=C.+L.+Shafferauthor=R.+S.+Hurstauthor=R.+J.+Scialisauthor=S.+M.+Osgoodauthor=D.+K.+Bryceauthor=W.+E.+Hoffmannauthor=J.+T.+Lazzaroauthor=A.+N.+Hanksauthor=S.+Lotarskiauthor=M.+L.+Weberauthor=J.+Liuauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Haj%C3%B3s&title=Positive+allosteric+modulation+of+AMPA+receptors+from+efficacy+to+toxicity%3A+the+interspecies+exposure%E2%80%93response+continuum+of+the+novel+potentiator+PF-4778574"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13aR"><div class="casContent"><span class="casTitleNuber">13a</span><div class="casTitle"><span class="NLM_cas:atitle">Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574</span></div><div class="casAuthors">Shaffer, Christopher L.; Hurst, Raymond S.; Scialis, Renato J.; Osgood, Sarah M.; Bryce, Dianne K.; Hoffmann, William E.; Lazzaro, John T.; Hanks, Ashley N.; Lotarski, Susan; Weber, Mark L.; Liu, Jian Hua; Menniti, Frank S.; Schmidt, Christopher J.; Hajos, Mihaly</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-224</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) pos. allosteric modulation (i.e., "potentiation") has been proposed to overcome cognitive impairments in schizophrenia, but AMPAR overstimulation can be excitotoxic.  Thus, it is crit. to define carefully a potentiator's mechanism-based therapeutic index (TI) and to det. confidently its translatability from rodents to higher-order species.  Accordingly, the novel AMPAR potentiator N-{(3R,4S)-3-[4-(5-cyano-2-thienyl)phenyl]tetrahydro-2H-pyran-4-yl}propane-2-sulfonamide (PF-4778574) was characterized in a series of in vitro assays and single-dose animal studies evaluating AMPAR-mediated activities related to cognition and safety to afford an unbound brain compd. concn. (Cb,u)-normalized interspecies exposure-response relationship.  Because it is unknown which AMPAR subtype(s) may be selectively potentiated for an optimal TI, PF-4778574 binding affinity and functional potency were detd. in rodent tissues expected to express a native mixt. of AMPAR subunits and their assocd. proteins to afford composite pharmacol. values.  Functional activity was also quantified in recombinant cell lines stably expressing human GluA2 flip or flop homotetramers.  Procognitive effects of PF-4778574 were evaluated in both rat electrophysiol. and nonhuman primate (nhp) behavioral models of pharmacol. induced N-methyl-D-aspartate receptor hypofunction.  Safety studies assessed carebellum-based AMPAR activation (mouse) and motor coordination disruptions (mouse, dog, and nhp), as well as convulsion (mouse, rat, and dog).  The resulting empirically derived exposure-response continuum for PF-4778574 defines a single-dose-based TI of 8- to 16-fold for self-limiting tremor, a readily monitorable clin. adverse event.  Importantly, the Cb,u mediating each physiol. effect were highly consistent across species, with efficacy and convulsion occurring at just fractions of the in vitro-derived pharmacol. values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpP5MdXGBbRYrVg90H21EOLACvtfcHk0lggWJnRx7hGyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2ks7jE&md5=8fead71db7d49812f68c25f603132679</span></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.204735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.204735%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DWeber%26aufirst%3DM.%2BL.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DPositive%2520allosteric%2520modulation%2520of%2520AMPA%2520receptors%2520from%2520efficacy%2520to%2520toxicity%253A%2520the%2520interspecies%2520exposure%25E2%2580%2593response%2520continuum%2520of%2520the%2520novel%2520potentiator%2520PF-4778574%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D212%26epage%3D224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Patel, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoover, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fliri, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallaschun, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanks, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span> </span><span class="NLM_article-title">Discovery and characterization of a novel dihydroisoxazole class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor potentiators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">9180</span><span class="NLM_x">–</span> <span class="NLM_lpage">9191</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401274b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=9180-9191&author=N.+C.+Patelauthor=J.+Schwarzauthor=X.+J.+Houauthor=D.+J.+Hooverauthor=L.+Xieauthor=A.+J.+Fliriauthor=R.+J.+Gallaschunauthor=J.+T.+Lazzaroauthor=D.+K.+Bryceauthor=W.+E.+Hoffmanauthor=A.+N.+Hanksauthor=D.+McGinnisauthor=E.+S.+Marrauthor=J.+L.+Gazardauthor=M.+Hajosauthor=R.+J.+Scialisauthor=R.+S.+Hurstauthor=C.+L.+Shafferauthor=J.+Panditauthor=C.+J.+O%E2%80%99Donnell&title=Discovery+and+characterization+of+a+novel+dihydroisoxazole+class+of+%CE%B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic+acid+%28AMPA%29+receptor+potentiators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1021%2Fjm401274b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401274b%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DHoover%26aufirst%3DD.%2BJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DFliri%26aufirst%3DA.%2BJ.%26aulast%3DGallaschun%26aufirst%3DR.%2BJ.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHanks%26aufirst%3DA.%2BN.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DGazard%26aufirst%3DJ.%2BL.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520a%2520novel%2520dihydroisoxazole%2520class%2520of%2520%25CE%25B1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520acid%2520%2528AMPA%2529%2520receptor%2520potentiators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D9180%26epage%3D9191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Garthwaite, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garthwaite, J.</span><span> </span><span class="NLM_article-title">Mechanisms of AMPA neurotoxicity in rat brain slices</span> <span class="citation_source-journal">Eur. J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">729</span><span class="NLM_x">–</span> <span class="NLM_lpage">736</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1111%2Fj.1460-9568.1991.tb01669.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=12106459" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1991&pages=729-736&author=G.+Garthwaiteauthor=J.+Garthwaite&title=Mechanisms+of+AMPA+neurotoxicity+in+rat+brain+slices"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1991.tb01669.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1991.tb01669.x%26sid%3Dliteratum%253Aachs%26aulast%3DGarthwaite%26aufirst%3DG.%26aulast%3DGarthwaite%26aufirst%3DJ.%26atitle%3DMechanisms%2520of%2520AMPA%2520neurotoxicity%2520in%2520rat%2520brain%2520slices%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1991%26volume%3D3%26spage%3D729%26epage%3D736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brorson, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzolillo, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R. J.</span><span> </span><span class="NLM_article-title">AMPA receptor desensitization predicts the selective vulnerability of cerebellar purkinje cells to excitotoxicity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4515</span><span class="NLM_x">–</span> <span class="NLM_lpage">4524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7540678" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2MXmt1aqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1995&pages=4515-4524&author=J.+R.+Brorsonauthor=P.+A.+Manzolilloauthor=S.+J.+Gibbonsauthor=R.+J.+Miller&title=AMPA+receptor+desensitization+predicts+the+selective+vulnerability+of+cerebellar+purkinje+cells+to+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity</span></div><div class="casAuthors">Brorson, James R.; Manzolillo, Patricia A.; Gibbons, Simon J.; Miller, Richard J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4515-24</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Cerebellar Purkinje cells are selectively vulnerable to ischemia, although the reasons for this are unknown.  In cultured embryonic rat cerebellar neurons, the steady state responses to the desensitizing agonist AMPA (α-amino-3- hydroxy-5-methyl-4-isoxazole propionic acid) relative to responses to the nondesensitizing agonist kainate were greater in Purkinje cells compared to other cells, as measured by whole cell voltage clamp studies.  Fluorimetric [Ca2+]i imaging expts. similarly found greater responses to AMPA relative to kainate in Purkinje cells than in other cerebellar neurons.  In toxicity expts., measuring cell survival 24 h following agonist exposure, AMPA and glutamate produced Ca2+-dependent toxicity which was selective for the Purkinje cell fraction of the neurons, whereas kainate produced nonselective toxicity, and NMDA selectively spared the mature Purkinje cells.  Cyclothiazide, which inhibits AMPA receptor desensitization, enhanced steady state current responses to AMPA and increased the toxicity of AMPA.  Thus, the vulnerability of cerebellar neurons in culture to glutamate agonist-induced toxicity parallels the magnitude of the steady state currents produced, and that Purkinje cells may be selectively vulnerable because they express AMPA receptors which undergo less complete desensitization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosGWfViNuLPLVg90H21EOLACvtfcHk0lhe8lnY2B7-hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmt1aqtbc%253D&md5=1fc628fd3b70b92ca24c0efcf5ad0e07</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrorson%26aufirst%3DJ.%2BR.%26aulast%3DManzolillo%26aufirst%3DP.%2BA.%26aulast%3DGibbons%26aufirst%3DS.%2BJ.%26aulast%3DMiller%26aufirst%3DR.%2BJ.%26atitle%3DAMPA%2520receptor%2520desensitization%2520predicts%2520the%2520selective%2520vulnerability%2520of%2520cerebellar%2520purkinje%2520cells%2520to%2520excitotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D1995%26volume%3D15%26spage%3D4515%26epage%3D4524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Yamada, K. A.</span><span> </span><span class="NLM_article-title">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1006%2Fnbdi.1998.0190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9746904" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1998&pages=67-80&author=K.+A.+Yamada&title=Modulating+excitatory+synaptic+neurotransmission%3A+potential+treatment+for+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?</span></div><div class="casAuthors">Yamada, Kelvin A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">67-80</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A review, with 84 refs.  Excitatory neurotransmission at many CNS synapses depends upon AMPA-type glutamate receptors.  Derangements in AMPA receptor-mediated synaptic transmission may be a contributing factor in neurol. and neurodegenerative diseases and could be a target for therapeutic intervention.  Drugs that pos. modulate AMPA receptors by reducing AMPA receptor desensitization and/or slowing AMPA receptor deactivation, such as thiazide derivs. (cyclothiazide, diazoxide, IDRA 21) and benzoylpiperidine derivs. (1-BCP, CX516, aniracetam), facilitate AMPA receptor-mediated processes and may have beneficial therapeutic effects.  For example, AMPA modulators facilitate long-term potentiation, which may be important for memory storage, and facilitate memory encoding in behavioral expts.  Thus, AMPA modulators might ameliorate memory deficits that occur in dementia, such as Alzheimer's disease.  However, AMPA receptor-mediated excitotoxicity may occur with excessive AMPA receptor activation such as in seizures or ischemia, and pos. AMPA modulators would promote neuronal injury under those conditions.  Regardless of the ultimate clin. utility of pos. AMPA modulators, their discovery and study have already provided significant insight into the physiol. and structural determinants of important AMPA receptor properties.  This review attempts to synthesize a variety of studies that have utilized these AMPA modulators to gain insight into fundamental as well as clin. relevant AMPA receptor-mediated processes.  (c) 1998 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfjdGogGo9LLVg90H21EOLACvtfcHk0ljHi99n2IYrdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlentbc%253D&md5=5f8211686883cffc773c302d8ef24877</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1006%2Fnbdi.1998.0190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fnbdi.1998.0190%26sid%3Dliteratum%253Aachs%26aulast%3DYamada%26aufirst%3DK.%2BA.%26atitle%3DModulating%2520excitatory%2520synaptic%2520neurotransmission%253A%2520potential%2520treatment%2520for%2520neurological%2520disease%26jtitle%3DNeurobiol.%2520Dis.%26date%3D1998%26volume%3D5%26spage%3D67%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Qi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span> </span><span class="NLM_article-title">Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo</span> <span class="citation_source-journal">J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">571</span><span class="NLM_x">, </span> <span class="NLM_fpage">605</span><span class="NLM_x">–</span> <span class="NLM_lpage">618</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1113%2Fjphysiol.2005.103812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16423850" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVCkuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=571&publication_year=2006&pages=605-618&author=J.+Qiauthor=Y.+Wangauthor=M.+Jiangauthor=P.+Warrenauthor=G.+Chen&title=Cyclothiazide+induces+robust+epileptiform+activity+in+rat+hippocampal+neurons+both+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo</span></div><div class="casAuthors">Qi, Jinshun; Wang, Yun; Jiang, Min; Warren, Philippa; Chen, Gong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">571</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">605-618</span>CODEN:
                <span class="NLM_cas:coden">JPHYA7</span>;
        ISSN:<span class="NLM_cas:issn">0022-3751</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Cyclothiazide (CTZ) is a potent blocker of AMPA receptor desensitization.  We have recently demonstrated that CTZ also inhibits GABAA receptors.  Here we report that CTZ induces robust epileptiform activity in hippocampal neurons both in vitro and in vivo.  We first found that chronic treatment of hippocampal cultures with CTZ (5 μM, 48 h) results in epileptiform activity in the majority of neurons (80%).  The epileptiform activity lasts more than 48 h after washing off CTZ, suggesting a permanent change of the neural network properties after CTZ treatment.  We then demonstrated in in vivo recordings that injection of CTZ (5 μmol in 5 μl) into the lateral ventricles of anesthetized rats also induces spontaneous epileptiform activity in the hippocampal CA1 region.  The epileptogenic effect of CTZ is probably due to its enhancing glutamatergic neurotransmission as shown by increasing the frequency and decay time of mEPSCs, and simultaneously inhibiting GABAergic neurotransmission by reducing the frequency of mIPSCs.  Comparing to a well-known epileptogenic agent kainic acid (KA), CTZ affects neuronal activity mainly through modulating synaptic transmission without significant change of the intrinsic membrane excitability.  Unlike KA, which induces significant cell death in hippocampal cultures, CTZ treatment does not result in any apparent neuronal death.  Therefore, the CTZ-induced epilepsy model may provide a novel research tool to elucidate the mol. and cellular mechanisms of epileptogenesis without any complication from drug-induced cell death.  The long-lasting epileptiform activity after CTZ washout may also make it a very useful model in screening antiepileptic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLdYudVEld6LVg90H21EOLACvtfcHk0ljHi99n2IYrdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVCkuro%253D&md5=b67d0b87e6cd40109a18dcd372c514ae</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1113%2Fjphysiol.2005.103812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1113%252Fjphysiol.2005.103812%26sid%3Dliteratum%253Aachs%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DM.%26aulast%3DWarren%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DG.%26atitle%3DCyclothiazide%2520induces%2520robust%2520epileptiform%2520activity%2520in%2520rat%2520hippocampal%2520neurons%2520both%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DJ.%2520Physiol.%26date%3D2006%26volume%3D571%26spage%3D605%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Natta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilenski, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worboys, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monshouwer, M.</span><span> </span><span class="NLM_article-title">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">793</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fdmd.108.024125" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=19116265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=787-793&author=X.+Liuauthor=K.+Van+Nattaauthor=H.+Yeoauthor=O.+Vilenskiauthor=P.+E.+Wellerauthor=P.+D.+Worboysauthor=M.+Monshouwer&title=Unbound+drug+concentration+in+brain+homogenate+and+cerebral+spinal+fluid+at+steady+state+as+a+surrogate+for+unbound+concentration+in+brain+interstitial+fluid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16aR"><div class="casContent"><span class="casTitleNuber">16a</span><div class="casTitle"><span class="NLM_cas:atitle">Unbound drug concentration in brain homogenate and cerebral spinal fluid at steady state as a surrogate for unbound concentration in brain interstitial fluid</span></div><div class="casAuthors">Liu, Xingrong; Van Natta, Kristine; Yeo, Helen; Vilenski, Olga; Weller, Paul E.; Worboys, Philip D.; Monshouwer, Mario</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-793</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The objective of the present study was to examine the accuracy of using unbound brain concn. detd. by a brain homogenate method (Cub), cerebral spinal fluid concn. (CCSF), and unbound plasma concn. (Cup) as a surrogate for brain interstitial fluid concn. detd. by brain microdialysis (Cm).  Nine compds.-carbamazepine, citalopram, ganciclovir, metoclopramide, N-desmethylclozapine, quinidine, risperidone, 9-hydroxyrisperidone, and thiopental-were selected, and each was administered as an i.v. bolus (up to 5 mg/kg) followed by a const. i.v. infusion (1-9 mg/kg/h) for 6 h in rats.  For eight of the nine compds., the Cubs were within 3-fold of their Cm; thiopental had a Cm 4-fold of its Cub.  The CCSFs of eight of the nine compds. were within 3-fold of their corresponding Cm; 9-hydroxyrisperidone showed a CCSF 5-fold of its Cm.  The Cups of five of the nine compds. were within 3-fold of their Cm; four compds. (ganciclovir, metoclopramide, quinidine, and 9-hydroxyrisperidone) had Cups 6- to 14-fold of their Cm.  In conclusion, the Cub and CCSF were within 3-fold of the Cm for the majority of the compds. tested.  The Cups were within 3-fold of Cm for lipophilic non-P-glycoprotein (-P-gp) substrates and greater than 3-fold of Cm for hydrophilic or P-gp substrates.  The present study indicates that the brain homogenate and cerebral spinal fluid methods may be used as surrogate methods to predict brain interstitial fluid concns. within 3-fold of error in drug discovery and development settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVK_I2XYWfrrVg90H21EOLACvtfcHk0ljHi99n2IYrdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktVSku7s%253D&md5=feb6abdcfa4e2e007c5abd44066c0e19</span></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024125&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024125%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DVan%2BNatta%26aufirst%3DK.%26aulast%3DYeo%26aufirst%3DH.%26aulast%3DVilenski%26aufirst%3DO.%26aulast%3DWeller%26aufirst%3DP.%2BE.%26aulast%3DWorboys%26aufirst%3DP.%2BD.%26aulast%3DMonshouwer%26aufirst%3DM.%26atitle%3DUnbound%2520drug%2520concentration%2520in%2520brain%2520homogenate%2520and%2520cerebral%2520spinal%2520fluid%2520at%2520steady%2520state%2520as%2520a%2520surrogate%2520for%2520unbound%2520concentration%2520in%2520brain%2520interstitial%2520fluid%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D787%26epage%3D793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mancuso, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">An evaluation of using rat-derived single-dose neuropharmacokinetic parameters to project accurately large animal unbound brain drug concentrations</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2162</span><span class="NLM_x">–</span> <span class="NLM_lpage">2173</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2012&pages=2162-2173&author=A.+C.+Doranauthor=S.+M.+Osgoodauthor=J.+Y.+Mancusoauthor=C.+L.+Shaffer&title=An+evaluation+of+using+rat-derived+single-dose+neuropharmacokinetic+parameters+to+project+accurately+large+animal+unbound+brain+drug+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DMancuso%26aufirst%3DJ.%2BY.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DAn%2520evaluation%2520of%2520using%2520rat-derived%2520single-dose%2520neuropharmacokinetic%2520parameters%2520to%2520project%2520accurately%2520large%2520animal%2520unbound%2520brain%2520drug%2520concentrations%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2012%26volume%3D40%26spage%3D2162%26epage%3D2173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarotsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moran, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toublanc, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coutant, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span> </span><span class="NLM_article-title">Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects</span> <span class="citation_source-journal">J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1177%2F0091270006286899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16554450" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XjslWhurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2006&pages=424-432&author=S.+S.+Jheeauthor=A.+S.+Chappellauthor=V.+Zarotskyauthor=S.+V.+Moranauthor=M.+Rosenthalauthor=E.+Kimauthor=S.+Chalonauthor=N.+Toublancauthor=J.+Brandtauthor=D.+E.+Coutantauthor=L.+Ereshefsky&title=Multiple-dose+plasma+pharmacokinetic+and+safety+study+of+LY450108+and+LY451395+%28AMPA+receptor+potentiators%29+and+their+concentration+in+cerebrospinal+fluid+in+healthy+human+subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Multiple-dose plasma pharmacokinetic and safety study of LY450108 and LY451395 (AMPA receptor potentiators) and their concentration in cerebrospinal fluid in healthy human subjects</span></div><div class="casAuthors">Jhee, S. S.; Chappell, A. S.; Zarotsky, V.; Moran, S. V.; Rosenthal, M.; Kim, E.; Chalon, S.; Toublanc, N.; Brandt, J.; Coutant, D. E.; Ereshefsky, L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">424-432</span>CODEN:
                <span class="NLM_cas:coden">JCPCBR</span>;
        ISSN:<span class="NLM_cas:issn">0091-2700</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">The objective of this study was to measure the steady-state cerebrospinal fluid (CSF) concn. of LY450108 and LY451395 (pos. modulators of AMPA receptors) in healthy subjects after the administration of 1 mg and 5 mg.  Secondary objectives included the evaluation of safety, pharmacokinetics, and steady-state ratio of plasma:CSF concns. of LY450108 and LY451395 after multiple dosing.  This study was an open-label, multiple oral dose study evaluating 1 mg and 5 mg LY450108 and 1 mg and 5 mg LY451395 in 12 (3 subjects per dosing group) healthy subjects, aged 18 to 49 years.  Twelve healthy male subjects completed the study.  LY450108 and LY451395 were quantifiable in CSF after 1-mg and 5-mg multiple-dose administrations with plasma:CSF ratio of 82:1 and 44:1, resp.  LY450108 and LY451395 1 mg and 5 mg were measured in the CSF.  Single and multiple oral doses of LY450108 and LY451395 were detd. to be safe and well tolerated in healthy subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlcTZEPsQAabVg90H21EOLACvtfcHk0liUgfWgm9MkaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjslWhurk%253D&md5=cbb4725f14502afea7b51b27c816c85c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1177%2F0091270006286899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0091270006286899%26sid%3Dliteratum%253Aachs%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DChappell%26aufirst%3DA.%2BS.%26aulast%3DZarotsky%26aufirst%3DV.%26aulast%3DMoran%26aufirst%3DS.%2BV.%26aulast%3DRosenthal%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DChalon%26aufirst%3DS.%26aulast%3DToublanc%26aufirst%3DN.%26aulast%3DBrandt%26aufirst%3DJ.%26aulast%3DCoutant%26aufirst%3DD.%2BE.%26aulast%3DEreshefsky%26aufirst%3DL.%26atitle%3DMultiple-dose%2520plasma%2520pharmacokinetic%2520and%2520safety%2520study%2520of%2520LY450108%2520and%2520LY451395%2520%2528AMPA%2520receptor%2520potentiators%2529%2520and%2520their%2520concentration%2520in%2520cerebrospinal%2520fluid%2520in%2520healthy%2520human%2520subjects%26jtitle%3DJ.%2520Clin.%2520Pharmacol.%26date%3D2006%26volume%3D46%26spage%3D424%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chappell, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witte, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R.</span><span> </span><span class="NLM_article-title">AMPA potentiator treatment of cognitive deficits in Alzheimer disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2007&pages=1008-1012&author=A.+S.+Chappellauthor=C.+Gonzalesauthor=J.+Williamsauthor=M.+M.+Witteauthor=R.+C.+Mohsauthor=R.+Sperling&title=AMPA+potentiator+treatment+of+cognitive+deficits+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChappell%26aufirst%3DA.%2BS.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DWitte%26aufirst%3DM.%2BM.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DSperling%26aufirst%3DR.%26atitle%3DAMPA%2520potentiator%2520treatment%2520of%2520cognitive%2520deficits%2520in%2520Alzheimer%2520disease%26jtitle%3DNeurology%26date%3D2007%26volume%3D68%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Trzepacz, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Konechnik, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrester, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennehy, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shuler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabas, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C.</span><span> </span><span class="NLM_article-title">Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer’s disease</span> <span class="citation_source-journal">Int. Psychogeriatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">707</span><span class="NLM_x">–</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1017%2FS1041610212002141" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=23257314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BC3s3js1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=707-719&author=P.+T.+Trzepaczauthor=J.+Cummingsauthor=T.+Konechnikauthor=T.+D.+Forresterauthor=C.+Changauthor=E.+B.+Dennehyauthor=B.+A.+Willisauthor=C.+Shulerauthor=L.+B.+Tabasauthor=C.+Lyketsos&title=Mibampator+%28LY451395%29+randomized+clinical+trial+for+agitation%2Faggression+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18bR"><div class="casContent"><span class="casTitleNuber">18b</span><div class="casTitle"><span class="NLM_cas:atitle">Mibampator (LY451395) randomized clinical trial for agitation/aggression in Alzheimer's disease</span></div><div class="casAuthors">Trzepacz Paula T; Cummings Jeffrey; Konechnik Thomas; Forrester Tammy D; Chang Curtis; Dennehy Ellen B; Willis Brian A; Shuler Catherine; Tabas Linda B; Lyketsos Constantine</div><div class="citationInfo"><span class="NLM_cas:title">International psychogeriatrics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">707-19</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Mibampator, an amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor potentiator, was evaluated for treatment of agitation and aggression (A/A) in Alzheimer's disease (AD).  METHODS:  Outpatients (n = 132) with probable AD and A/A randomized to 12 weeks of double-blind treatment with 3-mg po mibampator or placebo were assessed using the 4-domain A/A subscale of the Neuropsychiatric Inventory (NPI-4-A/A) derived from the Neuropsychiatric Inventory.  Secondary measures included the Cohen-Mansfield Agitation Inventory, Cornell Scale for Depression in Dementia, Frontal Systems Behavior Inventory (FrSBe), and Alzheimer's Disease Assessment Scale-Cognitive.  Efficacy was analyzed using mixed-effects model repeated measures from baseline to endpoint.  Adverse events (AEs), labs, vital signs, and electrocardiograms were monitored.  RESULTS:  Baseline characteristics were comparable between groups.  Both groups improved on the NPI-4-A/A, but without group differences.  Among secondaries, mibampator was significantly better (p = 0.007) than placebo only on the FrSBe.  AEs were similar between groups.  One death occurred in the placebo group.  CONCLUSION:  Possible explanations for no significant group differences include caregiver, drug target engagement, and design issues.  This trial is registered on ClinicalTrials.gov; ID: NCT00843518.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9rGUvPivaH-2qxNLjzXe8fW6udTcc2eblT51XpNR3abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s3js1GqtQ%253D%253D&md5=d709ce625fff2b2f017074a981f495f1</span></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=10.1017%2FS1041610212002141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1041610212002141%26sid%3Dliteratum%253Aachs%26aulast%3DTrzepacz%26aufirst%3DP.%2BT.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DKonechnik%26aufirst%3DT.%26aulast%3DForrester%26aufirst%3DT.%2BD.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDennehy%26aufirst%3DE.%2BB.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DShuler%26aufirst%3DC.%26aulast%3DTabas%26aufirst%3DL.%2BB.%26aulast%3DLyketsos%26aufirst%3DC.%26atitle%3DMibampator%2520%2528LY451395%2529%2520randomized%2520clinical%2520trial%2520for%2520agitation%252Faggression%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DInt.%2520Psychogeriatr.%26date%3D2013%26volume%3D25%26spage%3D707%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ward, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreotti, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballantine, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bax, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harker, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melarange, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mingardi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Profeta, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yusaf, S. P.</span><span> </span><span class="NLM_article-title">Discovery of <i>N</i>-[(2<i>S</i>)-5-(6-fluoro-3-pyridinyl)-2,3-dihydro-1<i>H</i>-inden-2-yl]-2-propanesulfonamide, a novel clinical AMPA receptor positive modulator</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">5801</span><span class="NLM_x">–</span> <span class="NLM_lpage">5812</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1005429" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=5801-5812&author=S.+E.+Wardauthor=M.+Harriesauthor=L.+Aldegheriauthor=D.+Andreottiauthor=S.+Ballantineauthor=B.+D.+Baxauthor=A.+J.+Harrisauthor=A.+J.+Harkerauthor=J.+Lundauthor=R.+Melarangeauthor=A.+Mingardiauthor=C.+Mookherjeeauthor=J.+Mosleyauthor=M.+Neveauthor=B.+Oliosiauthor=R.+Profetaauthor=K.+J.+Smithauthor=P.+W.+Smithauthor=S.+Spadaauthor=K.+M.+Thewlisauthor=S.+P.+Yusaf&title=Discovery+of+N-%5B%282S%29-5-%286-fluoro-3-pyridinyl%29-2%2C3-dihydro-1H-inden-2-yl%5D-2-propanesulfonamide%2C+a+novel+clinical+AMPA+receptor+positive+modulator"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm1005429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1005429%26sid%3Dliteratum%253Aachs%26aulast%3DWard%26aufirst%3DS.%2BE.%26aulast%3DHarries%26aufirst%3DM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DAndreotti%26aufirst%3DD.%26aulast%3DBallantine%26aufirst%3DS.%26aulast%3DBax%26aufirst%3DB.%2BD.%26aulast%3DHarris%26aufirst%3DA.%2BJ.%26aulast%3DHarker%26aufirst%3DA.%2BJ.%26aulast%3DLund%26aufirst%3DJ.%26aulast%3DMelarange%26aufirst%3DR.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DMosley%26aufirst%3DJ.%26aulast%3DNeve%26aufirst%3DM.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DProfeta%26aufirst%3DR.%26aulast%3DSmith%26aufirst%3DK.%2BJ.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DSpada%26aufirst%3DS.%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DYusaf%26aufirst%3DS.%2BP.%26atitle%3DDiscovery%2520of%2520N-%255B%25282S%2529-5-%25286-fluoro-3-pyridinyl%2529-2%252C3-dihydro-1H-inden-2-yl%255D-2-propanesulfonamide%252C%2520a%2520novel%2520clinical%2520AMPA%2520receptor%2520positive%2520modulator%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D5801%26epage%3D5812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Fleming, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">England, P. M.</span><span> </span><span class="NLM_article-title">Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">–</span> <span class="NLM_lpage">1387</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1381-1387&author=J.+J.+Flemingauthor=P.+M.+England&title=Developing+a+complete+pharmacology+for+AMPA+receptors%3A+a+perspective+on+subtype-selective+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFleming%26aufirst%3DJ.%2BJ.%26aulast%3DEngland%26aufirst%3DP.%2BM.%26atitle%3DDeveloping%2520a%2520complete%2520pharmacology%2520for%2520AMPA%2520receptors%253A%2520a%2520perspective%2520on%2520subtype-selective%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1381%26epage%3D1387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Harms, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benveniste, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maclean, J. K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamieson, C.</span><span> </span><span class="NLM_article-title">Functional analysis of a novel allosteric modulator of AMPA receptors derived from a structure-based drug design strategy</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=45-52&author=J.+E.+Harmsauthor=M.+Benvenisteauthor=J.+K.+F.+Macleanauthor=K.+M.+Partinauthor=C.+Jamieson&title=Functional+analysis+of+a+novel+allosteric+modulator+of+AMPA+receptors+derived+from+a+structure-based+drug+design+strategy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarms%26aufirst%3DJ.%2BE.%26aulast%3DBenveniste%26aufirst%3DM.%26aulast%3DMaclean%26aufirst%3DJ.%2BK.%2BF.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26aulast%3DJamieson%26aufirst%3DC.%26atitle%3DFunctional%2520analysis%2520of%2520a%2520novel%2520allosteric%2520modulator%2520of%2520AMPA%2520receptors%2520derived%2520from%2520a%2520structure-based%2520drug%2520design%2520strategy%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D45%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rong, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Obach, R. S.</span><span> </span><span class="NLM_article-title">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse events</span> <span class="citation_source-journal">Biopharm. Drug Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">84</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1002%2Fbdd.1768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=22213407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=72-84&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=H.+Rongauthor=R.+S.+Obach&title=Using+Simcyp+to+project+human+oral+pharmacokinetic+variability+in+early+drug+research+to+mitigate+mechanism-based+adverse+events"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Using Simcyp to project human oral pharmacokinetic variability in early drug research to mitigate mechanism-based adverse eventsProjecting Human Cmax Variability after an Oral Dose via PBPK ModelingC.L. SHAFFER ET AL.</span></div><div class="casAuthors">Shaffer, Christopher L.; Scialis, Renato J.; Rong, Haojing; Obach, R. Scott</div><div class="citationInfo"><span class="NLM_cas:title">Biopharmaceutics & Drug Disposition</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">72-84</span>CODEN:
                <span class="NLM_cas:coden">BDDID8</span>;
        ISSN:<span class="NLM_cas:issn">0142-2782</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Pos. allosteric modulators ( potentiators') of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) have been shown to display a mechanism-based exposure-response continuum in preclin. species with procognitive electrophysiol. and behavioral effects ( efficacy') at low exposures and motor coordination disruptions at progressively higher exposures.  Due to the dose-capping nature of such motor coordination deficits, an exposure threshold-mediated adverse event (CAE), the adequacy of sepn. between the maximal total plasma compd. concn. (Cmax) at a predicted clin. efficacious oral dose and this adverse event (AE) was explored in early drug research with three AMPAR potentiators considered potential candidates for clin. trials.  In vitro metab. studies in human liver microsomes and human hepatocytes demonstrated the metabolic clearance for each compd. was predominately due to cytochromes P 450 (CYP).  Thus, for each compd.'s anticipated clin. efficacious dose, human Cmax variability following oral administration was assessed using Simcyp software, which combines its virtual human populations database using extensive demog., physiol. and genomic information with routinely collected compd.-specific in vitro biochem. data to simulate and predict drug disposition.  Using a combination of exptl. detd. recombinant human CYP intrinsic clearances for CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6 and CYP3A4, human binding factors, expected fraction absorbed and estd. steady-state vol. of distribution, Simcyp simulations demonstrated that two of the three potentiators had acceptable projected Cmax variability (i.e. the 95th percentile Cmax did not breach CAE).  This evaluation aided in the selection of compds. for preclin. progression, and represents a novel application of pharmacol. based pharmacokinetic (PBPK) software approaches to predict interpatient variability.  Copyright © 2011 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYHYc71vaExbVg90H21EOLACvtfcHk0lgorXzR7s2-Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xnt1yhsw%253D%253D&md5=0ff126a5b34085f42606277651aa40e2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fbdd.1768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fbdd.1768%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DRong%26aufirst%3DH.%26aulast%3DObach%26aufirst%3DR.%2BS.%26atitle%3DUsing%2520Simcyp%2520to%2520project%2520human%2520oral%2520pharmacokinetic%2520variability%2520in%2520early%2520drug%2520research%2520to%2520mitigate%2520mechanism-based%2520adverse%2520events%26jtitle%3DBiopharm.%2520Drug%2520Dispos.%26date%3D2012%26volume%3D33%26spage%3D72%26epage%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lotarski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Defining the mechanism-mediated exposure–response continuum of a novel AMPA receptor potentiator (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">883</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=883&publication_year=2009&pages=17&author=C.+L.+Shafferauthor=R.+J.+Scialisauthor=S.+Lotarskiauthor=D.+K.+Bryceauthor=J.+Liuauthor=M.+J.+Majchrzakauthor=C.+Christoffersenauthor=W.+E.+Hoffmannauthor=B.+Campbellauthor=R.+S.+Hurstauthor=S.+McLeanauthor=A.+H.+Ganongauthor=M.+Hajosauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidt&title=Defining+the+mechanism-mediated+exposure%E2%80%93response+continuum+of+a+novel+AMPA+receptor+potentiator+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DLotarski%26aufirst%3DS.%26aulast%3DBryce%26aufirst%3DD.%2BK.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DCampbell%26aufirst%3DB.%26aulast%3DHurst%26aufirst%3DR.%2BS.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DDefining%2520the%2520mechanism-mediated%2520exposure%25E2%2580%2593response%2520continuum%2520of%2520a%2520novel%2520AMPA%2520receptor%2520potentiator%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2009%26volume%3D883%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">McNeish, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roach, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hambor, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mather, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weibley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lazzaro, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gazard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volkmann, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machacek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stice, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawadzke, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurst, R.</span><span> </span><span class="NLM_article-title">High-throughput screening in embryonic stem cell-derived neurons identifies potentiators of α-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type glutamate receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">17209</span><span class="NLM_x">–</span> <span class="NLM_lpage">17217</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=17209-17217&author=J.+McNeishauthor=M.+Roachauthor=J.+Hamborauthor=R.+J.+Matherauthor=L.+Weibleyauthor=J.+Lazzaroauthor=J.+Gazardauthor=J.+Schwarzauthor=R.+Volkmannauthor=D.+Machacekauthor=S.+Sticeauthor=L.+Zawadzkeauthor=C.+O%E2%80%99Donnellauthor=R.+Hurst&title=High-throughput+screening+in+embryonic+stem+cell-derived+neurons+identifies+potentiators+of+%CE%B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type+glutamate+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcNeish%26aufirst%3DJ.%26aulast%3DRoach%26aufirst%3DM.%26aulast%3DHambor%26aufirst%3DJ.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DWeibley%26aufirst%3DL.%26aulast%3DLazzaro%26aufirst%3DJ.%26aulast%3DGazard%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%26aulast%3DVolkmann%26aufirst%3DR.%26aulast%3DMachacek%26aufirst%3DD.%26aulast%3DStice%26aufirst%3DS.%26aulast%3DZawadzke%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%26aulast%3DHurst%26aufirst%3DR.%26atitle%3DHigh-throughput%2520screening%2520in%2520embryonic%2520stem%2520cell-derived%2520neurons%2520identifies%2520potentiators%2520of%2520%25CE%25B1-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate-type%2520glutamate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D17209%26epage%3D17217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ornstein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleisch, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cantrell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarrinmayeh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tizzano, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleakman, D.</span><span> </span><span class="NLM_article-title">Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3-(5-methyl-3-hydroxyisoxazol-4-yl)-propanoic Acid (AMPA) Receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4354</span><span class="NLM_x">–</span> <span class="NLM_lpage">4358</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0002836" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnsVKns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4354-4358&author=P.+L.+Ornsteinauthor=D.+M.+Zimmermanauthor=M.+B.+Arnoldauthor=T.+J.+Bleischauthor=B.+Cantrellauthor=R.+Simonauthor=H.+Zarrinmayehauthor=S.+R.+Bakerauthor=M.+Gatesauthor=J.+P.+Tizzanoauthor=D.+Bleakman&title=Biarylpropylsulfonamides+as+Novel%2C+Potent+Potentiators+of+2-Amino-3-%285-methyl-3-hydroxyisoxazol-4-yl%29-propanoic+Acid+%28AMPA%29+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24aR"><div class="casContent"><span class="casTitleNuber">24a</span><div class="casTitle"><span class="NLM_cas:atitle">Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)propanoicacid (AMPA) Receptors</span></div><div class="casAuthors">Ornstein, Paul L.; Zimmerman, Dennis M.; Arnold, M. Brian; Bleisch, Thomas J.; Cantrell, Buddy; Simon, Richard; Zarrinmayeh, Hamideh; Baker, S. Richard; Gates, Mary; Tizzano, Joseph P.; Bleakman, David; Mandelzys, Allan; Jarvie, Kieth R.; Ho, Ken; Deverill, Michelle; Kamboj, Rajender K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4354-4358</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of biarylpropyl sulfonamides that are very potent potentiators of responses mediated through AMPA receptors are presented.  Structure-activity studies demonstrated significant changes in potency when the methylsulfonamide was changed to an propylsulfonamide in the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAkGeRcI8km7Vg90H21EOLACvtfcHk0lifHO15raU2NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnsVKns7k%253D&md5=35f2071cc486af8212d8308ed4608d21</span></div><a href="/servlet/linkout?suffix=cit24a&amp;dbid=16384&amp;doi=10.1021%2Fjm0002836&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0002836%26sid%3Dliteratum%253Aachs%26aulast%3DOrnstein%26aufirst%3DP.%2BL.%26aulast%3DZimmerman%26aufirst%3DD.%2BM.%26aulast%3DArnold%26aufirst%3DM.%2BB.%26aulast%3DBleisch%26aufirst%3DT.%2BJ.%26aulast%3DCantrell%26aufirst%3DB.%26aulast%3DSimon%26aufirst%3DR.%26aulast%3DZarrinmayeh%26aufirst%3DH.%26aulast%3DBaker%26aufirst%3DS.%2BR.%26aulast%3DGates%26aufirst%3DM.%26aulast%3DTizzano%26aufirst%3DJ.%2BP.%26aulast%3DBleakman%26aufirst%3DD.%26atitle%3DBiarylpropylsulfonamides%2520as%2520Novel%252C%2520Potent%2520Potentiators%2520of%25202-Amino-3-%25285-methyl-3-hydroxyisoxazol-4-yl%2529-propanoic%2520Acid%2520%2528AMPA%2529%2520Receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4354%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit24b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Quirk, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nisenbaum, E. S.</span><span> </span><span class="NLM_article-title">LY404187: A novel positive allosteric modulator of AMPA receptors</span> <span class="citation_source-journal">CNS Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2002&pages=255-282&author=J.+C.+Quirkauthor=E.+S.+Nisenbaum&title=LY404187%3A+A+novel+positive+allosteric+modulator+of+AMPA+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DQuirk%26aufirst%3DJ.%2BC.%26aulast%3DNisenbaum%26aufirst%3DE.%2BS.%26atitle%3DLY404187%253A%2520A%2520novel%2520positive%2520allosteric%2520modulator%2520of%2520AMPA%2520receptors%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2002%26volume%3D8%26spage%3D255%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lifHO15raU2NQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+recognition+of+the+inhibitor+AG-1343+by+HIV-1+protease%3A+conformationally+flexible+docking+by+evolutionary+programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lg1adtIIgq-PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520recognition%2520of%2520the%2520inhibitor%2520AG-1343%2520by%2520HIV-1%2520protease%253A%2520conformationally%2520flexible%2520docking%2520by%2520evolutionary%2520programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Cram, D. J.</span><span> </span><span class="NLM_article-title">Preorganization—from solvents to spherands</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">–</span> <span class="NLM_lpage">1134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1986&pages=1039-1134&author=D.+J.+Cram&title=Preorganization%E2%80%94from+solvents+to+spherands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCram%26aufirst%3DD.%2BJ.%26atitle%3DPreorganization%25E2%2580%2594from%2520solvents%2520to%2520spherands%26jtitle%3DAngew.%2520Chem.%26date%3D1986%26volume%3D25%26spage%3D1039%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cram, D. J.</span><span> </span><span class="NLM_article-title">The design of molecular hosts, guests, and their complexes (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1009</span><span class="NLM_x">–</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=1009-1112&author=D.+J.+Cram&title=The+design+of+molecular+hosts%2C+guests%2C+and+their+complexes+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCram%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520design%2520of%2520molecular%2520hosts%252C%2520guests%252C%2520and%2520their%2520complexes%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D1009%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lehn, J.-M.</span><span> </span><span class="NLM_article-title">Supramolecular chemistry—scope and perspectives. Molecules, supermolecules, and molecular devices (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=89-112&author=J.-M.+Lehn&title=Supramolecular+chemistry%E2%80%94scope+and+perspectives.+Molecules%2C+supermolecules%2C+and+molecular+devices+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehn%26aufirst%3DJ.-M.%26atitle%3DSupramolecular%2520chemistry%25E2%2580%2594scope%2520and%2520perspectives.%2520Molecules%252C%2520supermolecules%252C%2520and%2520molecular%2520devices%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D89%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lehn, J.-M.</span><span> </span><span class="NLM_article-title">Perspectives in supramolecular chemistry—from molecular recognition towards molecular information processing and self-organization</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">–</span> <span class="NLM_lpage">1319</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1990&pages=1304-1319&author=J.-M.+Lehn&title=Perspectives+in+supramolecular+chemistry%E2%80%94from+molecular+recognition+towards+molecular+information+processing+and+self-organization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLehn%26aufirst%3DJ.-M.%26atitle%3DPerspectives%2520in%2520supramolecular%2520chemistry%25E2%2580%2594from%2520molecular%2520recognition%2520towards%2520molecular%2520information%2520processing%2520and%2520self-organization%26jtitle%3DAngew.%2520Chem.%26date%3D1990%26volume%3D29%26spage%3D1304%26epage%3D1319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Pedersen, C. J.</span><span> </span><span class="NLM_article-title">The discovery of crown ethers (Nobel lecture)</span> <span class="citation_source-journal">Angew. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1027</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1988&pages=1021-1027&author=C.+J.+Pedersen&title=The+discovery+of+crown+ethers+%28Nobel+lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPedersen%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520discovery%2520of%2520crown%2520ethers%2520%2528Nobel%2520lecture%2529%26jtitle%3DAngew.%2520Chem.%26date%3D1988%26volume%3D27%26spage%3D1021%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wolfe, S.</span><span> </span><span class="NLM_article-title">The gauche effect. Some stereochemical consequences of adjacent electron pairs and polar bonds</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">102</span><span class="NLM_x">–</span> <span class="NLM_lpage">111</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar50051a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaE38Xht1KhtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1972&pages=102-111&author=S.+Wolfe&title=The+gauche+effect.+Some+stereochemical+consequences+of+adjacent+electron+pairs+and+polar+bonds"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Gauche effect.  Stereochemical consequences of adjacent electron pairs and polar bonds</span></div><div class="casAuthors">Wolfe, Saul</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">102-111</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    </div><div class="casAbstract">The gauche effect is a term proposed to describe the tendency of species contg. adjacent electron pairs or polar bonds to exist preferentially in that structure which has the max. no. of gauche interactions between these electron pairs and polar bonds.  Organosulfur stereochemistry, esp. sulfonium ylides, and bimol. elimination reactions are discussed in terms of the effect.  The effect is reproduced and, therefore, explained by non-empirical MO calcns.  The explanation requires recognition of the fact that the stable structure of a mol. is not simply the result of a minimization of repulsive interactions, but is rather a subtle balance of attractive as well as repulsive forces.  For the specific cases of 2 adjacent electron pairs or 2 electron pairs adjacent to a polar bond the balance is between attraction and repulsion involving bonded electron pairs and the nuclei.  The notion that non-bonding electron pairs behave as directed ligands is not supported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUy1sB5iAG0bVg90H21EOLACvtfcHk0lgZOCvzjw7OdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xht1KhtLw%253D&md5=2598a509adb1d341188744f1c2ab87c7</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1021%2Far50051a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far50051a003%26sid%3Dliteratum%253Aachs%26aulast%3DWolfe%26aufirst%3DS.%26atitle%3DThe%2520gauche%2520effect.%2520Some%2520stereochemical%2520consequences%2520of%2520adjacent%2520electron%2520pairs%2520and%2520polar%2520bonds%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D1972%26volume%3D5%26spage%3D102%26epage%3D111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Juaristi, E.</span><span> </span><span class="NLM_article-title">The attractive and repulsive gauche effects</span> <span class="citation_source-journal">J. Chem. Educ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">438</span><span class="NLM_x">–</span> <span class="NLM_lpage">441</span></span><div class="citationLinks">[<a href="/doi/10.1021/ed056p438" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1979&pages=438-441&author=E.+Juaristi&title=The+attractive+and+repulsive+gauche+effects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1021%2Fed056p438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fed056p438%26sid%3Dliteratum%253Aachs%26aulast%3DJuaristi%26aufirst%3DE.%26atitle%3DThe%2520attractive%2520and%2520repulsive%2520gauche%2520effects%26jtitle%3DJ.%2520Chem.%2520Educ.%26date%3D1979%26volume%3D56%26spage%3D438%26epage%3D441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Burke, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Donnell, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, Y.</span><span> </span><span class="NLM_article-title">Cyclic hydropyran oligolides as preorganized ligand arrays: cumulative effects of structural elements on shape and cation binding</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">12649</span><span class="NLM_x">–</span> <span class="NLM_lpage">12650</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00155a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1995&pages=12649-12650&author=S.+D.+Burkeauthor=C.+J.+O%E2%80%99Donnellauthor=W.+J.+Porterauthor=Y.+Song&title=Cyclic+hydropyran+oligolides+as+preorganized+ligand+arrays%3A+cumulative+effects+of+structural+elements+on+shape+and+cation+binding"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1021%2Fja00155a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00155a035%26sid%3Dliteratum%253Aachs%26aulast%3DBurke%26aufirst%3DS.%2BD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26aulast%3DPorter%26aufirst%3DW.%2BJ.%26aulast%3DSong%26aufirst%3DY.%26atitle%3DCyclic%2520hydropyran%2520oligolides%2520as%2520preorganized%2520ligand%2520arrays%253A%2520cumulative%2520effects%2520of%2520structural%2520elements%2520on%2520shape%2520and%2520cation%2520binding%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1995%26volume%3D117%26spage%3D12649%26epage%3D12650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Thewlis, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aldegheri, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harries, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mookherjee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliosi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. E.</span><span> </span><span class="NLM_article-title">N-Substituted pyrollidones and tetrahydrofurans as novel AMPAR positive modulators</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7116</span><span class="NLM_x">–</span> <span class="NLM_lpage">7119</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7116-7119&author=K.+M.+Thewlisauthor=L.+Aldegheriauthor=M.+H.+Harriesauthor=C.+Mookherjeeauthor=B.+Oliosiauthor=S.+E.+Ward&title=N-Substituted+pyrollidones+and+tetrahydrofurans+as+novel+AMPAR+positive+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThewlis%26aufirst%3DK.%2BM.%26aulast%3DAldegheri%26aufirst%3DL.%26aulast%3DHarries%26aufirst%3DM.%2BH.%26aulast%3DMookherjee%26aufirst%3DC.%26aulast%3DOliosi%26aufirst%3DB.%26aulast%3DWard%26aufirst%3DS.%2BE.%26atitle%3DN-Substituted%2520pyrollidones%2520and%2520tetrahydrofurans%2520as%2520novel%2520AMPAR%2520positive%2520modulators%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7116%26epage%3D7119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Strategies to optimize the brain availability of central nervous system drug candidates</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">371</span><span class="NLM_x">–</span> <span class="NLM_lpage">381</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=371-381&author=T.+T.+Wagerauthor=A.+Villalobosauthor=P.+R.+Verhoestauthor=X.+J.+Houauthor=C.+L.+Shaffer&title=Strategies+to+optimize+the+brain+availability+of+central+nervous+system+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DHou%26aufirst%3DX.%2BJ.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DStrategies%2520to%2520optimize%2520the%2520brain%2520availability%2520of%2520central%2520nervous%2520system%2520drug%2520candidates%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2011%26volume%3D6%26spage%3D371%26epage%3D381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0ljsEtKvEgN0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Jin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weeks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dudman, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouaux, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Partin, K. M.</span><span> </span><span class="NLM_article-title">Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">9027</span><span class="NLM_x">–</span> <span class="NLM_lpage">9036</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.2567-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=16192394" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=9027-9036&author=R.+Jinauthor=S.+Clarkauthor=A.+M.+Weeksauthor=J.+T.+Dudmanauthor=E.+Gouauxauthor=K.+M.+Partin&title=Mechanism+of+Positive+Allosteric+Modulators+Acting+on+AMPA+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of positive allosteric modulators acting on AMPA receptors</span></div><div class="casAuthors">Jin, Rongsheng; Clark, Suzanne; Weeks, Autumn M.; Dudman, Joshua T.; Gouaux, Eric; Partin, Kathryn M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9027-9036</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Ligand-gated ion channels involved in the modulation of synaptic strength are the AMPA, kainate, and NMDA glutamate receptors.  Small mols. that potentiate AMPA receptor currents relieve cognitive deficits caused by neurodegenerative diseases such as Alzheimer's disease and show promise in the treatment of depression.  Previously, there has been limited understanding of the mol. mechanism of action for AMPA receptor potentiators.  Here the authors present cocrystal structures of the glutamate receptor GluR2 S1S2 ligand-binding domain in complex with aniracetam [1-(4-methoxybenzoyl)-2-pyrrolidinone] or CX614 (pyrrolidino-1,3-oxazino benzo-1,4-dioxan-10-one), two AMPA receptor potentiators that preferentially slow AMPA receptor deactivation.  Both potentiators bind within the dimer interface of the nondesensitized receptor at a common site located on the twofold axis of mol. symmetry.  Importantly, the potentiator binding site is adjacent to the "hinge" in the ligand-binding core "clamshell" that undergoes conformational rearrangement after glutamate binding.  Using rapid soln. exchange, patch-clamp electrophysiol. expts., the authors show that point mutations of residues that interact with potentiators in the cocrystal disrupt potentiator function.  The authors suggest that the potentiators slow deactivation by stabilizing the clamshell in its closed-cleft, glutamate-bound conformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo15HIwmBGNTrVg90H21EOLACvtfcHk0ljsEtKvEgN0rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVOqs7jP&md5=d035b142e3911e5e44a0ec4a825dc0a8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2567-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2567-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DR.%26aulast%3DClark%26aufirst%3DS.%26aulast%3DWeeks%26aufirst%3DA.%2BM.%26aulast%3DDudman%26aufirst%3DJ.%2BT.%26aulast%3DGouaux%26aufirst%3DE.%26aulast%3DPartin%26aufirst%3DK.%2BM.%26atitle%3DMechanism%2520of%2520Positive%2520Allosteric%2520Modulators%2520Acting%2520on%2520AMPA%2520Receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D9027%26epage%3D9036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Olney, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newcomer, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farber, N. B.</span><span> </span><span class="NLM_article-title">NMDA receptor hypofunction model of schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">–</span> <span class="NLM_lpage">533</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1016%2FS0022-3956%2899%2900029-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10628529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1999&pages=523-533&author=J.+W.+Olneyauthor=J.+W.+Newcomerauthor=N.+B.+Farber&title=NMDA+receptor+hypofunction+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor hypofunction model of schizophrenia</span></div><div class="casAuthors">Olney J W; Newcomer J W; Farber N B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">523-33</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Several decades of research attempting to explain schizophrenia in terms of the dopamine hyperactivity hypothesis have produced disappointing results.  A new hypothesis focusing on hypofunction of the NMDA glutamate transmitter system is emerging as a potentially more promising concept.  In this article, we present a version of the NMDA receptor hypofunction hypothesis that has evolved from our recent studies pertaining to the neurotoxic and psychotomimetic effects of PCP and related NMDA antagonist drugs.  In this article, we examine this hypothesis in terms of its strengths and weaknesses, its therapeutic implications and ways in which it can be further tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8PJv1HPbUrDEC-75aqa5AfW6udTcc2eYYagRJ6liZVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3c%252Fpt1Wisg%253D%253D&md5=1450b1d092fbd5075e730c8aa68f1153</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0022-3956%2899%2900029-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-3956%252899%252900029-1%26sid%3Dliteratum%253Aachs%26aulast%3DOlney%26aufirst%3DJ.%2BW.%26aulast%3DNewcomer%26aufirst%3DJ.%2BW.%26aulast%3DFarber%26aufirst%3DN.%2BB.%26atitle%3DNMDA%2520receptor%2520hypofunction%2520model%2520of%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D1999%26volume%3D33%26spage%3D523%26epage%3D533" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harvey, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piotrowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Downs, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rago, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El-Kattan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duplantier, A. J.</span><span> </span><span class="NLM_article-title">Modulation of NMDA receptor function by inhibition of <span class="smallcaps smallerCapital">d</span>-amino acid oxidase in rodent brain</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">1001</span><span class="NLM_x">–</span> <span class="NLM_lpage">1015</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=1001-1015&author=C.+A.+Strickauthor=C.+Liauthor=L.+Scottauthor=B.+Harveyauthor=M.+Hajosauthor=S.+J.+Steynauthor=M.+A.+Piotrowskiauthor=L.+C.+Jamesauthor=J.+T.+Downsauthor=B.+Ragoauthor=S.+L.+Beckerauthor=A.+El-Kattanauthor=Y.+Xuauthor=A.+H.+Ganongauthor=F.+D.+Tingleyauthor=A.+D.+Ramirezauthor=P.+A.+Seymourauthor=V.+Guanowskyauthor=M.+J.+Majchrzakauthor=C.+B.+Foxauthor=C.+J.+Schmidtauthor=A.+J.+Duplantier&title=Modulation+of+NMDA+receptor+function+by+inhibition+of+d-amino+acid+oxidase+in+rodent+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DHarvey%26aufirst%3DB.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DPiotrowski%26aufirst%3DM.%2BA.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DDowns%26aufirst%3DJ.%2BT.%26aulast%3DRago%26aufirst%3DB.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DRamirez%26aufirst%3DA.%2BD.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26atitle%3DModulation%2520of%2520NMDA%2520receptor%2520function%2520by%2520inhibition%2520of%2520d-amino%2520acid%2520oxidase%2520in%2520rodent%2520brain%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D1001%26epage%3D1015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit34b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Kozak, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strick, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horner, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dounay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Reduction of brain kynurenic acid improves cognitive function</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">10592</span><span class="NLM_x">–</span> <span class="NLM_lpage">10602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1523%2FJNEUROSCI.1107-14.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=25100593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1ertbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=10592-10602&author=R.+Kozakauthor=B.+M.+Campbellauthor=C.+A.+Strickauthor=W.+E.+Hornerauthor=W.+E.+Hoffmanauthor=T.+Kissauthor=D.+S.+Chapinauthor=D.+McGinnisauthor=A.+L.+Abbottauthor=B.+M.+Robertsauthor=K.+Fonsecaauthor=V.+Guanowskyauthor=D.+A.+Youngauthor=P.+A.+Seymourauthor=A.+Dounayauthor=M.+Hajosauthor=G.+V.+Williamsauthor=S.+A.+Castner&title=Reduction+of+brain+kynurenic+acid+improves+cognitive+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34bR"><div class="casContent"><span class="casTitleNuber">34b</span><div class="casTitle"><span class="NLM_cas:atitle">Reduction of brain kynurenic acid improves cognitive function</span></div><div class="casAuthors">Kozak, Rouba; Campbell, Brian M.; Strick, Christine A.; Horner, Weldon; Hoffmann, William E.; Kiss, Tamas; Chapin, Douglas S.; McGinnis, Dina; Abbott, Amanda L.; Roberts, Brooke M.; Fonseca, Kari; Guanowsky, Victor; Young, Damon A.; Seymour, Patricia A.; Dounay, Amy; Hajos, Mihaly; Williams, Graham V.; Castner, Stacy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">32</span>),
    <span class="NLM_cas:pages">10592-10602, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The elevation of kynurenic acid (KYNA) obsd. in schizophrenic patients may contribute to core symptoms arising from glutamate hypofunction, including cognitive impairments.  Although increased KYNA levels reduce excitatory neurotransmission, KYNA has been proposed to act as an endogenous antagonist at the glycine site of the glutamate NMDA receptor (NMDAR) and as a neg. allosteric modulator at the α7 nicotinic acetylcholine receptor.  Levels of KYNA are elevated in CSF and the postmortem brain of schizophrenia patients, and these elevated levels of KYNA could contribute to NMDAR hypofunction and the cognitive deficits and neg. symptoms assocd. with this disease.  However, the impact of endogenously produced KYNA on brain function and behavior is less well understood due to a paucity of pharmacol. tools.  To address this issue, we identified PF-04859989, a brain-penetrable inhibitor of kynurenine aminotransferase II (KAT II), the enzyme responsible for most brain KYNA synthesis.  In rats, systemic administration of PF-04859989 dose-dependently reduced brain KYNA to as little as 28% of basal levels, and prevented amphetamine- and ketamine-induced disruption of auditory gating and improved performance in a sustained attention task.  It also prevented ketamine-induced disruption of performance in a working memory task and a spatial memory task in rodents and nonhuman primates, resp.  Together, these findings support the hypotheses that endogenous KYNA impacts cognitive function and that inhibition of KAT II, and consequent lowering of endogenous brain KYNA levels, improves cognitive performance under conditions considered relevant for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVW5CSu94ClLVg90H21EOLACvtfcHk0liiCeZkZ7bgMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1ertbfP&md5=537ed93c7548a6968c8a6599b6be69b8</span></div><a href="/servlet/linkout?suffix=cit34b&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1107-14.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1107-14.2014%26sid%3Dliteratum%253Aachs%26aulast%3DKozak%26aufirst%3DR.%26aulast%3DCampbell%26aufirst%3DB.%2BM.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DHorner%26aufirst%3DW.%2BE.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DAbbott%26aufirst%3DA.%2BL.%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DYoung%26aufirst%3DD.%2BA.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DDounay%26aufirst%3DA.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DReduction%2520of%2520brain%2520kynurenic%2520acid%2520improves%2520cognitive%2520function%26jtitle%3DJ.%2520Neurosci.%26date%3D2014%26volume%3D34%26spage%3D10592%26epage%3D10602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Critchett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganong, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welch, W. M.</span><span> </span><span class="NLM_article-title">CP-465,022, a selective noncompetitive AMPA receptor antagonist, blocks AMPA receptors but is not neuroprotective in vivo</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=171-176&author=F.+S.+Mennitiauthor=A.+M.+Buchanauthor=B.+L.+Chenardauthor=D.+J.+Critchettauthor=A.+H.+Ganongauthor=V.+Guanowskyauthor=P.+A.+Seymourauthor=W.+M.+Welch&title=CP-465%2C022%2C+a+selective+noncompetitive+AMPA+receptor+antagonist%2C+blocks+AMPA+receptors+but+is+not+neuroprotective+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DBuchan%26aufirst%3DA.%2BM.%26aulast%3DChenard%26aufirst%3DB.%2BL.%26aulast%3DCritchett%26aufirst%3DD.%2BJ.%26aulast%3DGanong%26aufirst%3DA.%2BH.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DWelch%26aufirst%3DW.%2BM.%26atitle%3DCP-465%252C022%252C%2520a%2520selective%2520noncompetitive%2520AMPA%2520receptor%2520antagonist%252C%2520blocks%2520AMPA%2520receptors%2520but%2520is%2520not%2520neuroprotective%2520in%2520vivo%26jtitle%3DStroke%26date%3D2003%26volume%3D34%26spage%3D171%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">Working memory dysfunction in schizophrenia</span> <span class="citation_source-journal">J. Neuropsychiatry Clin. Neurosci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">348</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fjnp.6.4.348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=7841806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1994&pages=348-357&author=P.+S.+Goldman-Rakic&title=Working+memory+dysfunction+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Working memory dysfunction in schizophrenia</span></div><div class="casAuthors">Goldman-Rakic P S</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of neuropsychiatry and clinical neurosciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">348-57</span>
        ISSN:<span class="NLM_cas:issn">0895-0172</span>.
    </div><div class="casAbstract">Recent advances in anatomical, behavioral, and physiological techniques have produced new information about the nature of prefrontal function, its cellular basis, and its anatomical underpinnings in nonhuman primates.  These findings are changing our views of prefrontal function and providing insight into possible bases for human mental disorder.  A major advance is the recognition that various prefrontal areas are engaged in holding information "on line" and updating past and current information on a moment-to-moment basis.  Studies of animals and of cognitive function in normal, brain-injured, and schizophrenic subjects support the theory that a defect in working memory--the ability to guide behavior by representations--may be the fundamental impairment leading to schizophrenic thought disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyESdDKBz6etTiMd2aNQVUfW6udTcc2eY8AfgXU0BJerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M7ktl2mtQ%253D%253D&md5=4a864a3c0cf5268f35615668e11246c3</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1176%2Fjnp.6.4.348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fjnp.6.4.348%26sid%3Dliteratum%253Aachs%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DWorking%2520memory%2520dysfunction%2520in%2520schizophrenia%26jtitle%3DJ.%2520Neuropsychiatry%2520Clin.%2520Neurosci%26date%3D1994%26volume%3D6%26spage%3D348%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tamminga, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. D.</span><span> </span><span class="NLM_article-title">The hippocampal formation in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">167</span><span class="NLM_x">, </span> <span class="NLM_fpage">1178</span><span class="NLM_x">–</span> <span class="NLM_lpage">1193</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1176%2Fappi.ajp.2010.09081187" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=20810471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADC%252BC3cfms1Snug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2010&pages=1178-1193&author=C.+A.+Tammingaauthor=A.+D.+Stanauthor=A.+D.+Wagner&title=The+hippocampal+formation+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37aR"><div class="casContent"><span class="casTitleNuber">37a</span><div class="casTitle"><span class="NLM_cas:atitle">The hippocampal formation in schizophrenia</span></div><div class="casAuthors">Tamminga Carol A; Stan Ana D; Wagner Anthony D</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1178-93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The hippocampal formation is one of the most extensively studied regions of the brain, with well-described anatomy and basic physiology; moreover, aspects of human memory mediated by the hippocampus are well characterized.  In schizophrenia, alterations in hippocampal anatomy, perfusion, and activation are consistently reported; impairments in declarative memory function, especially in the flexible use of event memories (e.g., in the service of memory-based inference), are common.  Postmortem molecular changes suggest a selective reduction in glutamate transmission in the dentate gyrus and in its efferent fibers, the mossy fiber pathway.  A reduction in dentate gyrus glutamatergic output and in its information processing functions could generate two co-occurring outcomes in the hippocampus: 1) a change in homeostatic plasticity processes in cornu ammonis 3 (CA3), accompanied by increased activity due to reduced afferent stimulation from the dentate gyrus onto CA3 neurons, a process that could increase the pattern completion functions of CA3, and 2) the loss of mnemonic functions specific to the dentate gyrus, namely pattern separation, a change that could increase the prevalence of illusory pattern completion and reduce discrimination between present and past experiences in memory.  The resulting increase in "runaway" CA3-mediated pattern completion could result in cognitive "mistakes," generating psychotic associations and resulting in memories with psychotic content.  Tests of this model could result in novel approaches to the treatment of psychosis and declarative memory alterations and in novel animal preparations for basic schizophrenia research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR9GNGZ90AjCxpyrDyM_m9cfW6udTcc2ebV61R7xa8oh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfms1Snug%253D%253D&md5=741343d58ac33cf03c4e74859553d6ca</span></div><a href="/servlet/linkout?suffix=cit37a&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2010.09081187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2010.09081187%26sid%3Dliteratum%253Aachs%26aulast%3DTamminga%26aufirst%3DC.%2BA.%26aulast%3DStan%26aufirst%3DA.%2BD.%26aulast%3DWagner%26aufirst%3DA.%2BD.%26atitle%3DThe%2520hippocampal%2520formation%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatr.%26date%3D2010%26volume%3D167%26spage%3D1178%26epage%3D1193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit37b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lisman, J.</span><span> </span><span class="NLM_article-title">Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=537-544&author=J.+Lisman&title=Excitation%2C+inhibition%2C+local+oscillations%2C+or+large-scale+loops%3A+what+causes+the+symptoms+of+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLisman%26aufirst%3DJ.%26atitle%3DExcitation%252C%2520inhibition%252C%2520local%2520oscillations%252C%2520or%2520large-scale%2520loops%253A%2520what%2520causes%2520the%2520symptoms%2520of%2520schizophrenia%253F%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2012%26volume%3D22%26spage%3D537%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lidow, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldman-Rakic, P. S.</span><span> </span><span class="NLM_article-title">The cerebral cortex: a case for a common site of action of antipsychotics</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">136</span><span class="NLM_x">–</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1998&pages=136-140&author=M.+S.+Lidowauthor=G.+V.+Williamsauthor=P.+S.+Goldman-Rakic&title=The+cerebral+cortex%3A+a+case+for+a+common+site+of+action+of+antipsychotics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLidow%26aufirst%3DM.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DGoldman-Rakic%26aufirst%3DP.%2BS.%26atitle%3DThe%2520cerebral%2520cortex%253A%2520a%2520case%2520for%2520a%2520common%2520site%2520of%2520action%2520of%2520antipsychotics%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1998%26volume%3D19%26spage%3D136%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Calabrese, E. J.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease drugs: an application of the hormetic dose–response model</span> <span class="citation_source-journal">Crit. Rev. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">451</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1080%2F10408440802003991" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=18568864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsFahu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=419-451&author=E.+J.+Calabrese&title=Alzheimer%E2%80%99s+disease+drugs%3A+an+application+of+the+hormetic+dose%E2%80%93response+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38bR"><div class="casContent"><span class="casTitleNuber">38b</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's Disease Drugs: An Application of the Hormetic Dose-Response Model</span></div><div class="casAuthors">Calabrese, Edward J.</div><div class="citationInfo"><span class="NLM_cas:title">Critical Reviews in Toxicology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">419-451</span>CODEN:
                <span class="NLM_cas:coden">CRTXB2</span>;
        ISSN:<span class="NLM_cas:issn">1040-8444</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  This article provides an evaluation of the dose-response features of drugs that are intended to improve memory, some of which have been used in the treatment of Alzheimer's disease (AD).  A common feature of these drugs is that they act via an inverted U-shaped dose response, consistent with the hormetic dose response model.  This article assesses historical foundations that lead to the development of AD drugs, their dose-response features and how the quant. features of such dose responses affected drug discovery and development, and the successes and possible failures of such agents in preclin. and clin. settings.  This story begins about 150 years ago with the discovery of an active agent in the Calabar bean plant called physostigmine, its unfolding medical applications, and its implications for dose-response relationships, memory enhancement, and improved drug discovery activities.  The article also demonstrates the occurrence of U-shaped dose responses for memory with numerous endogenous agonists including neurosteroids, various peptides (e.g., vasopressin, CCK-8, neuropeptide Y), and other agents (e.g., epinephrine, antagonists for platelet activity factor and nicotinic receptors), supporting the generalizability of the hormetic biphasic dose response.  Finally, the significance of the U-shaped dose response is crit. for successful clin. application, since it defines the therapeutic window.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoU_PWZvojlALVg90H21EOLACvtfcHk0lj66nEORTyY9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsFahu7k%253D&md5=b1590655a2d50950decdf417cf72ceae</span></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=10.1080%2F10408440802003991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10408440802003991%26sid%3Dliteratum%253Aachs%26aulast%3DCalabrese%26aufirst%3DE.%2BJ.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%2520drugs%253A%2520an%2520application%2520of%2520the%2520hormetic%2520dose%25E2%2580%2593response%2520model%26jtitle%3DCrit.%2520Rev.%2520Toxicol.%26date%3D2008%26volume%3D38%26spage%3D419%26epage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B3S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B3S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Zasadny, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callahan, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuszpit, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown-Proctor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span> </span><span class="NLM_article-title">FDG-PET imaging provides insights into efficacy and safety for an AMPA receptor potentiator (Abstract)</span> <span class="citation_source-journal">World Mol. Imaging Soc. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_fpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=909&author=K.+Zasadnyauthor=M.+J.+Callahanauthor=K.+Kuszpitauthor=L.+Chenauthor=M.+Skaddanauthor=C.+Brown-Proctorauthor=R.+Harrisauthor=A.+Zhuauthor=C.+L.+Shafferauthor=R.+J.+Scialis&title=FDG-PET+imaging+provides+insights+into+efficacy+and+safety+for+an+AMPA+receptor+potentiator+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DCallahan%26aufirst%3DM.%2BJ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSkaddan%26aufirst%3DM.%26aulast%3DBrown-Proctor%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DR.%26aulast%3DZhu%26aufirst%3DA.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26atitle%3DFDG-PET%2520imaging%2520provides%2520insights%2520into%2520efficacy%2520and%2520safety%2520for%2520an%2520AMPA%2520receptor%2520potentiator%2520%2528Abstract%2529%26jtitle%3DWorld%2520Mol.%2520Imaging%2520Soc.%2520Abstr.%26date%3D2009%26spage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scialis, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandiego, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Cerebral metabolic correlates of ketamine-induced cognitive deficits and their reversal by a positive allosteric modulator of the AMPA receptor: a functional imaging study in the nonhuman primate using FDG-PET (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">883</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=883&publication_year=2009&pages=17&author=G.+V.+Williamsauthor=B.+M.+Robertsauthor=D.+E.+Holdenauthor=D.+W.+Campbellauthor=C.+L.+Shafferauthor=R.+J.+Scialisauthor=P.+A.+Seymourauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=C.+M.+Sandiegoauthor=R.+E.+Carsonauthor=S.+A.+Castner&title=Cerebral+metabolic+correlates+of+ketamine-induced+cognitive+deficits+and+their+reversal+by+a+positive+allosteric+modulator+of+the+AMPA+receptor%3A+a+functional+imaging+study+in+the+nonhuman+primate+using+FDG-PET+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DRoberts%26aufirst%3DB.%2BM.%26aulast%3DHolden%26aufirst%3DD.%2BE.%26aulast%3DCampbell%26aufirst%3DD.%2BW.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DScialis%26aufirst%3DR.%2BJ.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSandiego%26aufirst%3DC.%2BM.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DCerebral%2520metabolic%2520correlates%2520of%2520ketamine-induced%2520cognitive%2520deficits%2520and%2520their%2520reversal%2520by%2520a%2520positive%2520allosteric%2520modulator%2520of%2520the%2520AMPA%2520receptor%253A%2520a%2520functional%2520imaging%2520study%2520in%2520the%2520nonhuman%2520primate%2520using%2520FDG-PET%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2009%26volume%3D883%26spage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Williams, G. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abbott, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honey, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaffer, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandiego, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castner, S. A.</span><span> </span><span class="NLM_article-title">Investigation of the dose-dependent effect of the AMPA potentiator PF-04958242 on cerebral glucose metabolism: significance for development of a PET biomarker for efficacy of procognitive agents in schizophrenia (Abstract)</span> <span class="citation_source-journal">Soc. Neurosci. Abstr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">899</span><span class="NLM_x">, </span> <span class="NLM_fpage">07</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=899&publication_year=2011&pages=07&author=G.+V.+Williamsauthor=A.+L.+Abbottauthor=D.+W.+Campbellauthor=G.+D.+Honeyauthor=C.+L.+Shafferauthor=S.+M.+Osgoodauthor=P.+A.+Seymourauthor=C.+J.+Schmidtauthor=C.+M.+Sandiegoauthor=R.+E.+Carsonauthor=S.+A.+Castner&title=Investigation+of+the+dose-dependent+effect+of+the+AMPA+potentiator+PF-04958242+on+cerebral+glucose+metabolism%3A+significance+for+development+of+a+PET+biomarker+for+efficacy+of+procognitive+agents+in+schizophrenia+%28Abstract%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DG.%2BV.%26aulast%3DAbbott%26aufirst%3DA.%2BL.%26aulast%3DCampbell%26aufirst%3DD.%2BW.%26aulast%3DHoney%26aufirst%3DG.%2BD.%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26aulast%3DOsgood%26aufirst%3DS.%2BM.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSandiego%26aufirst%3DC.%2BM.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DCastner%26aufirst%3DS.%2BA.%26atitle%3DInvestigation%2520of%2520the%2520dose-dependent%2520effect%2520of%2520the%2520AMPA%2520potentiator%2520PF-04958242%2520on%2520cerebral%2520glucose%2520metabolism%253A%2520significance%2520for%2520development%2520of%2520a%2520PET%2520biomarker%2520for%2520efficacy%2520of%2520procognitive%2520agents%2520in%2520schizophrenia%2520%2528Abstract%2529%26jtitle%3DSoc.%2520Neurosci.%2520Abstr.%26date%3D2011%26volume%3D899%26spage%3D07" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Jamei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marciniak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rostami-Hodjegan, A.</span><span> </span><span class="NLM_article-title">The Simcyp population-based ADME simulator</span> <span class="citation_source-journal">Expert Opin. Drug Metab. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">223</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1517%2F17425250802691074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=19199378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1elu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=211-223&author=M.+Jameiauthor=S.+Marciniakauthor=K.+Fengauthor=A.+Barnettauthor=G.+Tuckerauthor=A.+Rostami-Hodjegan&title=The+Simcyp+population-based+ADME+simulator"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Simcyp Population-based ADME Simulator</span></div><div class="casAuthors">Jamei, Masoud; Marciniak, Steve; Feng, Kairui; Barnett, Adrian; Tucker, Geoffrey; Rostami-Hodjegan, Amin</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-223</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The Simcyp population-based absorption, distribution, metab. and excretion simulator is a platform and database for bottom-up' mechanistic modeling and simulation of the processes of oral absorption, tissue distribution, metab. and excretion of drugs and drug candidates in healthy and disease populations.  It combines exptl. data generated routinely during preclin. drug discovery and development from in vitro enzyme and cellular systems and relevant physicochem. attributes of compd. and dosage form with demog., physiol. and genetic information on different patient populations.  The mechanistic approach implemented in the Simcyp Simulator allows simulation of complex absorption, distribution, metab. and excretion outcomes, particularly those involving multiple drug interactions, parent drug and metabolite profiles and time- and dose-dependent phenomena such as auto-induction and auto-inhibition.  This review describes the framework and organization of the simulator and how it combines the different categories of information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbau4KimjnBLVg90H21EOLACvtfcHk0lih8pj-zinnZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1elu7c%253D&md5=11548b35c66fe6f07a917f0718421427</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1517%2F17425250802691074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F17425250802691074%26sid%3Dliteratum%253Aachs%26aulast%3DJamei%26aufirst%3DM.%26aulast%3DMarciniak%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DBarnett%26aufirst%3DA.%26aulast%3DTucker%26aufirst%3DG.%26aulast%3DRostami-Hodjegan%26aufirst%3DA.%26atitle%3DThe%2520Simcyp%2520population-based%2520ADME%2520simulator%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2009%26volume%3D5%26spage%3D211%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bednar, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeMartinis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowditch, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaudreault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zumpano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, F. R.</span><span> </span><span class="NLM_article-title">The safety and efficacy of PF-04958242 in age-related sensorineural hearing loss: a randomized, double-blind, placebo-controlled, single-dose, crossover study</span> <span class="citation_source-journal">JAMA Otolaryngol.—Head Neck Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_fpage">in press</span><span class="refDoi"> DOI: 10.1001/jamaoto.2015.0791</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1001%2Fjamaoto.2015.0791" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=in+press&author=M.+M.+Bednarauthor=N.+DeMartinisauthor=A.+Banerjeeauthor=S.+Bowditchauthor=F.+Gaudreaultauthor=L.+Zumpanoauthor=F.+R.+Lin&title=The+safety+and+efficacy+of+PF-04958242+in+age-related+sensorineural+hearing+loss%3A+a+randomized%2C+double-blind%2C+placebo-controlled%2C+single-dose%2C+crossover+study&doi=10.1001%2Fjamaoto.2015.0791"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1001%2Fjamaoto.2015.0791&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaoto.2015.0791%26sid%3Dliteratum%253Aachs%26aulast%3DBednar%26aufirst%3DM.%2BM.%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DBowditch%26aufirst%3DS.%26aulast%3DGaudreault%26aufirst%3DF.%26aulast%3DZumpano%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DF.%2BR.%26atitle%3DThe%2520safety%2520and%2520efficacy%2520of%2520PF-04958242%2520in%2520age-related%2520sensorineural%2520hearing%2520loss%253A%2520a%2520randomized%252C%2520double-blind%252C%2520placebo-controlled%252C%2520single-dose%252C%2520crossover%2520study%26jtitle%3DJAMA%2520Otolaryngol.%25E2%2580%2594Head%2520Neck%2520Surg.%26date%3D2015%26spage%3Din%2520press%26doi%3D10.1001%2Fjamaoto.2015.0791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span>Guide for the Care and Use of Laboratory Animals, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">Institute of Laboratory Animal Resources, National Research Council</span>, <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Guide+for+the+Care+and+Use+of+Laboratory+Animals%2C+7th+ed.%3B+Institute+of+Laboratory+Animal+Resources%2C+National+Research+Council%2C+Washington%2C+DC%2C+1996."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dgov%26sid%3Dliteratum%253Aachs%26jtitle%3DGuide%2520for%2520the%2520Care%2520and%2520Use%2520of%2520Laboratory%2520Animals%26pub%3DInstitute%2520of%2520Laboratory%2520Animal%2520Resources%252C%2520National%2520Research%2520Council%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falcone, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manro, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merchant, K. M.</span><span> </span><span class="NLM_article-title">Pharmacological Characterization of cGMP Regulation by the Biarylpropylsulfonamide Class of Positive, Allosteric Modulators of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">319</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1124%2Fjpet.106.105734" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=319&publication_year=2006&pages=293-298&author=J.+W.+Ryderauthor=J.+F.+Falconeauthor=J.+R.+Manroauthor=K.+A.+Svenssonauthor=K.+M.+Merchant&title=Pharmacological+Characterization+of+cGMP+Regulation+by+the+Biarylpropylsulfonamide+Class+of+Positive%2C+Allosteric+Modulators+of+%CE%B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic+Acid+Receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors</span></div><div class="casAuthors">Ryder, John W.; Falcone, Julie F.; Manro, Jason R.; Svensson, Kjell A.; Merchant, Kalpana M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">319</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">293-298</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biarylpropylsulfonamide class of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) potentiators represented by N-2-(4-(4-cyanophenol)phenol)propyl-2-propanesulfonamide (LY404187) and (R)-4'-[1-fluoro-1-methyl-2-(propane-2-sulfonylamino)-ethyl]-biphenyl-4-carboxylic acid methylamide (LY503430) are pos., allosteric AMPA receptor activators, which enhance AMPA receptor-mediated neurotransmission by reducing desensitization of the ion channel.  Although these compds. have efficacy in in vivo rodent models of cognition, depression, and Parkinson's disease, little is known about biochem. pathways activated by these agents.  Given the well established regulation of the nitric oxide/cGMP pathway by excitatory neurotransmission, the current study characterized AMPA receptor potentiator-mediated cGMP response in mouse cerebellum.  Acute treatment by both LY404187 and LY503430 [2.0, 5.0, or 10 mg/kg s.c.] elevated basal cerebellar cGMP levels in a dose-dependent manner.  Pretreatment with the noncompetitive, allosteric AMPA receptor-selective antagonist 7H-1,3-dioxolo[4,5-h][2,3]benzodiazepine-7-carboxamide, 5-(4-aminophenyl)-8,9-dihydro-N,8-dimethyl-monohydrochloride-(9CI) (GYKI 53655) [3.0 mg/kg i.p.], completely blocked the effect of LY404187, demonstrating that activation of AMPA receptors induces cGMP levels.  Interestingly, pretreatment with the N-methyl-D-aspartate (NMDA) open channel blocker dizocilpine (0.3 and 1.0 mg/kg i.p.) also abolished the AMPA receptor potentiator-mediated cGMP accumulation, indicating that activation of AMPA receptors leads to NMDA receptor-mediated transmission involved in cGMP regulation.  Pharmacol. augmentation of the endogenous glutamate tone via the alkaloid harmaline (20-60 mg/kg i.p.) synergized with AMPA potentiator activity and provided further direct evidence of in vivo allosteric activation of AMPA receptors by LY404187.  The synergism between harmaline and LY404187 was specific, since cGMP accumulation induced by foot-shock stress was not augmented by the AMPA receptor potentiator.  Taken together, these data indicate that the cGMP system may play an important role in pharmacol. efficacy of the biarylpropylsulfonamide class of AMPA receptor potentiators.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoeZVDKiSOi7LVg90H21EOLACvtfcHk0lih8pj-zinnZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCksLrO&md5=e1fff3ab717a74321b389e96ea575889</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.105734&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.105734%26sid%3Dliteratum%253Aachs%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DFalcone%26aufirst%3DJ.%2BF.%26aulast%3DManro%26aufirst%3DJ.%2BR.%26aulast%3DSvensson%26aufirst%3DK.%2BA.%26aulast%3DMerchant%26aufirst%3DK.%2BM.%26atitle%3DPharmacological%2520Characterization%2520of%2520cGMP%2520Regulation%2520by%2520the%2520Biarylpropylsulfonamide%2520Class%2520of%2520Positive%252C%2520Allosteric%2520Modulators%2520of%2520%25CE%25B1-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic%2520Acid%2520Receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2006%26volume%3D319%26spage%3D293%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Dunham, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miya, T. S.</span><span> </span><span class="NLM_article-title">A note on a simple apparatus for detecting neurological deficit in rats and mice</span> <span class="citation_source-journal">J. Am. Pharm. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">XLVI</span><span class="NLM_x">, </span> <span class="NLM_fpage">208</span><span class="NLM_x">–</span> <span class="NLM_lpage">209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=XLVI&publication_year=1957&pages=208-209&author=N.+W.+Dunhamauthor=T.+S.+Miya&title=A+note+on+a+simple+apparatus+for+detecting+neurological+deficit+in+rats+and+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDunham%26aufirst%3DN.%2BW.%26aulast%3DMiya%26aufirst%3DT.%2BS.%26atitle%3DA%2520note%2520on%2520a%2520simple%2520apparatus%2520for%2520detecting%2520neurological%2520deficit%2520in%2520rats%2520and%2520mice%26jtitle%3DJ.%2520Am.%2520Pharm.%2520Assoc.%26date%3D1957%26volume%3DXLVI%26spage%3D208%26epage%3D209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Kiss, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawabe, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milici, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsen, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajós, M.</span><span> </span><span class="NLM_article-title">Role of thalamic projection in NMDA receptor-induced disruption of cortical slow oscillation and short-term plasticity</span> <span class="citation_source-journal">Front. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.3389%2Ffpsyt.2011.00014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=1-12&author=T.+Kissauthor=W.+E.+Hoffmanauthor=L.+Scottauthor=T.+T.+Kawabeauthor=A.+J.+Miliciauthor=E.+A.+Nilsenauthor=M.+Haj%C3%B3s&title=Role+of+thalamic+projection+in+NMDA+receptor-induced+disruption+of+cortical+slow+oscillation+and+short-term+plasticity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.3389%2Ffpsyt.2011.00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffpsyt.2011.00014%26sid%3Dliteratum%253Aachs%26aulast%3DKiss%26aufirst%3DT.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DScott%26aufirst%3DL.%26aulast%3DKawabe%26aufirst%3DT.%2BT.%26aulast%3DMilici%26aufirst%3DA.%2BJ.%26aulast%3DNilsen%26aufirst%3DE.%2BA.%26aulast%3DHaj%25C3%25B3s%26aufirst%3DM.%26atitle%3DRole%2520of%2520thalamic%2520projection%2520in%2520NMDA%2520receptor-induced%2520disruption%2520of%2520cortical%2520slow%2520oscillation%2520and%2520short-term%2520plasticity%26jtitle%3DFront.%2520Psychiatry%26date%3D2011%26volume%3D2%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Cox, R. W.</span><span> </span><span class="NLM_article-title">AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</span> <span class="citation_source-journal">Comput. Biomed. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">162</span><span class="NLM_x">–</span> <span class="NLM_lpage">173</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=10.1006%2Fcbmr.1996.0014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=8812068" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A280%3ADyaK28vgvVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1996&pages=162-173&author=R.+W.+Cox&title=AFNI%3A+software+for+analysis+and+visualization+of+functional+magnetic+resonance+neuroimages"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">AFNI: software for analysis and visualization of functional magnetic resonance neuroimages</span></div><div class="casAuthors">Cox R W</div><div class="citationInfo"><span class="NLM_cas:title">Computers and biomedical research, an international journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">162-73</span>
        ISSN:<span class="NLM_cas:issn">0010-4809</span>.
    </div><div class="casAbstract">A package of computer programs for analysis and visualization of three-dimensional human brain functional magnetic resonance imaging (FMRI) results is described.  The software can color overlay neural activation maps onto higher resolution anatomical scans.  Slices in each cardinal plane can be viewed simultaneously.  Manual placement of markers on anatomical landmarks allows transformation of anatomical and functional scans into stereotaxic (Talairach-Tournoux) coordinates.  The techniques for automatically generating transformed functional data sets from manually labeled anatomical data sets are described.  Facilities are provided for several types of statistical analyses of multiple 3D functional data sets.  The programs are written in ANSI C and Motif 1.2 to run on Unix workstations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpCKGKbuk0ozToTC3aBaesfW6udTcc2eaAiTlooKKF9bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vgvVChug%253D%253D&md5=23dbf7895a72f130092406163664ed25</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1006%2Fcbmr.1996.0014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fcbmr.1996.0014%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DR.%2BW.%26atitle%3DAFNI%253A%2520software%2520for%2520analysis%2520and%2520visualization%2520of%2520functional%2520magnetic%2520resonance%2520neuroimages%26jtitle%3DComput.%2520Biomed.%2520Res.%26date%3D1996%26volume%3D29%26spage%3D162%26epage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Obach, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baxter, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silber, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rance, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wastall, P.</span><span> </span><span class="NLM_article-title">The Prediction of Human Pharmacokinetic Parameters from Preclinical and in Vitro Metabolism Data</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">46</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=9336307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;key=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1997&pages=46-58&author=R.+S.+Obachauthor=J.+G.+Baxterauthor=T.+E.+Listonauthor=B.+M.+Silberauthor=B.+C.+Jonesauthor=F.+MacIntyreauthor=D.+J.+Ranceauthor=P.+Wastall&title=The+Prediction+of+Human+Pharmacokinetic+Parameters+from+Preclinical+and+in+Vitro+Metabolism+Data"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49aR"><div class="casContent"><span class="casTitleNuber">49a</span><div class="casTitle"><span class="NLM_cas:atitle">The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data</span></div><div class="casAuthors">Obach, R. Scott; Baxter, James G.; Liston, Theodore E.; Silber, B. Michael; Jones, Barry C.; Macintyre, Flona; Rance, David J.; Wastall, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">283</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">46-58</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with 35 refs.  We describe a comprehensive retrospective anal. in which the abilities of several methods by which human pharmacokinetic parameters are predicted from preclin. pharmacokinetic data and/or in vitro metab. data were assessed.  The prediction methods examd. included both methods from the scientific literature as well as some described in this report for the first time.  Four methods were examd. for their ability to predict human vol. of distribution.  Three were highly predictive, yielding, on av., predictions that were within 60% to 90% of actual values.  Twelve methods were assessed for their utility in predicting clearance.  The most successful allometric scaling method yielded clearance predictions that were, on av., within 80% of actual values.  The best methods in which in vitro metab. data from human liver microsomes were scaled to in vivo clearance values yielded predicted clearance values that were, on av., within 70% to 80% of actual values.  Human t1/2 was predicted by combining predictions of human vol. of distribution and clearance.  The best t1/2 prediction methods successfully assigned compds. to appropriate dosing regimen categories (e.g., once daily, twice daily and so forth) 70% to 80% of the time.  In addn., correlations between human t1/2 and t1/2 values from preclin. species were also generally successful (72-87%) when used to predict human dosing regimens.  In summary, this retrospective anal. has identified several approaches by which human pharmacokinetic data can be predicted from preclin. data.  Such approaches should find utility in the drug discovery and development processes in the identification and selection of compds. that will possess appropriate pharmacokinetic characteristics in humans for progression to clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppAngniZ4izLVg90H21EOLACvtfcHk0lhJq38K6sxNPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmslCltr0%253D&md5=68d1910d925e26ec4a8ef23043ffb1ed</span></div><a href="/servlet/linkout?suffix=cit49a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DBaxter%26aufirst%3DJ.%2BG.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DSilber%26aufirst%3DB.%2BM.%26aulast%3DJones%26aufirst%3DB.%2BC.%26aulast%3DMacIntyre%26aufirst%3DF.%26aulast%3DRance%26aufirst%3DD.%2BJ.%26aulast%3DWastall%26aufirst%3DP.%26atitle%3DThe%2520Prediction%2520of%2520Human%2520Pharmacokinetic%2520Parameters%2520from%2520Preclinical%2520and%2520in%2520Vitro%2520Metabolism%2520Data%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D283%26spage%3D46%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit49b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Brown, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houston, J. B.</span><span> </span><span class="NLM_article-title">Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=293-301&author=H.+S.+Brownauthor=M.+Griffinauthor=J.+B.+Houston&title=Evaluation+of+cryopreserved+human+hepatocytes+as+an+alternative+in+vitro+system+to+microsomes+for+the+prediction+of+metabolic+clearance"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DH.%2BS.%26aulast%3DGriffin%26aufirst%3DM.%26aulast%3DHouston%26aufirst%3DJ.%2BB.%26atitle%3DEvaluation%2520of%2520cryopreserved%2520human%2520hepatocytes%2520as%2520an%2520alternative%2520in%2520vitro%2520system%2520to%2520microsomes%2520for%2520the%2520prediction%2520of%2520metabolic%2520clearance%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2007%26volume%3D35%26spage%3D293%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5','PDB','4LZ5'); return false;">PDB: 4LZ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X48" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X48','PDB','4X48'); return false;">PDB: 4X48</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/acs.jmedchem.5b00300">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_45837"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures and characterization data for <b>3</b> and <b>6</b>–<b>28</b>, single X-ray crystallography data for <b>3</b>, X-ray data collection and refinement statistics for protein/ligand complexes, summary of electrophysiology experiments with <b>3</b> in rat primary cortical neurons, and preclinical pharmacokinetics and biotransformation data for <b>3</b>. The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b00300">10.1021/acs.jmedchem.5b00300</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b00300/suppl_file/jm5b00300_si_001.pdf">jm5b00300_si_001.pdf (553.55 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors have been deposited to the Protein Data Bank for human GluA2o complexes of <b>5</b> (LY451646) (ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4LZ5">4LZ5</a>) and <b>3</b> (PF-04958242) (ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4X48">4X48</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b00300&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b00300%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-10%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b00300" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994b8fb970221c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
